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ABSTRACT

Grabowski, Jeffrey M. Ph.D., Purdue University, August 2015. Tick-Flavivirus
Interactions: Discovery of Host Proteins That Are Affected in Virus Infection.
Major Professors: Catherine A. Hill and Richard J. Kuhn.
Tick-borne flavivirus (TBF) infections cause morbidity and mortality
worldwide. A primary goal of vector-borne disease research is to identify ways to
prevent pathogen and parasite transmission. The black-legged tick, Ixodes
scapularis, is the only tick species with a sequenced and annotated genome and
is a vector of TBFs. This project utilizes Langat virus (LGTV) to model TBF infection
in I. scapularis ISE6 cells. The aims were to (1) characterize the LGTV-ISE6
system, (2) discover differentially-expressed proteins associated with LGTV
infection, and (3) identify key genes of interest that were involved in LGTV infection.
Two proteomic analyses by LC-MS/MS identified 486 and 579 ISE6 proteins (total
of 764 ISE6 proteins combined). First and second proteomic analyses identified
68 and 246 ISE6 proteins with increased expression and 198 and 188 ISE6
proteins with decreased expression, respectively. Greater than 265 ISE6 proteins
were mapped to cellular function/pathways using Kyoto Encyclopedia of Genes
and Genomes (KEGG). Greater than 221 ISE6 proteins were identified with no
KEGG function/pathway. After filtering based on strength of protein identification,
cellular function/pathway involvement, and an increased expression following

xii
LGTV infection, ten proteins were selected. Ten selected proteins/genes of interest
included eight with known function (Fumar, ERP29, DPCD, CNHydro, MDH2,
PARP, CUKinase, and ACAT1) and two with unknown function (Hypo195 and
Hypo576). RNA interference knockdown assays were established in ISE6 cells to
determine effect on LGTV infection. Inhibition of genes of interest involved in
cellular amino acid, carbohydrate/lipid, and cofactor/vitamin metabolism as well as
unknown proteins were shown to affect LGTV genome replication and replication.
In addition, LGTV replication was reduced by perturbing ISE6 metabolic function
using trichostatin A and oligomycin A and glutamate metabolic function using
hexachlorophene and epicatechin gallate small molecules in compound assays.
This research suggested that carbohydrate and amino acid metabolic enzymes
were involved in LGTV infection in the tick vector and possibly for transmission.
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CHAPTER 1: INTRODUCTION

1.1 THE IXODIDAE (HARD TICKS) AS VECTORS OF PARASITES AND
PATHOGENS
Hard ticks (Phylum Arthropoda, Subphylum Chelicerata, Subclass Acari,
Superorder Parasitiformes, Order Ixodida, Family Ixodidae) are pests of global
medical and veterinary importance. These obligate ectoparasites transmit a wide
variety of viruses, bacteria and protozoa to humans and animals. Examples of tickborne disease affecting human health include babesiosis, caused by the parasite
Babesia microti [1], Lyme disease, caused by the bacterium Borrelia burgdorferi
[2], Rocky Mountain spotted fever, caused by the bacterium Rickettsia rickettsii [3],
and granulocytic anaplasmosis, caused by Anaplasma phagocytophilum [4]. In
addition, domesticated animals can be at risk from borreliosis, babesiosis, spotted
fever, ehrichiosis caused by Ehrlichia species, and hepatozoonosis caused by
hepatozoon species [5].

In North America, the tick-borne flavivirus (TBF)

Powassan virus (POWV) and its genotype Deer Tick virus (DTV) can cause
meningitis and encephalitis in humans and potentially in domestic animals [6, 7].
1.2 IXODES SCAPULARIS; GEOGRAPHIC DISTRIBUTION, LIFE CYCLE, AND
DISEASE TRANSMISSION
In United States (U.S.A.), I. scapularis tick is found east of the Rocky
Mountains from Canada to Florida, and west to the state of Texas. High
populations of I. scapularis occur in the upper Midwest and northeast states
primarily [8-11].
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Ixodes scapularis has a two year life cycle in the wild with four
developmental stages: egg, larva, nymph, and adult. It is considered a three host
tick as the larva, nymph, and adult feed to repletion on different hosts before
molting to the next lifestage [12]. Larvae and nymphs feed primarily in the spring
and throughout summer on small mammals, reptiles, or birds [13, 14]. Adults feed
primarily in the fall on larger mammals such as deer, fox, raccoon, etc and mate
during this time. After feeding, adult females drop from the host and lay thousands
of eggs that then hatch in the following spring. The nymph and adult stages
(primarily adult females) are primarily responsible for transmission of Lyme
disease and other tick-borne diseases.
Ixodes scapularis is a competent vector for a number of protozoa, bacteria,
and viruses that cause disease including Babesia microti, Anaplasma spp bacteria,
Borrelia spp bacteria, and POWV/DTV in the U.S.A. [15-18]. The acquisition of
parasite and bacteria can occur with the larvae or nymph blood meal, making the
subsequent stage infective. POWV/DTV can be acquired by transovarial
transmission and therefore the larva, nymph, and adult stages may be infected
and capable of virus transmission.
1.3 TBFS
TBFs are a complex of 10-11 kb single-stranded, ribonucleic acid (RNA)
viruses that cause high human morbidity and mortality [19]. Of the family
Flaviviridae and genus Flavivirus, TBFs have ten proteins that are translated as a
polyprotein and cleaved by a combination of host and viral proteases. Three
structural proteins consist of the capsid (C), membrane (M), and envelope (E)
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proteins. Seven nonstructural proteins consist of the nonstructural protein 1 (NS1),
nonstructural protein 2A (NS2A), nonstructural protein 2B (NS2B), nonstructural
protein 3 (NS3), nonstructural protein 4A (NS4A), and nonstructural protein (NS4B).
Many exotic TBFs are identified on the Centers for Disease Control and
Prevention “Select Biological Agents and Toxins” list (http://www.selectagents.gov/)
as they have the potential to become established zoonotic diseases in the U.S.A.
and they are considered possible bioterrorism agents [20]. TBFs result in
hemorrhagic fever and encephalitis, and are transmitted to human via bite of
infected Ixodes species tick [21-23].
Tick-borne encephalitis virus (TBEV) is arguably one of the most important
TBFs, and has been reported in Europe, the Far East, and Siberia. Mansfield et al
reported a 400% increase in TBEV cases in Europe from 1974 to 2003 [23]. The
geographic range of TBEVs may be changing as several TBEVs have recently
been reported from a number of “non-endemic” regions, including Norway in 2004
[24]. Each year more than 10,000 cases of TBEV are reported globally. TBEVassociated case fatality rates range from 10-40%. Additionally, survivors of TBEV
infection have a high incidence of permanent neurological sequelae. The actual
incidence of TBEV is thought to be much higher as many cases are presumably
undiagnosed [23, 25]. TBEV is classified as biosafety level 4 (BSL-4), and
consequently, most research aimed at understanding TBFs have been conducted
using less pathogenic TBFs other than TBEV. Effective prophylactic anti-TBEV
vaccines [26] have been developed in the past but there is no direct treatment for
infection.
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The POWV is the only TBF documented in the U.S.A. POWV can cause
encephalitis in humans and domesticated animals, specifically horses, and in rare
cases, dogs [27]. The virus was first discovered in 1958. POWV is of considerable
concern because the virus has a high case fatality rate of 10-15% [28] in humans.
However, confirmed human cases of POWV infection are low in comparison to
WNV and other mosquito-borne arboviruses. From 2004 to 2013, an average of
six to seven POWV neuroinvasive diseases cases were reported and fifteen
confirmed

cases

were

reported

from

2013-2014

(CDC;

cdc.gov/powassan/statistics; diseasemaps.usgs.gov/). Diagnostic testing is limited
for POWV in patients with symptoms of encephalitis. The incidence rate of POWV
infection in the U.S.A. is seriously misjudged [29, 30] and more recognition and
treatment of this emerging viral infection is necessary. The POWV/DTV has no
anti-viral vaccine or specific therapy for treatment. In addition, survivors have a
high rate (approximately 50-55% of confirmed cases of infection) of permanent,
recurring neurological problems [22]. This situation is similar with DTV, which is
also prevalent in mammal reservoirs and transmitted by I. scapularis [31]. Both
POWV and DTV are classified as BSL-3, limiting research on these viruses to a
small number of approved facilities.
Langat (LGTV) virus is classified as BSL-2 and is widely used as a model
for TBF research. LGTV is vectored by Ixodes grandulatus and Haemaphysalis
spp. ticks and the natural mammal reservoir is forest rats (Fig 1; [20]). It can cause
encephalitis in humans and animals (although LGTV has a low virulence in human
beings). LGTV is thought to have originated in either Malaysia, Thailand, or Siberia
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[32]. Human disease cases of LGTV infection have not been reported but LGTVantibodies have been detected in blood samples collected off individuals living in
endemic regions [20, 23]. In the 1970s, LGTV was used successfully as a live
vaccine for TBEV, but its use was terminated when it was discovered that the
vaccine caused encephalitis in approximately 1:10,000 vaccinated individuals [21].
1.4 PATHOGENESIS OF TBFS IN THE MAMMALIAN HOST AND TICK
VECTOR
1.4.1 TBF life cycle
The flavivirus life cycle begins when the virus binds to the cell surface where
receptor-mediated endocytosis occurs with the virus entering the cell in an
endocytic vacuole [33]. Fusion of the viral membrane with the endosomal
membrane results in the uncoating of the viral nucleocapsid, which releases viral
RNA into the cell cytoplasm. Protein translation occurs forming a single polyprotein
formed in the cytoplasm and is intertwined within endoplasmic reticulum (ER)
membrane. Viral genome replication occurs on the ER membrane [34] in
replication complexes. Virus assembly and the viral envelope formation occurs
within the ER and appears as “budding” under electron microscopy imaging. The
immature (noninfectious) viruses bud into the ER and move through the transGolgi network (TGN), where eventually they are cleaved by a host protease [35].
This cleavage creates mature (infectious) viruses, which then exit the host cell
through exocytosis.
It has been found that TBF maturation differs between mammalian and tick
cells. A key difference is that TBEV particles have been detected in the Golgi
apparatus in mammalian cells, but were not detected in the Golgi apparatus and
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detected in the lumen of vacuoles [36] in tick cells. Yoshii et al has shown that
TBEV envelope (E) glycosylation, a modification required in the secretory process
of virions in mammalian cells, does not affect infectious TBEV release from tick
cells [37]. In addition, inhibiting transport to the Golgi apparatus from the ER
affected TBEV release in mammalian cells, but not in tick cells. The model for the
TBF life cycle in mammalian and tick cells is shown in Fig 2.
1.4.2 Mammalian host
TBFs first invade epithelial cells at the site of introduction from the bite of
an infected tick. Eventually, the virus drains into the lymph nodes and systemic
infection ensues [25]. TBFs are neurotropic where neurons are the primary cell
type infected [38]. Infection of the brain, spinal cord, and meninges results in
encephalitic and meningitis symptoms.
1.4.3 Tick vector
Once a tick stage takes a blood meal that contains infectious TBF, infection
of the midgut tissue occurs and subsequently, invasion of the hemolymph and
salivary glands. Mitzel et al identified that LGTV titer is an additional factor that
determines infection within the I. scapularis larva [39]. No reduction in survival of
I. scapularis larvae occurs with LGTV infection, which suggests that TBF infection
is not detrimental to tick life stages. LGTV initially infects midgut tissue
approximately three days post LGTV exposure and secondary organs (including
salivary glands) at approximately ten days post LGTV exposure. Transstadial and
transovarial transmission of LGTV and POWV can occur within I. scapularis where
larvae, nymphs, and adult ticks can be infected [40, 41].
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1.5 IXODES SCAPULARIS GENOMIC RESOURCES
The only sequenced and assembled tick genome is that of the black-legged
tick, I. scapularis, available from Genbank, that currently contains 20,486 gene
models predicted via a combination of ab initio methods and manual curation [42,
43]. This assembly has been an important resource used to understand both tick
biology and tick-borne pathogenesis at the molecular level. Mining this genome
assembly has also allowed for identification of new targets for tick control.
1.6 TICK CELL LINES AND I. SCAPULARIS ISE6 CELLS
Development of tick cell lines are a valuable tool for studies of tick-borne
pathogenesis [44, 45]. Tick cells have been used extensively to explore tick-borne
bacterial pathogenesis [46-50]. Tick cell lines have also been utilized as models to
explore responses to tick-borne viruses [51, 52]. The I. scapularis ISE6 cell line
and the model TBF LGTV was used to form an in vitro TBF pathogenesis model
here. One disadvantage of using tick cell lines is possible contamination with
endogenous tick-borne bacteria or viruses. The I. scapularis IDE8 cell line is known
to have an endogenous orbivirus, St. Croix River virus [53] and virus-like particles
have been observed in other tick cell lines as well [54]. Coinfection in tick cell lines
with some pathogens has shown variable effects on pathogen replication [55].
Overall, this emphasizes that proper experimental controls need to be developed
before conducting TBF research with tick cells.
1.7 IDENTIFICATION OF HOST CELL FACTORS INVOLVED IN TBF
INFECTION
Research has shown that proteins and metabolites produced by human [56,
57] and mosquito [58-61] cells (i.e., “host-cell factors”) may facilitate or play roles
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in flaviviral infection [62-65]. The mechanisms by which these molecules contribute
to the replication of flaviviruses are not well understood. Human host cell factors
have been identifed with Hepatitis C virus (HCV), Dengue virus (DENV), and West
Nile virus (WNV); however, little is known regarding factors involved in flaviviral
infection in the vector. Studies conducted in Drosophila and a number of mosquito
species [58, 62, 66] have identified host factors. However, there has been little
attention directed towards understanding host factors in the tick system. Studies
dealing with whole tick and tick cells infected with the tick-borne pathogens
Anaplasma spp. and Rickettsia montanensis have shown differentially-regulated
genes and differentially-expressed proteins in response to infection [50, 67-71].
These studies give insight into genes and proteins that are upregulated/increased
expression or downregulated/decreased expression from a pathogen infection,
respectively.
Little work has been done to identify factors produced by the arthropod or
mammalian host in response to TBF infection. Many studies have focused on
factors produced by mosquitoes in response to flaviviruses. However, there is
significant variation between the genomes and host specificities of TBFs and
mosquito-borne flaviviruses. Studies have also investigated global changes in the
transcriptome in I. scapularis and in tick cells following LGTV infection [72],
although there is little known about how these responses correlate to changes at
the protein level. Tick proteins that facilitate viral infection and replication in the
arthropod vector are logical targets for interventions aimed at disrupting
transmission of TBF.
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1.8 PROTEOMIC ANALYSES OF HARD TICKS
A useful tool includes proteomics, used to understand protein expression
and has the utility for improving genome annotations. High throughput proteomic
analyses have identified cellular pathways/functions associated with basic tick
physiology, such as host attachment and blood feeding [73]. Recently, proteomic
analyses of the I. scapularis ISE6 and IDE12 cell lines, and synganglia have
identified neuronal proteins suggesting ISE6 cells may be a potential in vitro model
of the tick synganglia/neurons. Proteomics has also been used to investigate
interactions between ticks (including tick cells) and bacterial pathogens [70, 71, 74,
75]. Currently, there is limited understanding of how tick protein expression
changes following TBF infection.
1.9 THE NEED FOR DEVELOPMENT OF NEW STRATEGIES AGAINST TBFS
One of the biggest challenges in vector biology and the long-term goal of
this research is to identify new ways to prevent transmission of TBFs. There are
currently no anti-tick vaccines or anti-viral drugs against TBFs [76, 77] and there
is limited research to understand the infection process of TBFs in the tick vector.
This gap in our knowledge base is an impediment to the development of new
strategies against TBFs.
Historically, developing arthropod control approaches have focused on
neuronal proteins, enzymes, and receptors. More recently, attention has shifted to
novel pest control approaches such as those employing RNAi transcript
knockdown

of

genes

in

the

invertebrate

[Macron,

Doug;

http://www.genomeweb.com/rnai/monsanto-moves-four-rnai-products-through-
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pipeline-posts-improved-fiscal-first-q]. RNAi transcript knockdown to identify
genes of interest in ticks implicated in bacterial pathogenesis has been undertaken
[78, 79]. Genome assemblies are an important source of sequence information but
a significant proportion of the gene and conceptual protein repertoire produced by
automated annotation of arthropod genomes are considered “orphan” sequences,
or proteins of no known function. These orphan proteins are a potential source of
novel targets for traditional chemical pesticide development and RNAi-based pest
control as they may potentially be unique to the arthropod vector. The impact of
experimentally-identified, tick proteins will allow for identification of potential
control targets against TBF infection and the tick itself.
An approach to translate the research herein may rely on the use of proteins
from this study as antigens to screen to identify small, inhibitory compounds. It was
hypothesized that the inhibition/knockdown of tick proteins/genes of interest
involved in TBF infection will reduce virus infection and production of progeny virus
spread. Upon the identification of involved tick proteins in viral infection, the goal
is to use specific therapeutic products (antigen development, small molecules,
proteins/peptides, RNAi-based molecules, etc) to disrupt TBF transmission. It is
feasible to first identify a select few proteins/genes of interest involved in TBF
infection within a tick cell line and then to confirm these proteins are involved in
TBF infection with in vivo studies using whole ticks (Fig 3).
1.10 OVERVIEW OF THESIS RESEARCH
The goal of this project was to discover I. scapularis proteins involved in
TBF infection in the cell. The study focused on development, characterization, and

11
analysis of the LGTV-ISE6 cell line model using proteomics to identify tick protein
expression levels following LGTV infection. The rationale was that some of these
proteins were involved in viral infection in the cell and whole tick and were thus
logical targets for strategies to disrupt virus transmission. Overall, it was
hypothesized that ISE6 cell proteins with increased expression following LGTV
infection were involved in LGTV infection. The aims were (1) to establish a
proteomic screen to identify tick proteins associated with TBF infection, (2) to
characterize tick cellular pathways and functions of tick proteins with altered
expression following TBF infection, and (3) to determine key tick proteins involved
in TBF infection.
This multidisciplinary, collaborative project was the first to investigate how
flaviviruses perturb the tick proteome. This work was expected to have a broad
scientific impact as it will provide an essential basis to understand the molecular
processes that operate in tick cells during infection by TBFs. The findings may lead
to better medicine to control flavivirus infections, better tick control strategies,
improved public health, and countermeasures to protect against bioterrorism. In
addition, it was an integral component of an ongoing international effort to
understand TBF pathogenesis and analyze the I. scapularis genome.
Chapter 2 introduces the establishment of the LGTV-ISE6 cell model
system. This chapter describes the ISE6 cell growth, LGTV growth within ISE6
cells, creation of a noninfectious LGTV control, effect on cell population numbers
following LGTV infection, effect on cell viability following LGTV infection, and effect
on cell mortality following LGTV infection. Chapter 3 describes two high throughput
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proteomic analyses, a differential and quantitative analysis, to identify hundreds of
ISE6 proteins with changing expression following LGTV infection associated with
cellular pathways. Comparative proteomic analysis to other flavivirus-host systems
were presented as well as cellular pathway changes at different time points
following LGTV infection, and lysine acetylation of ISE6 proteins associated with
LGTV infection. Chapter 4 describes small molecule compound and RNA
interference assays to inhibit a subset of ISE6 proteins (discovered from Chapter
3) with increased expression following LGTV infection and identify tick molecular
pathways involved in LGTV infection.
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1.11 FIGURES, TABLES, AND LEGENDS

Fig 1. Natural transmission cycle of LGTV. LGTV is a zoonotic pathogen and is
naturally transmitted by Ixodes and Haemaphysalis hard tick species to forest rats.
Rats are the mammalian reservoir for LGTV. Incidental hosts include humans.
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Fig 2. LGTV life cycle within the cell. Stages of the LGTV life cycle predicted in
the mammalian and tick cell. Red box denotes a different LGTV egress route
suggested in the cell tick, but not in the mammalian cell. Black circles denote
cellular ribosomes. Blue lines denote positive strand, LGTV RNA genomes.
Orange lines denote negative strand, LGTV RNA genomes used as a template for
further positive strand, LGTV RNA genome production. Red circles denote viral
proteins in association with replication complexes on/in the ER. Purple
particles/virions denote immature LGTV before prM-furin cleavage. Green circles
denote furin, which cleaves pr from prM, creating mature LGTV. Pre-membrane=
prM.
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Fig 3. Schematic showing key steps proposed in the translational research
pipeline to identify tick proteins to use for development of therapeutics and
anti-tick vaccines. Proposed pipeline to identify ISE6 proteins involved with LGTV
infection from the present study. Selected proteins can be pursued via functional
studies and investigated for potential development of antigens or therapeutics
against TBF infection. Selected proteins need to be characterized with in vivo
studies in the whole tick to confirm reduced transmission of TBF.
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CHAPTER 2: CHARACTERIZATION OF ACUTE LGTV INFECTION IN I.
SCAPULARIS ISE6 CELLS

2.1 INTRODUCTION
Tick cell lines have become appropriate models for tick-borne pathogen
research [46, 51, 52, 80], especially to identify molecular components involved in
pathogen infection. LGTV infections have been carried out in ISE6 cells before to
characterize virus replication [81-83], hence ISE6 cells make an effective model
for proteomic-based analyses studying tick protein responses with TBF infection.
Identifying tick protein changes following TBF infection in ISE6 cells first
requires characterization of the ISE6-LGTV system (Fig 1). For this study,
characterization involves (1) identifying ISE6 cell growth, (2) LGTV growth within
ISE6 cells, (3) effect on cell population numbers following LGTV infection, (4) effect
on cell viability following post LGTV infection, and effect on cell mortality following
LGTV infection. It was hypothesized that ISE6 cell viability would not change with
LGTV infection in comparison with mock (uninfected) treatment. Characterizing the
biological response of the tick cells to LGTV infection was a necessary prerequisite
for proteomic analyses.
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2.2 MATERIALS AND METHODS
2.2.1 Cell and virus culture
Ixodes scapularis embryonic ISE6 cells (provided by T. Kurtti, University of
Minnesota, Minneapolis, MN) were cultured at 34°C in L15B-300 media in the
absence of CO2 [44, 45]. Baby hamster kidney 15 (BHK15) cells, used for plaque
assay and immunofluorescent focus assay (IFA), were cultured with at 37°C in
Minimum Essential Media (MEM) supplemented with L-glutamine, non-essential
amino acids (NEAA), and 10% heat-inactivated fetal calf serum (FCS) with 5%
CO2. Green African monkey kidney Vero cells, used to create LGTV stock and for
IFA to determine LGTV stock titer, were cultured at 37°C in MEM supplemented
with L-glutamine, NEAA and 10% heat-inactivated FCS with 5% CO2. LGTV TP21
wildtype strain, passage 2 (obtained from A. Pletnev, NIH-NAID, Bethesda, MD
[84]) stock was amplified in Vero cells (multiplicity of infection 0.01) [85] and grown
as described above, except with 2.5% heat-inactivated FCS, up to passage 4 (p4)
to provide a working stock for experimental infections. Serial IFAs were conducted
in parallel as previously described [86] in 96-well cell culture plates to determine
LGTV stock titers.
2.2.2 Measurement of ISE6 cell concentrations
The concentration of cells in each sample (cells/ml) was estimated by
counting cell number on a Scepter 2.0 Automated Cell Counter with 40 µM Scepter
sensors (EMD Millipore; PHCC20040) in order to equalize cell numbers between
biological replicates and between treatment groups prior to protein extraction. For
cell growth analyses, initial cell counts (cells/mL) were determined manually using
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a hemocytometer and subsequently verified by sample analysis on the Scepter 2.0
Automated Cell Counter.
2.2.3 LGTV infection in ISE6 cells and measurement of infectious LGTV
As described in Grabowski et al [87], serial plaque assays were performed
using BHK cells to assess LGTV growth and replication via plaque development.
Media collected from culture of LGTV-infected mammalian or tick cells was serially
diluted ten-fold in PBS++ (calcium and magnesium) and adsorbed for one hour onto
~80% confluent BHK cells in 6 well cell culture plates. An agarose overlay infused
with a 2X MEM, 5% FCS and 2% agarose was added following adsorption.
Following solidification of agarose, MEM and 2.5% calf serum was added, and
plates were incubated at 37°C in 5% CO2. Plaque formation was assessed 4-5
days-post infection (dpi) and cells were stained with ~4% Neutral Red solution
(Sigma-Aldrich; T6567).
Serial immunofluorescent focus assays were conducted in parallel as
previously described [86, 88] in 96 well cell culture plates to determine LGTV stock
titers. Ten-fold serial dilutions of media collected from culture of LGTV-infected
cells was adsorbed (50 uL total volume) onto BHK cells for one hour at 37°C in 5%
CO2. An infusion of 1.5% carboxymethylcellulose sodium (CMC) solution
supplemented with 3% MEM with 2.5% fetal calf serum media was added to each
well and plates were incubated for 36 hours post infection at 37°C in 5% CO2. The
CMC and media overlay were removed and cells were rinsed five times with 1X
PBS. Cells were fixed using 4% paraformaldehyde for 15 minutes at room
temperature. Fixative was removed and 2% Triton-X 100 was added for 10 minutes
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at room temperature to permeabilize cells. Following removal of Triton-X 100, cells
were rinsed five times and blocked with addition of solution BSA/PBS (10mg/mL
BSA in PBS). Cells were labelled with primary and secondary antibodies and
immunofluorescent foci were identified at 20x magnification as described above.
IFAs were used to assess the level of LGTV infection in ISE6 cells.
Detection of the LGTV non-structural protein 3 (NS3) was performed using YPconjugated chicken anti-LGTV NS3 (provided by S. Best, NIH-NAID, Hamilton, MT)
as primary antibody and IgG-conjugated goat anti-chicken, Alexa Fluor 488
(Invitrogen, Grand Island, NY; A11039) as secondary antibody. Cell nuclei were
labeled with 4',6-diamidino-2-phenylindole (DAPI; Life Technologies, Grand Island,
NY; D1306). Glass coverslips were used to culture and infect cells for the IFAs and
were placed onto microscope slides, which were viewed on an Olympus model
IX81F-3 microscope and images were collected using an Olympus U-CMAD3
camera. Fluorescence excitation was provided by the EXFO X-Cite Series 120PC
and Olympus IX2-UCB. Image overlays were produced with Metamorph Basic
v7.6.5.0 software.
To establish an MOI and time-point corresponding to optimal LGTV
replication in ISE6 cells, three concentrations (MOIs of 7, 13, and 26) of LGTV
were used to infect cells. For each, cells were fixed at 3, 9, 24, and 48 hpi with five
technical replicates that were imaged under 20x magnification. On the basis of
complete infection (>96%) in ISE6 cells between two MOIs (7 and 13) and time
points (24 and 48), an MOI of 10 was selected for subsequent experiments for
maximum infection.
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Separately, an assessment of the cumulative virus release was carried out
in LGTV-infected ISE6 cells at an MOI of 10. Media from these LGTV-infected ISE6
cells was harvested at 12 hour intervals for up to 120 hours, and subjected to
plaque assays to measure replication. In addition, LGTV one step growth was
analyzed in ISE6 cells, where all media were removed and replaced with fresh
complete media at each time point. Media removed were then subjected to plaque
assays to measure replication at each time point.
2.2.4 Production of non-infectious LGTV
To create non-infectious LGTV (UV-LGTV), LGTV p4 stock media (~4 x 106
pfu/mL) was placed in 48 well cell culture plates and treated with UV radiation at a
distance of 11 cm from a standard (12.4 watt) UV lamp in a biological safety cabinet
(Nuaire Labgard ES, Plymouth, MN) for 30 second intervals over a five minute
period. LGTV inactivation was confirmed by blind passage of UV-LGTV on ~2 x
107 ISE6 cells and ~80% confluent BHK cells, followed by immunofluorescent and
plaque assay as described by Perera et al. [89] to demonstrate lack of infectivity.
2.2.5 Cell viability and mortality assays
To assess cell viability, cells were treated with alamarBlue reagent (AbD
Serotec; BUF012A) diluted 1:10 with fresh media for 12 and 2 hours for ISE6 and
Vero cells, respectively. Fluorescence (excitation at 560nm, emission at 590 nm)
was measured using a Molecular Devices SpectraMax M5 plate reader coupled
with SoftMax Pro v4.8 software. Five technical replicates were performed for each
time point with biological replicates (n=2).
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A trypan blue cell exclusion assay was used to assess mortality in ISE6
cells following LGTV infection. Poly-L-Lysine-treated 96-well plates were seeded
with ISE6 cells for 48 hours to a cell density of ~9 x 104 cells/well. Cells were
treated with LGTV infection (MOI 10; p4 LGTV stock) or condition media as
described above. Cells were harvested at 12, 24, 36, and 48 hpi, centrifuged at
1,510 x g for 5 min, media was removed and the cell pellet was re-suspended in
1X PBS. Subsequently, a 1:1 0.4% trypan blue:cell suspension, was prepared,
incubated for ~3 min at RT, the cells were immediately counted using a
hemocytometer [90] and the percentage of stained ISE6 cells was determined for
LGTV and mock treatments. Three technical replicates were collected per
treatment with two biological replicates (n=2).
2.2.6 Statistical analyses
Graphpad Prism (v4.03) was used to perform two-tailed t-test analyses.
Standard error was completed to show error between technical replicates. At least
two biological replicate experiments were completed for each experiment.
2.3 RESULTS
2.3.1 ISE6 cell growth and characterization of LGTV growth in ISE6 cells
Ixodes scapularis ISE6 cell growth was first established before
characterization of LGTV infection in ISE6 cells was carried out. ISE6 cell doubling
time was determined to be between 4 to 5 days (Fig 2). Timothy J. Kurtti (University
of Minnesota) confirmed that the Ixodes species-derived cell lines had a 4-7 day
doubling time (personal communication; March 14, 2011). The growth of ISE6 cells
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were slow when compared to most mammalian cell cells and ISE6 cells do not
form monolayers but grow on top of each other.
IFAs were used in time course experiments to assess levels of LGTV in
ISE6 cells (Fig 3). Under the assay conditions described herein, IFA revealed that
the maximum level of LGTV infection in the ISE6 cell population (>96%)
corresponded to an MOI of 10 as determined by percentage of cells positive with
the LGTV NS3 protein (Figs 3A and 3B), and plaque assays revealed that the peak
of LGTV release from ISE6 cells occurred at 36 hpi (Fig 4). These conditions were
selected for subsequent proteomic analyses. In addition, an LGTV one step growth
curve in ISE6 cells with an MOI of 10 identified initial LGTV release at around 12
hpi and a peak LGTV release at 48 hpi (Fig 5). This suggested that the first round
of LGTV replication (without reinfection in cells) was ≤12 hpi and that the 36-48 hpi
range was the period with maximum infectious LGTV release.
2.3.2 UV inactivated, noninfectious control LGTV
Plaque assays revealed that UV radiation for 30-60 seconds leads to 50%
inactivation and ≥120 sec was sufficient to achieve 100% inactivation of LGTV as
determined by the lack of plaque formation (Fig 6). The minimum time observed
for lack of LGTV NS3 protein appearance was 3.5 minutes (data not shown). UVLGTV used for proteomic analyses and subsequent assays was inactivated for five
minutes.
2.3.3 ISE6 cell population numbers, viability, and mortality following LGTV infection
ISE6 cell population numbers did not change in comparison between LGTV
infected and mock treated ISE6 cells (Fig 7). ISE6 cell viability was reduced during

23
the initial infection with LGTV (i.e., ≤48 hpi) but does not change after 48 hpi (4860 hpi), as measured based on presence of cellular reducing agents (Fig 8). ISE6
cell mortality, as measured by counting cells treated with trypan blue after LGTV
infection or mock treatment, revealed no change with LGTV infection groups (Fig
9).
2.4 DISCUSSION
LGTV can establish persistent infection in ISE6 cells after initial, or acute,
infection. After peak infectious LGTV release from ISE6 cells, in combination with
published studies [83], LGTV replication remains primarily linear. This also
provides phenotypic data that suggested ISE6 cells undergo molecular changes in
cellular pathways that LGTV may utilize. However, the hypothesis that ISE6 cell
viability does not change with LGTV infection in comparison with mock treatment
is rejected since ISE6 cell viability was reduced at ≤48 hpi with LGTV.
2.4.1 Conditions established for proteomic analyses
Characterization of a virus-host system is required before performing any
type of genomic, transcriptomic, or proteomic analyses. The effect LGTV infection
has on ISE6 cell population numbers, viability, and mortality can be used to explain
molecular responses but also can be used to optimize biological sample collection
for subsequent proteomic analyses. For example, completing the one step growth
analysis of LGTV-infected ISE6 cells identifies the initial release of infectious LGTV
around 12 hpi. In addition, cumulative and one step growth analyses identify the
peak LGTV release from ISE6 cells between 36 to 48 hpi. In initial acute infection,
it was suggested that 12 hpi was early, 24 hpi was early/intermediate, and 36/48
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hpi was late. Identification of proteins and corresponding pathways/functions can
now be categorized based on the different stages of acute LGTV infection.
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2.5 FIGURES, TABLES, AND LEGENDS

Fig 1. LGTV-ISE6 flavivirus-tick cell system. ISE6 cells are derived from I.
scapularis embryonic eggs. Wildtype TP21 strain LGTV was utilized in this study
for the model tick-borne flavivirus of choice to infect ISE6 cells.
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Fig 2. Ixodes scapularis ISE6 cell population growth. Confluent ISE6 cells are
~5 x 107 cells. ISE6 cells were split and plated in 48 well plates. Cells were
consistently flushed off 96 cell surfaces via pipette action and placed on a glass
hemocytometer for cell counting under a microscope. Standard error shown in
error bars with three technical replicates. Two biological replicate experiments
were completed.
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Fig 3. Quantification of LGTV infection in I. scapularis ISE6 cells via
immunofluorescence. (A) Immunofluorescent detection of virus in ISE6 cells at
3, 9, 24 and 48 hours post infection (hpi) with LGTV MOIs of 7, 13 and 26. LGTV
NS3 nonstructural protein (green), DAPI-stained nuclei (blue). (B) Percentage of
infected ISE6 cells at 3, 9, 24 and 48 hpi following treatment with LGTV at MOIs
of 7, 13 and 26 as determined from quantifying ISE6 cells with immunofluorescent
LGTV NS3 expression.
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Fig 4. LGTV cumulative growth in ISE6 cells. Time course experiment showing
amount of infectious LGTV (Log pfu/mL) released from ISE6 cells initially infected
with LGTV MOI = 10 (n=3). Small media volume (100 µL) was removed for titration
and replaced with the same volume of fresh media at each time point. Titration
was performed using both plaque assays and immunofluorescent focus forming
assays in BHK cells. Standard error shown in error bars with three technical
replicates. Two biological replicate experiments were completed.
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Fig 5. LGTV one step growth in ISE6 cells. Time course experiment showing
amount of infectious LGTV (pfu/mL) released from ISE6 cells initially infected with
LGTV MOI = 10. All media was removed for titration and replaced with fresh media
at each time point. Titration was performed using plaque assays in BHK cells.
Standard error shown in error bars using three technical replicates. Two biological
replicate experiments were completed.
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Fig 6. UV-activation of LGTV to create noninfectious LGTV (UV-LGTV). Plaque
assays in BHK cells showing the reduction in infectious viral titer (pfu/mL) following
treatment with UV-irradiated LGTV viral stocks for up to 300 seconds. Three
technical replicates with standard error bars shown. Two biological replicates were
completed.
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Fig 7. ISE6 cell growth following LGTV infection. LGTV infection (MOI 10) and
mock treatment of ISE6 cells were completed on ISE6 cells in a 96 well plate. Cells
were consistently flushed off 96 cell surfaces via pipette action, diluted 1/10th the
original volume, and placed on a glass hemocytometer for cell counting under a
microscope. Standard error shown in error bars with three technical replicates.
Two biological replicate experiments were completed.
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Fig 8. ISE6 cell viability following LGTV infection. Alteration of ISE6 cell viability
at 12-24, 24-36, 36-48 hours post infection are shown with and without LGTV
(mock-treated) infection. * denotes p<0.05 and ** denotes p<0.01. RLU denotes
relative light units (fluorescent measurement with 560 nm excitation and 590
emission). Standard error of the mean shown in error bars with five technical
replicates. Two biological replicate experiments were completed.
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Fig 9. ISE6 cell mortality following LGTV infection. Using the trypan Blue cell
exclusion assay, cell mortality percentage at 12, 24, 36, 48 hours post infection
with and without LGTV (mock-treated) infection was completed. Standard error
shown in error bars with five technical replicates. Two biological replicate
experiments were completed.
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CHAPTER 3: LC-MS/MS PROTEOMIC ANALYSES OF LGTV-INFECTED I.
SCAPULARIS ISE6 CELLS

3.1 INTRODUCTION
Based on the results presented in Chapter 2 for optimizing/characterizing
LGTV infection in ISE6 cells, preparation of biological samples necessary for
proteomic analyses was carried out as described in this chapter. Identification of
ISE6 proteins with altered levels following LGTV infection was completed at 36 hpi,
or peak infectious LGTV release. To compare different biological treatment groups,
comparative/quantitative (differential) proteomics was an appropriate method to
identify alteration in tick protein expression levels. Once proteins were identified,
cellular pathway/function and protein domain analyses were carried out. Key
metabolic and gene regulation pathways were identified, along with identification
of tick proteins with or without orthology.
The proteomic response in earlier time points post LGTV acute infection
was also explored, where key proteins/pathways may be linked with the initial
release of LGTV from ISE6 cells. Also, further validation of ISE6 proteins with a
second proteomic analysis provided an increased confidence of protein
identification. In addition, a recent proteomic study of I. scapularis tick cells and
synganglia [91] provided identification of tick neuronal proteins that overlap with
ISE6 protein identifications. This study has been able show overlapping proteins
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to change in expression levels following neurovirulent LGTV infection. Third, by
identifying changing ISE6 proteins following different time points post LGTV
infection, cellular pathways/functions that were changing/fluctuating can be
identified. Fourth, PTMs during TBF infection have not been explored and were
hypothesized to be associated, and potentially involved in TBF infection.
Specifically, lysine acetylation level change among ISE6 proteins was explored
following LGTV infection. Label-free quantification (LFQ) proteomic analysis of
ISE6 cells at 12, 24, 36, and 48 hours post LGTV infection was carried out to
identify metabolic and gene regulatory proteins, which were further subjected to
comparative analyses, pathway/functional cluster analyses, and PTM searches.
Reduced ISE6 cell viability following LGTV infection was identified in
Chapter 2, a consequence of reduced cellular energy (a decrease in reducing
agents suggest reduced ATP levels). TCA cycle and oxidative phosphorylation
pathways were involved in cellular respiration and production of ATP. It was
hypothesized that more ISE6 TCA cycle and oxidative phosphorylation proteins
have decreased expression than increased expression following 12-48 hpi with
LGTV. The rationale was that reduced protein expression was leading to
decreased production of cellular reducing agents (NADH, NADPH, etc). The LFQ
proteomic analysis of ISE6 cells at 12, 24, 36, and 48 hours post LGTV infection
was used to assess this hypothesis.
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3.2 MATERIALS AND METHODS
3.2.1 Cell and virus culture
Cells and virus stocks were prepared as described in Chapter 2, Section
2.2.1.
3.2.2 LGTV infection in ISE6 cells and measurement of infectious LGTV
LGTV infection of ISE6 cells and measurement of infectious LGTV was
completed as described in Chapter 2, Section 2.2.3.
3.2.3 Production of non-infectious LGTV
Production of non-infectious LGTV was completed as described in Chapter
2, Section 2.2.4.
3.2.4 Preparation of peptide samples and mass spectrometry analyses
3.2.4.1 Preparation of ISE6 cell samples for LC-MS/MS analysis
To establish LGTV infection in ISE6 cells for LC-MS/MS analyses, ~2 x 106
ISE6 cells were adsorbed with LGTV p4 at an MOI of 10 for one hour as previously
mentioned. Infection of >96% of the cells was confirmed by IFA. In parallel, ISE6
cells were adsorbed with UV-inactivated LGTV and conditioned media (obtained
from uninfected Vero cell culture). The production of these three treatment groups
representing cells treated with (a) infectious LGTV (LGTV), (b) non-infectious
LGTV (UV-LGTV) and (c) conditioned media only (mock control) was replicated
five times (n=5 biological replicates). Samples were harvested at 36 hpi and were
adjusted to ~1.7 x 105 cells to ensure an equal concentration of cells per replicate.
Cells were then pelleted at 1,510 x g for 5 minutes, culture supernatant was
removed, and pellets were stored at -80°C. Cell pellets used for the differential
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proteomic analysis were thawed, re-suspended with hypotonic 100 mM
ammonium bicarbonate buffer, subjected to passive lysis (30 minutes), and mixed
manually by pipetting at room temperature (RT). Protein concentration was
determined using a NanoDrop 2000c (Thermo Scientific) in protein a280 mode
(v1.2.1). Cell pellets used for the LFQ proteomic analysis were thawed, resuspended with hypotonic 100 mM ammonium bicarbonate buffer, and subjected
to freeze-thaw lysis for three cycles with mixing via pipette action at each thaw.
Protein
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Chloroform:methanol (2:1) extraction was performed and proteins from the
aqueous phase was collected [92, 93]. Proteins were precipitated by addition of
ice cold 100% acetone to samples, followed by vortexing for five seconds, and
incubation at -20°C for one hour. Samples were spun at 16,000 x g for five minutes
and the protein pellet was re-suspended in 8M urea supplemented with 10mM DTT
and incubated at 37°C for 1.5 hours. Proteins were denatured by addition of a
50mM ammonium bicarbonate solution supplemented with acetonitrile (ACN),
triethylphosphine (TEP), and 2-iodoethanol (97.5%:0.5%:2%) [92, 93]. Protein
pellets for the differential proteomic analysis were dried on a speed vacuum for
two hours at 37°C and digested for 18 hours at 37°C in 50 mM trypsin (SigmaAldrich; T6567) solution (diluted in ammonium bicarbonate) at a ratio of 1:50 w/w
trypsin:protein [93]. Protein pellets for the LFQ quantitative proteomic analysis
were dried on a speed vacuum for two hours at 37°C, resuspended in 50 mM
trypsin (Sigma-Aldrich; T6567) solution (diluted in ammonium bicarbonate) at a
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ratio of 1:50 w/w trypsin:protein, subjected to barocycler (Pressure BioSciences
Inc.; NEP2320) pressure-induced digestion at 50°C for the following conditions: 60
cycles of 20,000 psi for 50 seconds on high pressure and 10 seconds on low
pressure, and macrospin C18 columns (The Nest Group, Inc.; SMM SS18V) were
used.
3.2.4.2 LC-MS/MS analyses and identification of proteins in ISE6 cell samples
3.2.4.2.1 Differential proteomic analysis
Trypic, molecular species of peptides were separated on a nanoLC system
(1100 Series LC, Agilent Technologies, Santa Clara, CA). Peptides were loaded
on an Agilent 300SB-C18 enrichment column for concentration and the column
was switched into the nano-flow path for five minutes. Peptides were separated
with a C18 reversed phase ZORBAX 300SB-C18 analytical column (0.75 μm x 150
mm, 3.5 μm) from Agilent.
The column was connected to the emission tip from New Objective and
coupled to the nano-electrospray ionization (ESI) source of the hybrid ion trap
mass spectrometer LTQ-Orbitrap LX (Thermo Scientific). The peptides were eluted
from the column using an acetonitrile/0.1% formic acid (FA; mobile phase B) linear
gradient. The column was equilibrated with 95% H2O/0.1% FA (mobile phase A)
for 5 min and proteins were eluted using a linear gradient of 5%-35% B for 50
minutes at 0.3 μL/min, followed by a linear gradient of 35%-100% B for 10 minutes.
The column was washed with 100% of ACN/0.1% FA and equilibrated with 95% of
H2O/0.1% FA before injection of the subsequent sample. A blank injection run

39
between every five samples (of each treatment group) was completed to avoid
carryover.
Operation was completed in the data-dependent positive acquisition mode
in which full MS scan (resolution 30,000) was followed by four MS/MS scans. The
four most abundant molecular ions were selected and fragmented by collisioninduced dissociation (CID) using a normalized collision energy of 35%. Raw data
was collected via Xcaliber (v 2.0.7). Database searches were conducted using
Spectrum

Mill

(MS

Proteomics

Workbench

v.03.02

software;

Agilent

Technologies). To identify peptides, a homology search was conducted against
the VectorBase I. scapularis IscaW1.2 annotation [94] protein dataset (precursor
mass tolerance=0.05 Da; fragment mass tolerance=0.6 Da; maximum of two
tryptic mis-cleavages) using Spectrum Mill [92, 93]. Only those peptides with a
Spectrum Mill score of ≥ 5 and scored peak intensity (% spi) of ≥ 70% were
considered [92, 93, 95].
To account for false positives, a decoy (reversed) database search was
performed using the MS/MS search option in Spectrum Mill. Peptide scores were
compared to those of reversed peptide scores to obtain a delta forward-reverse
score. The cut-off was established as >1 for +1 parent charged peptides and +2
parent charged peptides and >2 for +3 (and greater) parent charged peptides [95].
3.2.4.2.2 LFQ quantitative proteomic analysis
Peptides were loaded into a C18 trap column (200 µm x 0.5 mm, ChromXP
C18-CL, 3 µm, 120 Å, Eksigent) and the separation was carried out in a capillary
C18 column (75 µm x 15 cm, ChromXP C18-CL, 3 µm, 120 Å) connected to a
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nanoHPLC system (Ekspert nanoLC 400, Eksigent). The elution was performed
with the following gradient: 1 min in 5% solvent B (Solvent A: 0.1% FA and solvent
B: 100% ACN/ 0.1% FA), 5-35% solvent B in 90 min, 35-80% solvent B in 2 min,
5 min in 80% solvent B, 80-5% B in 2 min, and hold in 5% for 20 min. The flow rate
was constant at 200 nL/min over the whole gradient. Eluting peptides were directly
analyzed in an electrospray ionization mass spectrometer (TripleTOF 5600+, AB
Sciex). Full-MS spectra were collected in the range of 400 to 1600 m/z and the top
50 most intense parent ions were submitted to fragmentation for 50 milliseconds
using rolling-collision energy.
Identification and quantification of peptides were performed with MaxQuant
software (v 1.5.2.8). Species-specific sequence database of LGTV strain TP21 and
I. scapularis were downloaded from Uniprot on 01/20/2015. Database searches
were

performed

considering cysteine

carbamidomethylation as

a fixed

modification, protein N-terminal acetylation and oxidation of methionine as variable
modifications. Peptide mass tolerance was set to 0.07 and 0.02 Da for first and
second database searches, respectively. Identified peptides were filtered with 1%
false-discovery rate at peptide-spectrum match and protein levels. For extracting
peak areas, peptides that were not found in all the runs were matched based on
the precise mass and retention time alignment. Proteins only with two or more
peptides identified were selected. To account for false positives and protein
contaminants, a decoy (reversed) database search and UniProt contaminant
database was searched in parallel with the I. scapularis database.
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3.2.4.3 LC-MS differential analysis of LGTV-infected ISE6 cell samples
The Omics Discovery Pipeline (ODP; omicsdp.org) was employed for
differential protein analyses with mass spectrometry proteomics [92, 93, 96, 97].
Raw data from LC-MS/MS runs were uploaded and total ion chromatograph
visualization was completed with each sample run and treatment group.
Deconvolution of spectra into peaks was completed for each sample utilizing
XMass using the GISTool [98]. Alignment of peaks using XAlign [99] was
conducted and normalization was accomplished from a number of different
methods [100-102] that best fit the data. Normalized files were subject to statistical
analyses and pattern recognition analysis. A heat map was created using the
Heatmap.2 function of the ‘gplots’ package in R. Normalized files subjected to
statistical analyses also were subject to principal component analysis (PCA), selforganizing maps (SOM), and linear discriminate analysis (LDA) (unpublished data).
For more information regarding the specific components of the ODP, refer to [96].
3.2.4.4 LFQ quantitative analysis of LGTV-infected ISE6 cell samples
The average LFQ intensity values for the technical replicates were used for
each

sample

and

submitted

to

InfernoRDN

([103];

http://omics.pnl.gov/software/infernordn). All the values were transformed [log2(x)]
and the Liner Regression Normalization and Central Tendancy options were
applied. The results table files and GO annotation files were loaded into MS
Access and tables were merged into one.
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3.2.4.5 Post-translational modification search of ISE6 proteins
MaxQuant software was utilized to search the I. scapularis database with
lysine acetylation along with the other variable modifications mentioned above.
Upon search completion, proteins identified with modified peptides and identified
in at least three out of five samples of at least one treatment group were subjected
to two sample t-test and ANOVA statistical analyses via GraphPad Prism software
(v 4.03) to identify statistically-significant changes in modifications following LGTV
infection and UV-LGTV treatment.
3.2.5 Measurement of ISE6 cell concentrations
Measurement of ISE6 cell concentrations was completed as described in
Chapter 2, Section 2.2.2.
3.2.6 Statistical analyses
Following alignment and normalization of MS peaks, standard two-sample
t-test and Wilcoxon-Mann-Whitney rank test (unpublished data) were used to
compare significant differences between mass profiles of the samples. An ANOVA
was also utilized to identify significant masses across the three treatment groups
and identify group differences of the three-sample analysis. Statistics were
incorporated using the R statistical package (http://www.r-project.org/). Application
of a false discovery rate based correction method [104] was performed with the
significance tests.
For the differential proteomic analysis, the following methodology was used
to account for the average fold change of a protein with multiple peptides: (1) Log
of each peptide intensity value followed by (2) averaging these Log values,
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identified an averaged Log-valued protein intensity fold change; (3) the natural Log
(ln) of the averaged Log-valued protein intensity fold change was determined in
order to convert values to the original average fold change value for the
corresponding protein. The “flattening” of the data was a stringent approach to
identify the differential change in MS peak intensities for a particular protein. Fold
change of >2 was considered an increase in expression, 0.5-2 fold change denotes
no change in expression, and fold change of ˂0.5 corresponds to a decrease in
expression.
3.2.7 Assignment of ISE6 proteins to function, class, and pathway
Peptides with homology to I. scapularis, IscaW1.2 gene models were
assigned to a putative functional class by searching accession numbers against
the KEGG orthology database (http://www.genome.jp/kegg/ko.html) and the
KEGG pathway database (http://www.genome.jp/kegg/pathway.html). ISE6
proteins with orthology to KEGG entries were populated within KEGG pathways
that also included mammalian and arthropod orthologs.
3.2.8 Biological clustering and assignment of ISE6 proteins to function, class, and
pathway
Database for Annotation, Visualization, and Integrated Discovery (DAVID;
http://david.abcc.ncifcrf.gov/summary.jsp; [105, 106]) was utilized to identify I.
scapularis proteins with and without orthology (KEGG Orthology). In addition,
DAVD was utilized to identify significant, biological clustering from Gene
Ontologies and InterPro protein domains corresponding to the I. scapularis
proteins.
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Peptides with homology to I. scapularis, IscaW1 gene models were
assigned to putative functional class by searching accession numbers against the
KEGG orthology database (http://www.genome.jp/kegg/ko.html; [107, 108]) and
the KEGG pathway database (http://www.genome.jp/kegg/pathway.html). ISE6
proteins with orthology to KEGG entries were populated within KEGG pathways
that also included mammalian and arthropod orthologs.
3.3 RESULTS
3.3.1 Differential proteomics: Effects of LGTV infection on the ISE6 proteome
Completion of the virus life cycle as determined by release of infectious
virus particles was observed in ISE6 cells infected with LGTV. In comparison, in
cells treated with UV-inactivated virus (UV-LGTV) we observed no release of
infectious virus particles. Comparative proteomics analyses were used to identify
proteins expressed throughout the process of cell infection (LGTV) versus those
associated only with viral attachment and entry of the host cell (UV-LGTV). The
sequence of proteomic analyses performed using the three treatments (LGTV, UVLGTV, and mock) are shown in Fig 1 and Table 1.
LC-MS data were compared for LGTV, UV-LGTV and mock samples (Fig
2). The expression patterns of LC-MS peaks for LGTV samples were more similar
to that of UV-LGTV samples than to that of mock samples. The t-test and ANOVA
were used to identify proteins that exhibited differential expression (p < 0.05)
between LGTV and UV-LGTV samples as compared to the mock samples (Fig 3A).
In total, 486 ISE6 proteins were identified based by homology to NCBI/VectorBase
accessions. Of these, 266 and 248 proteins were identified as differentially

45
expressed in the LGTV and UV-LGTV samples, respectively, compared to mock
samples. Sixty-eight proteins had increased expression, while 198 proteins
showed decreased expression in the LGTV samples as compared to mock
samples. Additionally, 82 and 166 proteins showed increased and decreased
expression (Fig 3B), respectively, in the UV-LGTV samples in comparison to mock
samples. Overall, 243 proteins (50%) exhibited decreased expression while 120
(24.7%) showed increased expression in LGTV and UV-LGTV samples as
compared to the mock treatment (Fig 4A).
3.3.2 Differential proteomics: Functional analyses of I. scapularis ISE6 proteins
Of the 486 ISE6 proteins identified in this study, 265 (54.5%) mapped to
orthologous proteins in the KEGG database, while 221 proteins had no match
(KEGG; genome.jp/keg/ko). Of the 265 proteins, 176 (36.2%) mapped to 66 KEGG
pathways and 16 KEGG modules (Fig 5A). The KEGG pathways identified in the
present study were categorized into five cellular functions: “metabolism”, “genetic
information

processing”,

“environmental

information

processing”,

“cellular

processes”, and “organismal systems”. The majority of proteins (52%) were
identified to the functional category “genetic information processing”, followed by
“metabolic” (38.7%) and “cellular” (6.3%), “environmental information processing”
(2%), and “organismal systems” (1%) (Fig 5B).
LGTV samples exhibited the highest number of proteins (53) identified to
the KEGG pathway “genetic information processing” (Fig 4B-4D). Within this group,
eight proteins exhibited increased expression and were classified in the pathway,
“translation” (Fig 4B). For UV-LGTV samples, the majority of ISE6 proteins (57)
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were also classified in the pathway, “genetic information processing”. The majority
of proteins exhibiting increased expression (17) were classified in the protein
processing pathways of “folding, sorting, and degradation” (7 proteins; 41.2%),
followed by “translation” (6 proteins; 35.3%) and “transcription” (4 proteins; 23.5%).
Proteins from the LGTV and UV-LGTV samples that lacked a match to
KEGG database entries also displayed differential expression. Of these, 30
proteins had increased expression and 91 had decreased expression in LGTV
samples in comparison to mock samples (Fig 6). Additionally, 38 and 85 proteins
were identified with increased and decreased expression, respectively, in the UVLGTV samples as compared to mock samples.
3.3.3 Differential proteomics: Changes in the ISE6 cell proteome following LGTV
infection
Proteins that showed an increase in expression in LGTV samples were
mapped onto the KEGG functional categories of cell signaling (CYC, STK3, RPS6),
proteolysis (UCHL3, PSMA, UBE2N), carbon-nitrogen hydrolase activity (DDAH,
VNN), replication and mRNA processing (PARP, TRA2, CUTL, H2A, CSTF2),
translation (RPS6, RPL17, AARS, NARS), glutamate metabolism/glutaminolysis
(prostate-specific transglutaminase ISCW011739; Fig 7 and Table 2), pyruvate
metabolism and energy association (MDH2; Fig 8). Proteins that exhibited
decreased expression were associated with the functional categories of glycolysis
(GAPDH; Fig 8), energy processes (ATP5H, ATP5A1), and mRNA surveillance
(PABPC, PELO, MSI, THOC4).
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3.3.4 Differential proteomics: Changes in the ISE6 cell proteome following UVLGTV treatment
Proteins exhibiting increased expression in UV-LGTV samples were
mapped onto the KEGG functional categories of signaling (RHOGDI, RAB35, SIP,
LAMC1), cytoskeletal components, (ACTN, TUBA), unfolded protein response and
ER-associated degradation (HSPA1_8, RAB7A), lysosomal functions (PSAP), and
phagosome functions (RAB7A). Proteins that exhibited a decrease in expression
were associated with transport (BAP31), cell survival (BAP31, HYOU1, DERL1,
GROEL), cell growth (SUMO, NOP10, MAD1L), translation (NOP10), and protein
folding (GROEL).
3.3.5 Differential proteomics: Changes in the ISE6 cell proteome common to both
LGTV infection and UV-LGTV treatment
Responses common to LGTV and UV-LGTV samples included proteins
exhibiting increased expression and associated with signaling (ITGB, MO25),
cytoskeletal structure perturbation (TLN), amino acid metabolism (ACAT, DP5CD,
GLUD1, CARP, FAH), glutamate metabolism/glutaminolysis (DP5CD, GLUD1,
membrane protein (ISCW001521; Fig 7 and Table 2), RNA interference (AUB),
and energy-production (ACAT). Proteins with decreased expression and common
to both treatment groups were classified to KEGG functions of glycolysis
(ALDOA/B/C, ALDH2/1B1/3A2; Fig 8), energy association (ATP5D, ATP5B), RNA
interference (VIP), and structural manipulation (ACTB_G1, TUBB).
3.3.6 Differential proteomics: Comparative proteomics of tick, mosquito, and
human-flaviviral infection
185 of the 265 ISE6 proteins with orthology to KEGG entries (70%) were
also identified in a proteomics study of HCV infection of HUH7.5 cells [56] (Fig 9).
Sixteen ISE6 proteins (6%) matched orthologs identified in a study of West Nile

48
virus (WNV) infection of Vero cells [109], 16 proteins matched orthologs in a yeast
two-hybrid study of flavivirus-host interactions [110], and 15 proteins (5%) matched
orthologs identified in Aedes aegypti infected with dengue virus (DENV) [65]. A
subset of proteins that exhibited increased expression following LGTV infection
and/or UV-LGTV treatment and matched proteins in the studies above, were
associated with protein synthesis and proteolysis (Fig 10). Of the remaining 66
proteins (24.9%), those that exhibited increased expression in LGTV samples were
classified in the KEGG functional categories of proteolysis (PMSA, CARP), ATP
association/interaction (PSMA, ANMK), cell and matrix adhesion (VNN, ITGB), and
as well as oxidative stress and redox homeostasis (VNN and conserved
hypothetical protein ISCW020127-PA). Additionally, the cellular function of
hydrolase activity was suggested by increased expression of PSMA and VNN.
3.3.7 LFQ quantitative proteomics: ISE6 protein and neuronal protein overlap
The sequence of proteomic analyses performed using the three treatments
(LGTV, UV-LGTV, and mock) and the four time points (12, 24, 36, and 48 hpi) is
shown in Fig 11 and Table 3. Identification of 579 proteins (Fig 12) from the LFQ
proteomic analysis (all ISE6 proteins from 12, 24, 36, and 48 hpi; Fig 13)
overlapped with 301 proteins from the differential proteomics analysis (486 ISE6
proteins). A recent study published by Oliver et al [91] identified I. scapularis
synganglia proteins where 115 of these proteins overlap with the LFQ and/or
differential proteomic analyses (Fig 14). Changes in expression following LGTV
infection was initially searched and identified with the overlapped ISE6 and
neuronal proteins (data not shown).
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3.3.8 LFQ quantitative proteomics: Biological function clustering of ISE6 proteins
changing with LGTV infection
Of the ISE6 proteins with statistically-significant changing expressions
following LGTV infection, DAVID searches revealed greater numbers of biological
clusters (similar biological function among proteins identified with statistical
significance) within the 12 and 24 hpi time points than in the 36 and 48 hpi time
points (Table 4 and Table 5). ISE6 proteins with increased expression identified
the most clusters. At 12 hpi, the biological cluster of macromolecular complex
assembly and subunit assembly was unique to this time point. At 24 hpi, the
biological clusters of protein folding and unfolded protein response, glycosylation
activitiy and ER involvement, protein synthesis/elongation activity, and
cofactor/NAD/NADH binding were unique to this time point. At 12 and 24 hpi, the
biological clusters of ribonucleotide complex/ribosome/translation, heat shock
protein

activity,

nucleotide/ribonucleotide

binding,

thioredoxin

function/homeostatic response, and GTPase activity were observed. No biological
clusters were identified at 36 hpi and the biological cluster of RNA
recognition/nucleotide binding was observed at both 24 and 48 hpi. ISE6 proteins
with decreased expression identified two biological clusters only at 24 hpi, where
RNA recognition/nucleotide binding and ATP/nucleotide/ribonucleotide/nitrogen
biosynthetic/metabolic processes/cation transmembrane transporter activity was
observed.
3.3.9 LFQ quantitative proteomics: Cellular pathway fluctuations following LGTV
infection
Pathways with proteins with increased expression were seen in greater
amount at 12 and 24 hpi than at 36 and 48 hpi. Pathways with proteins with
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decreased expression were seen in great amount at 48 hpi (Fig 15). Pathways with
proteins of increased expression (at 12 to 24 hpi) begin to have no to little protein
change (identified at 36 hpi) and then have decreased expression later (48 hpi) in
LGTV infection (Fig 16).
There were 34 pathways with at least two or more proteins identified with
increased and/or decreased expression following LGTV infection. In addition, there
were 36 pathways with proteins of increased expression at 12/24 hpi that shifted
to decreased expression at 36/48 hpi or vice versa. Metabolic pathways were
primarily perturbed across 12 to 48 hpi (Fig 17). Amino acid and carbohydrate
metabolic pathways were the top two pathways with proteins of increased
expression early in infection at 12 and 24 hpi. Two amino acid pathways (histidine
metabolism and lysine biosynthesis) were identified with proteins of increased
expression early infection. The third most important metabolic pathways with
proteins with increased expression at 12 hpi were lipid, cofactors/vitamins, and
xenobiotics biodegradation metabolism. The third most important metabolic
pathway with proteins with increased expression at 24 hpi was cofactors/vitamins.
Carbohydrate metabolism was identified with proteins with increased expression
only early in infection at 12 and 24 hpi. Pathway shifts occur, first with lipid/fatty
acid metabolism along with cofactor/vitamin metabolism, which were identified with
proteins of increased expression early in infection at 12 and 24 hpi, where lipid/fatty
acid metabolism (three pathways: fatty acid elongation, fatty acid degradation, and
fatty acid metabolism) was identified late in infection (36 and 48 hpi) with proteins
with decreased expression. Energy-associated metabolism (five pathways:
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citrate/TCA cycle, oxidative phosphorylation, pyruvate metabolism, carbon
metabolism, and 2-oxocarboxylic acid metabolism) which was identified with
proteins of increased expression at 12 and/or 24 hpi, where proteins have shifted
with decreased expression in these pathways at either 24, 36, and/or 48 hpi. Fig
18 highlights protein expression change in the citrate/TCA cycle following the early
and late time points post LGTV infection. Glycan biosynthesis was identified with
proteins with increased expression early in infection at 12 and 24 hpi, but have
proteins with decreased expression later at 48 hpi. Biosynthesis of amino acids
was found only at 12 hpi with increased protein expression, where a shift to
proteins with decreased expression occurred later at 24 and 48 hpi.
Genetic information processing (GIP; pathways involved with gene
regulation) pathways account for the second most common cellular function being
perturbed with LGTV infection across 12 to 48 hpi. Translation pathway was the
top GIP pathway with proteins of increased expression at 12 and 24 hpi. Only at
12 hpi, replication/repair pathway was also a shared top pathway with translation
with proteins of increased expression. Only three GIP pathways were perturbed
across 12 to 48 hpi: Translation, replication/repair, and folding/sorting/degradation.
The only GIP pathway identified with proteins of increased expression across 12,
24, 36, and 48 hpi was the folding/sorting/degradation pathway. Nine GIP
pathways (ribosome biogenesis in eukaryotes, ribosome, RNA transport, DNA
replication, spliceosome, proteasome, nucleotide excision repair, protein
processing in endoplasmic reticulum, and protein export) were identified with
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proteins of increased expression at 12 and/or 24 hpi and with proteins with
decreased expression at 36 and/or 48 hpi or vice versa.
The only cellular processes pathway being perturbed across 12 to 48 hpi
was transport and catabolism. A shift was clearly seen with proteins of increased
expression in this pathway only at 12 and 24 hpi and with proteins of decreased
expression in the pathway only at 36 and 48 hpi (four pathways: lysosome,
endocytosis, phagosome, and peroxisome). Endocytosis was the only specific
transport and catabolism pathway found with proteins with increased expression
only at 12 and 24 hpi.
Signaling transduction pathways (FoxO and Wnt signaling pathways) were
only found with proteins of increased expression early in infection, at 12 hpi.
Signaling molecules and interaction pathway ECM-receptor interaction was found
with proteins with decreased expression at 24 and 48 hpi.
3.3.10 LFQ quantitative proteomics: ISE6 protein lysine acetylation change
associated with LGTV infection and UV-LGTV treatment
Changes in expression of lysine acetylation of ISE6 proteins was shown
across 12 to 48 hpi with LGTV infection and/or UV-LGTV treatment. Only at 12
and 24 hpi, Histone H3 (ISCW002300 and ISCW003178) was identified with
changing expressions of lysine acetylated peptides with LGTV infection and/or UVLGTV treatment (Fig 19). However, more Histone H3 peptides with lysine
acetylation were identified with increased expression following LGTV infection than
with decreased expression. In addition, at 12 hpi the secreted protein
(ISCW020023) was identified with increased expression of an acetylated peptide
following LGTV infection. At 24 hpi, acetylated peptides with increased expression
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following LGTV infection were found with the SMC protein (ISCW015559) and the
Iron-containing

alcohol

dehydrogenase

(ISCW021748).

Additionally,

the

uncharacterized protein (ISCW006009) was found with an acetylated peptide with
decreased expression following UV-LGTV treatment. Histone H4 was found with
acetylated peptides with changing expression in all time points of LGTV infection
(Histone H3 acetylated peptides observed early in infection). Histone H4
acetylated peptides with increased and decreased expression were found in 12
and 36 hpi. Histone H4 acetylated peptides with increased expression only was
found at 48 hpi. Histone H4 acetylated peptides with decreased expression only
was found at 24 hpi.
3.4 DISCUSSION
We used an LC-MS/MS proteomics approach to analyze changes in the
global protein expression profile of I. scapularis ISE6 cells following infection with
LGTV and identified tick proteins tied to flavivirus infection and replication. The
present study focused on proteins expressed during 36 hours post infection or the
period of peak LGTV release from infected ISE6 cells. In total, 486 ISE6 proteins
were identified, and of these, 66 exhibited increased expression and 198 proteins
exhibited decreased expression following LGTV infection. Two hundred and sixtyfive of the proteins identified (54.5%) had orthology to proteins of known function
from a variety of eukaryotes.
The LFQ proteomic analysis was used to identify global protein expression
of ISE6 cells at different time points (early to late) following LGTV infection. More
ISE6 proteins (579) were identified in the LFQ proteomic analysis compared to the
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differential proteomic analysis (486). After characterizing proteins with altered
expression (a total of 70 I. scapularis pathways with protein expression change)
following LGTV infection at each time point, a comparison of pathways with
fluctuating protein changes following LGTV infection in early and late time points
was completed. In addition, changes in lysine acetylation of ISE6 proteins,
specifically histones, following LGTV infection and/or UV-LGTV treatment were
identified at early and late time points. Protein/pathway and modification changes
provide insight into possible cellular components that may be involved with TBF
infection.
3.4.1 Differential proteomics: Impact of LGTV infection on signaling in ISE6 cells
Several proteins were identified in the notch and mTOR signaling pathways.
The histone deacetylase 1,2,3 (ISCW007830-PA) exhibited decreased expression
in LGTV and UV-LGTV samples. Several studies [111, 112] suggest a link between
herpesvirus infection and gene regulation through with the binding of viral proteins
to histone deacetylases [112].

We test that LGTV infection may impact the

regulation of ISE6 genes via effects on histone deacetylase. In other systems, it
has been shown that histone deacetylase can act as a co-repressor in the notch
signaling pathway. The 40S ribosomal protein S6 (ISCW024315-PA) and Mo25
(ISCW004710-PA) exhibited increased expression in LGTV cells. These proteins
are members of the mTOR signaling pathway, which has been implicated in human
cytomegalovirus (HCMV) infection in mammalian cells [113, 114] and DENV
infection in A. aegypti mosquitoes [115]. Increased expression of Mo25 may reflect
a cellular stress response while increased expression of S6 may reflect an increase
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in translation to maintain growth of the infected cell or facilitate LGTV replication.
Manipulation of mTOR signaling has been noted with WNV infection in mammalian
systems [116]. The calcyclin-binding protein CacyBP (ISCW013691-PA) known to
function in the Wnt signaling pathway in other systems, had increased expression
in UV-LGTV-treated cells and decreased expression in LGTV-infected ISE6
samples. Our observation suggested an increase in proteolysis following virus
treatment since the Wnt pathway is associated with the Ca2+-dependent, ubiquitinmediated proteolysis pathway. Future investigations regarding roles of posttranslational modifications in regulating signaling pathways following tick-borne
flavivirus infection is necessary.
3.4.2 Differential proteomics: ISE6 anti-viral responses perturbed by LGTV
infection
Recently, the piwi-interacting RNA (piRNA) pathway has been implicated in
the antiviral response of mosquitoes [117] and tick I. scapularis IDE8 cells [118].
Esther et al identified three paralogs (ISCW015916, ISCW0021130, and
ISCW011768) of the tick I. scapularis argonaute (aubergine) protein as antiviral
factors to LGTV infection. The I. scapularis aubergine protein possesses the paz
and piwi domains [119] associated with RNA binding. Homologs of these proteins
were not identified in this study, although a homolog of argonaute (AUB;
ISCW011373-PA) was identified that exhibited increased expression in both LGTV
and UV-LGTV ISE6 cells and may play an antiviral role in LGTV infection.
Histone (H2A) is involved in DNA binding and chromatin packing of DNA,
and therefore likely has a role in gene regulation and downstream host protein
translation that may be important for homeostasis. The I. scapularis H2A
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(ISCW004478-PA) exhibited increased expression in LGTV-infected ISE6 cells.
H2A also had increased expression during DENV infection in HUH7 liver cells and
binds with the capsid protein to inhibit nucleosome formation in these human cells
[120]. This protein has also been found to bind antisense RNA [121], also
suggesting a possible anti-pathogen role as a result of changes in gene regulation.
The proteasome subunit alpha type protein (ISCW021572-PA) exhibited
increased expression in LGTV samples and the 20S proteasome, regulatory
subunit alpha type PSMA7/PRE6 (ISCW007139-PA) had increased expression in
both LGTV and UV-LGTV samples. These proteins are subunits of the
proteasome-associated 20S core particle and may exert antiviral roles through
proteolysis and transcriptional regulation. Protein subunits of the proteasome have
been shown to play a role in HCV internal ribosome entry site (IRES)-mediated
translation [122] and may also interact with the HIV protein TAT and HBV protein
HBX [123, 124].
3.4.3 Differential proteomics: Role of actin polymerization in ISE6 cells following
LGTV infection
Decreased expression of actin was observed in both LGTV-infected and
UV-LGTV-treated

samples.

Cofilin

(CFN;

ISCW006326-PA),

an

actin-

depolymerizing factor, exhibited decreased expression in these samples. CFN was
also identified in a proteomic study of HCV-infected HUH7.5 cells [56]. Actin
polymerization is involved with formation of actin stress fibers, a process that may
facilitate vacuole formation [125] and mammalian neuronal cell entry of Japanese
encephalitis virus [126]. UV-LGTV-treated cells exhibited increased expression of
the signaling and structural proteins RHOGDI, and ACTN and TUBA, respectively.
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RHOGDI has been implicated in actin depolarization [127] and showed increased
expression in HCV-infected HUH7.5 cells [56] at an early (12 hpi) infection time
point. ACTN showed increased expression in HUH7.5 cells at early (24 hpi) and
intermediate (48 hpi) time points post HCV infection and increased expression in
UV-HCV-treated cells at a late (72 hr) time point. In the present study, we observed
increased expression of ACTN in UV-LGTV samples at the 36 hpi time point. In
addition to crosslinking actin fibers and facilitating filament assembly, ACTN been
shown to bind the HCV nonstructural proteins NS3 and NS5 [110, 128]. We
hypothesize that this protein may assist LGTV cell entry in ISE6 cells.
3.4.4 Differential proteomics: Maintenance of metabolism in ISE6 cells following
LGTV infection
The proteins acetyl-CoA acetyltransferase (ACAT1; ISCW016117) and
aldehyde dehydrogenase 4A1 (DP5CD; ISCW015982) exhibited increased
expression in LGTV-infected cells. These enzymes operate upstream of the TCA
cycle and are associated with the production of acetoacetyl-CoA and pyruvate,
respectively during cellular metabolism. This result suggested an increase in
acetyl-CoA production following viral infection. Interestingly, citrate synthase (CS;
ISCW009586) showed decreased expression following LGTV infection and may
reflect a reduction of TCA protein activity late in LGTV infection. We observed a
decrease in expression of fumarate hydratase (FH; ISCW020593) that may also
similarly reflect reduction of TCA protein activity late in LGTV infection. The
increased expression of MDH2 (ISCW003528), a protein involved in the final steps
of the TCA cycle, may produce an increase in oxaloacetate, S-malate, and NADH
in ISE6 cells. Moreover, increased expression of fumarylacetoacetase (FAH;
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ISCW020196) may increase fumarate, also involved in the final steps of the TCA
cycle. ACAT1, DP5CD, MDH2, and FAH may aid in maintaining the TCA cycle late
in LGTV infection. In parallel, these observations suggest an impact of LGTV on
the TCA cycle at 36 hours post infection that may be linked to replication of the
virus.
Our observation of a decrease in expression of fructose-bisphosphate
aldolase

(ALDOA),

glyceraldehyde-3-phosphate

dehydrogenase

(GADH),

aldehyde dehydrogenase family 7 member A1 (ALDH3A2), and pyruvate kinase
(PKLR) in LGTV-infected and UV-LGTV-treated cells, suggested an impact of
LGTV on glycolytic processes. This finding was at odds with that of Patramool et
al 2011, who observed that DENV-infected C6/36 A. albopictus cells [64] exhibited
increased glycolysis. The study of Tchankouo-Nguetcheu et al identified an
increased expression of glycolytic proteins in the in vivo midgut tissues of DENVinfected A. aegypti [65]. Diamond et al 2010 also identified members of the
glycolysis pathway that exhibited increased expression at early to intermediate
time points (i.e., prior to peak release of infectious virus) following HCV infection,
but not at the late (during and following peak release of virus from the cell) time
point [56]. Collectively, these data suggest the possible increase in glycolysis at
early to intermediate time points post flaviviral infection, but a decrease in
glycolysis at later time points.
3.4.5 Differential proteomics: Glutaminolysis associated with LGTV replication
Glutaminolysis can produce an alternative energy source for the cell by
generating ATP during the conversion of glutamine to α-ketoglutarate. Increased
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expression of proteins associated with glutaminolysis suggested that LGTV
infection in ISE6 cells may stimulate glutaminolysis and the production of αketoglutarate, a key intermediate in the TCA cycle. Studies suggest that
glutaminolysis is manipulated during infection in human cells by both HCMV [129,
130] and HCV [56]. Thus, glutaminolysis and α-ketoglutarate are likely critical not
only for maintaining the TCA cycle, but also supporting oxidative phosphorylation
and ATP production in the infected cell. Additionally, stimulation of α-ketoglutarate
has been shown to increase mTOR activity [131, 132], which operates in parallel
with glutaminolysis. Chapter 4 shows an assessment of the manipulation of
glutamate dehydrogenase (GDH) activity using inhibitory compounds with the goal
of disrupting flaviviral infection.
3.4.6 LFQ quantitative proteomics: Feasibility of ISE6 cells as tick neuronal models
for neuroinvasive flavivirus pathogenesis
Neuronal proteins have traditionally been attractive targets for arthropod
pest control, including ticks. The proteins identified in the I. scapularis tick
synganglia [91] that overlap with the ISE6 proteins that are changing with LGTV
infection, may provide an in vitro model for what may occur with the tick synganglia
during flavivirus infection in vivo. As soon as the 115 synganglia proteins that
overlapped with ISE6 cell proteins identified in the LGTV-ISE6 proteomic analyses
are searched for their effect after LGTV infection, further cellular function/pathway
analyses can be determined. Implications can then be made that these responses
may translate to the neuronal system.
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3.4.7 LFQ quantitative proteomics: Perturbed ISE6 cellular functions associated
with acute LGTV infection
Biological function clusters identified the ISE6 cellular functions with
proteins with increased or decreased expression following LGTV infection. The
initial release of infectious LGTV occurs around 12 hpi and continuous release
continues from 12 to 36/48 hpi, where peak virus release occurs (Chapter 1). At
12 and 24 hpi, clusters of ribonucleotide complexes, ribosome, GTPase activity,
and translation were implicated in LGTV infection. In combination with biological
observation, LGTV completes the first translation of viral proteins early in acute
infection (<12 hpi) and with cluster observations, manipulates nuclear/genetic
functions to help aid in this task. Flavivirus proteins have been known to enter the
nucleus during infection [120, 133, 134], so effect on ribonucleotide proteins
(histones, histone deacetylases, etc) is imminent although poorly understood. At
24 hpi, protein folding, unfolded protein response, glycosylation activity,
endoplasmic

reticulum

(ER)

involvement,

RNA

recognition,

and

cofactor/NAD/NADH binding were also implicated in LGTV infection. Protein
folding and unfolding response may correlate with viral protein processing, virion
assembly, and/or egress/transport. Glycosylation and ER involvement suggested
the glycosylation activity of a protein that occurs in the ER right before budding into
the Golgi apparatus, where in this case, may be a host and/or viral protein. RNA
recognition may possibly correlate with the virus’ RNA replication and/or RNA
genome packaging during virion assembly. Stress related responses by the cell
were heat shock protein activity, reductase activity, and thioredoxin function at 12
and 24 hpi.
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In addition, a cellular environment with reduced energy and biosynthetic
metabolic processes was identified at 24 hpi with a cluster formed by proteins with
decreased expression. Also, more TCA cycle and oxidative phosphorylation
proteins with increased expression than decreased expression following LGTV
infection were identified at 12 and 24 hpi. TCA cycle and oxidative phosphorylation
proteins were identified with no change in expression at 36 hpi and more TCA
cycle and oxidative phosphorylation proteins were identified with decreased
expression than increased expression at 48 hpi. This suggested that cellular
substrates and components used for energy (ATP) production were used up early
(≤ 24 hpi) in LGTV infection, and may depict the cell responding/adjusting to this
decreased-nutrient environment. The hypothesis that more ISE6 TCA cycle and
oxidative phosphorylation proteins have decreased expression than increased
expression following 12-48 hpi with LGTV was rejected. Only at 48 hpi was when
this hypothesis was observed, not from 12-36 hpi. Further metabolite analyses
need to be completed in order to provide insight, in parallel with proteomics, into
ISE6 cell responses following LGTV infection.
3.4.8 LFQ quantitative proteomics: ISE6 proteins with increased and decreased
expression following acute LGTV infection reveal fluctuating cellular pathways
3.4.8.1 Metabolic pathways
A heavy reliance on amino acid and carbohydrate metabolism is crucial for
LGTV infection, not only because these pathways would produce substrates for
virus particle or protein production, but also because they provide substrates
necessary for maintaining cellular energy levels and health. This LFQ proteomic
analysis emphasizes this observation by identifying a vast proportion of the altered
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ISE6 proteins being identified in amino acid and carbohydrate pathways. With the
majority of metabolic proteins with increased expression residing in amino acid and
carbohydrate pathways, it may be characteristic of the amino acid supply needed
to produce viral proteins but also necessary to provide an alternative carbon
energy source (e.g. glutaminolysis) to ISE6 cells (glycolysis/gluconeogenesis
found with proteins of increased expression at 24 hpi but found with proteins of
decreased levels at 36 hpi in the differential proteomic analysis) as acute infection
continues.
The second tier of metabolic pathways identified with proteins of increased
expression were lipid, cofactors/vitamins, and xenobiotics biodegradation
metabolism. Flavivirus production of replication complexes require lipid
membranes and have been known to perturb lipid metabolism [59, 89, 135, 136],
so lipid metabolism was suggested to associate with LGTV replication complex
formation. The shift of lipid metabolic proteins with increased expression early in
infection (12 and 24 hpi) to a decreased expression late in infection (36 and 48 hpi)
was suggested to be characteristic of the lipids involved in viral replication
complexes and/or for production of cellular energy. Cofactors/vitamins provide the
substrates necessary for nucleotide and amino acid production and serve as key
intermediates for metabolic enzymes, hence it was suggested these proteins
involved in cofactor/vitamin metabolism early in infection (12 and 24 hpi) aid in
providing necessary substrates for viral genome and protein production.
Energy metabolism, or oxidative phosphorylation and 2-oxocarboxylic acid
metabolism, increased early in infection (12 hpi) and was suggested to be involved
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in many biosynthetic processes used by the virus (e.g. viral genome replication
complex formation and viral protein production). But they were found to be
decreased later (24, 36, and 48 hpi) as the acute infection continues. In addition,
three energy-associated (citrate/TCA cycle, pyruvate metabolism, and carbon
metabolism) pathways were identified with increased protein expression early in
infection and identified with decreased protein expression later in infection. The
decrease in energy may be characteristic of the ISE6 cells with decreased
substrate/intermediate levels and/or response to limit biosynthetic processes due
to viral infection/stress response (e.g. cell survival). Similarly, glycan biosynthesis
was increased early at 12 and 24 hpi, but decreased at 48 hpi. Glycans make up
some receptors that flaviviruses use for targeted entry receptors but also use
glycans as part of their viral proteins. So, increased LGTV production at 12 to 24
hpi was directly correlated with increased glycan biosynthesis.
3.4.8.2 Genetic information processing pathways
Translation, replication/repair, and folding/sorting/degradation pathways
were the only GIP pathways identified in the LFQ proteomic analysis. However,
proteins with increased expression residing in these pathways were suggested to
be involved with LGTV protein production, assembly, and egress/transport.
Proteins in the replication and repair pathway may also be increased due to
increased DNA damage that may result from LGTV infection and potential nuclear
interaction with viral proteins.
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3.4.8.3 Cellular processes pathways
Proteins identified with increased expression levels involved in the
endocytosis pathway at 12 and 24 hpi suggest this process to be increased early
in infection due to LGTV entering ISE6 cells via endocytosis. An increase in
phagosome function early in infection may be characteristic of ISE6 cells
consuming available cellular substrates to aid the increase in energy needed for
biosynthetic processes. An increase in peroxisomes early in LGTV infection was
presumably involved with the breakdown of substrates (e.g. fatty acids and amino
acids) and formation of acetyl-CoA for use in energy production that may aid in
LGTV replication complex formation, LGTV protein production, and/or cellular
energy. A decrease in peroxisomes later in LGTV infection (36 and 48 hpi) may
suggest that the ISE6 cell was limiting biosynthetic processes and does not need
free substrates. An increase of lysosome function may be due to the use of this
function to release infectious LGTV and/or due to a response to cellular stress.
3.4.8.4 Environmental information processing pathways
Signaling transduction response was primarily early in LGTV infection. Only
12 hpi revealed proteins with increased expression with signal transduction and as
early as 24 hpi signaling became decreased. This suggested that later in infection
that metabolic, cellular processes, and signaling all become reduced presumably
to limit cellular biosynthetic processes and to maintain a homeostatic condition.
3.4.9 LFQ quantitative proteomics: Histone lysine acetylation changes with LGTV
infection and UV-LGTV treatment
As mentioned before, flavivirus proteins have been shown to enter the
nucleus of infected cells to manipulate gene regulation-based functions [120, 137,
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138]. In addition, histone levels/expressions have been shown to be manipulated
with flavivirus infection where viral proteins have been implicated to sequester
histone proteins [120]. It was suggested that gene regulation was manipulated via
interactions of histones and viral proteins. The mechanism on how viral proteins
affect histone acetylation activity yet needs to be elucidated.
Histones have additionally been implicated in connection with controlling
metabolic processes by controlling transcription and subsequent translation of host
proteins. Acetylation is a modification that activates histones and allows for more
genetic material to be transcribed. Altered levels of acetylation of histones directly
alters the production of cellular proteins that may be involved with key metabolic
pathways [139, 140]. It is hypothesized that ATP-citrate synthase (ISCW009919),
increased expression following LGTV infection at 12 hpi, provides an increase flux
production of nuclear acetyl-CoA, a required cofactor used to acetylate lysine
residues. In addition to nuclear acetyl-CoA levels, cytoplasmic or mitochondrial
acetyl-CoA levels were predicted to be increased as well early in LGTV infection.
There were a number of histones identified with increased expression
following LGTV infection in the differential and LFQ proteomic analyses: Histone
H2A, Histone H1/5, and Histone H4. Also, a histone deacetylase was identified
with decreased expression following LGTV infection in the differential and LFQ
proteomic analyses.

In addition, identified ISE6 proteins with histone

acetyltransferase activity and acetyltransferase activity within the differential and
LFQ proteomic studies with increased expression following LGTV infection (data
not shown) were predicted to affect acetylation activity in multiple cellular
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compartments. Finally, the LFQ proteomic analysis identified histones with
increased and decreased expressions of lysine acetylation following LGTV
infection. Specifically, this included Histone H3 and Histone H4. From this
information, it may be possible that LGTV infection may affect activity of ISE6
histones, however the effect on histone levels/activity on ISE6 metabolic enzyme
production/activity remains unknown.
3.5 LGTV-ISE6 PROTOMIC ANALYSES SUMMARY
The differential proteomic analysis provided an initial look at cellular
pathway/function changes associated with LGTV infection, specifically at peak
LGTV replication. The LFQ proteomic analysis provides an additional validation of
ISE6 proteins identified from the differential proteomic analysis (with additional
ISE6 proteins), quantitated levels of ISE6 proteins following four different time
points following LGTV infection, identification of fluctuating cellular pathways from
early to late acute LGTV infection, and lysine acetylation changes of ISE6 proteins
following LGTV infection. In the future, additional post-translational modifications
(glycosylation, phosphorylation, and methylation) can be searched with the same
LFQ datasets to identify more modifications on ISE6 proteins associated with
LGTV infection.
Identification of 486 tick proteins from the differential proteomic analysis and
579 tick proteins from the quantitative proteomic analysis (301 ISE6 proteins
overlap) provided an extensive proteomic characterization of the ISE6 cell, at peak
LGTV release and 12-48 hpi acute LGTV infection. In combination with ISE6
proteins identified by Oliver et al (317 identified in total; [91]), 198 proteins overlap
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in all three proteomic analyses, 211 overlap with the differential proteomic analysis,
270 overlap with the quantitative proteomic analysis, and 386 overlap with two or
more of the three ISE6 protein datasets. For the first time, these analyses provided
tick proteome responses to a TBF infection.
The identification of these proteins and their cellular pathways provide a
critical resource to improve understanding of the I. scapularis proteome, improve
gene annotations, and facilitate further studies in the tick cell culture system. In
addition, to contribute to an improved understanding of flavivirus-I.scapularis
interactions, the differential and LFQ proteomic analyses provide proteins and
pathways that were changing in association with LGTV. The present study is an
important first step toward identifying tick proteins tied to LGTV replication and can
be used for anti-tick vaccines and/or for therapeutic screening to disrupt tick-borne
flavivirus transmission. Further understanding of protein function can also be
achieved using approaches such as IFA, targeted mass spectrometry, small
molecule in vitro assays, and RNAi. Chapter 4 will go more into depth of the small
molecule/RNAi in vitro assays and the proteins/cellular pathways that were
involved with LGTV infection.
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3.6 FIGURES, TABLES, AND LEGENDS

Fig 1. Summary of differential proteomic analysis of LGTV-infected and UVLGTV-treated I. scapularis ISE6 cells. After whole cell sample harvest of treated
ISE6 cells, cell pellet samples were subjected to lipid removal, protein precipitation,
peptide denaturation, and tryptic digest of peptides. Samples were prepared for
the separation phase (nano LC) by injection, using electrospray ionization (ESI).
Mass analysis of the precursor ion spectra was completed, followed by the second
fragment ion MS/MS dimension for downstream peptide identification. Two group
and three group statistical analyses with ISE6 cells treated with virus (LGTV), UVinactivated virus (UV-LGTV), and no virus (mock) were compared utilizing a
proteomic/metabolite pipeline, Omics Discovery Pipeline (ODP). After
identification of significantly-changing (p < 0.05) MS peaks from LGTV-infected
and UV-LGTV-treated ISE6 cells, corresponding peptides were identified to
specific I. scapularis proteins (VectorBase I. scapularis WIKEL genome IscaW1.2
predicted protein set database). ISE6 proteins were then subject to protein function
and pathway analyses (via KEGG). See materials and methods section for more
detail.
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Table 1. Summary of analyses used to identify proteins from LGTV-infected
and UV-LGTV-treated ISE6 cell samples
Processing Step
Description

Total
number of
LC-MS
peaks
observed
Number of
LC-MS
peaks with
correspondi
ng peptides
Number of
significant
LC-MS
peaks
between
treatment
groups
Data filtering
based on
Spectrum
Mill score

Number of
peaks
following
removal of
peptide
false
positives
Final List of
MS peaks

MS Data (Number of Peaks)
LC-MS data were
39,241
37,218
aligned and
normalized using
ODPa

31,364

46,590

All normalized
peaks that matched
to peptides

27,868

30,789

22,054

33,117

The ODP was used
to calculate a P
value based on the
intensities of each
LC-MS peak
between groupsb

14,658
T-test (P<
0.05)

18,759
T-test (P<
0.05)

5,247
T-test (P<
0.05)

18,402
ANOVA (P<
0.05)

Peptide score3 (>
5) and removal of
unidentified LC-MS
peaks
% scored peak
intensityc (%SPI≥
70%)
Δ fwd-rev scored >
1 with parent
charges +1 and +2

8,154

10,267

2,898

9,507

4,781

5,878

1,727

5,516

4,310

5,237

1,540

4,914

1,096

1,355

356

1,267

Number of Peptides
772
893

315

821

Number of Proteins
374
409

201

395

Δ fwd-rev score > 2
with parent charges
+3 and +4
Removal of
replicate MS peaks
identified in the
multiple samples

Peptides

Number of unique
peptides

Proteins

Proteins identified
to VectorBase
accession ISCWIDse

aODP

No MS peaks/Peptides/Proteins per Treatment
LGTV vs. UV-LGTV
LGTV vs.
LGTV vs.
mock
vs. mock
UV-LGTV
mock vs.
UV-LGTV

denotes Omics Discovery Pipeline
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bAfter

normalization of MS peaks in each treatment group (LGTV, UV-LGTV, and
mock), t-test and ANOVA analyses were performed in the Significance Test step
of the ODP.
cSpectrum Mill peptide score and % scored peak intensity are two criteria utilized
to identify peptides from in silico database searches. See material and methods
section for more details.
dSpectrum Mill reverse database search was completed to account for possible
false positives when identifying peptides from in silico database searches. See
material and methods section for more details.
e≥1 peptide match to a VectorBase gene model predicted peptide sequence was
considered a protein identification. See material and methods section for more
details.
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Fig 2. Hierarchical clustering of MS peak profiles of ISE6 cells treated with
LGTV, UV-LGTV, and mock. M1-5, mock1-5 samples; LGTV1-5, LGTV-infected
samples 1-5, and UV-LGTV1-5, UV-LGTV samples 1-5. Vertical rows depict n=5
biological replicates. Horizontal rows correspond to significant MS peaks of
peptides/proteins at 36 hours post infection/treatment. Clustering analysis shows
common patterns of protein expression profiles shared between the three
treatment groups. The red-green color scale denotes the Z score fold change with
red representing a Z score of -2 and green denoting a Z score of 2 [89].
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Fig 3. Identification and expression of ISE6 cell proteins following treatment
to LGTV, UV-LGTV, and mock. (A) Four statistical analyses were performed
using the ODP output. This included a three-way ANOVA of treatment groups
LGTV, UV-LGTV, mock and two-way t-test comparing the LGTV vs. mock, UVLGTV vs. mock, and LGTV vs. UV-LGTV samples. The Venn diagram shows
unique and common ISE6 protein identifications from these datasets. (B) Venn
diagrams showing the numbers of ISE6 proteins identified as exhibiting increased
or decreased expression following treatment to LGTV or UV-LGTV unique or
common to sample groups.
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Fig 4. ISE6 proteins identified in KEGG pathways with differential expression
following LGTV, UV-LGTV and mock treatment. (A) Total number of ISE6 cell
proteins
categorized
by
treatment
and
change
in
expression
(increase/decrease/no change). Total number of proteins showing (B) increased
expression, (C) decreased expression, and (D) no change in expression following
LGTV infection and UV-LGTV treatment as compared to mock-treated cells and in
LGTV-infected cells as compared to UV-LGTV-treated cells. Proteins were
categorized by the KEGG classes for cellular function: metabolism, genetic
information processing (GIP), environmental information processing (EIP), cellular
processes (CP), and organismal systems (OS).
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Fig 5. ISE6 protein orthology and cellular function distribution of proteins
found in KEGG pathways and modules. (A) Ixodes scapularis ISE6 proteins with
KEGG-mapped orthologs (or KEGG orthology [KO]) help to identify cellular
pathways in I. scapularis (genome.jp/kegg/ko). To be identified in a KEGG pathway,
KO is required. ISE6 proteins with KO and not identified in I. scapularis (KEGG)
pathways are also included. (B) Percent cellular function distribution of proteins
found in the 66 identified I. scapularis (KEGG) pathways with 16 modules.
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Fig 6. Summary of differentially-expressed ISE6 proteins without identified
pathways. Expression of ISE6 proteins with (A) or without (B) orthology and no
identified pathways. Refer to S2 Table for more specifics on the proteins. Red
dotted line denotes differentially-expressed proteins in LGTV-infected ISE6 cells
compared to UV-LGTV-treated ISE6 cells (no comparison to mock-treated ISE6
cells).
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Fig 7. ISE6 proteins associated with the TCA cycle and glutaminolysis. ISE6
glutaminolysis and mTOR signaling proteins altered with LGTV infection are shown.
GDH denotes glutamate dehydrogenase enzymes and Glase denotes glutaminase
enzymes. ISCWxxxxxx denotes corresponding VB accession ID for corresponding
I. scapularis protein.
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Table 2. ISE6 proteins putatively associated with glutaminolysis.
Protein
(VB
accession
name)

KEGG
ortholog

Putative functions
(GO predictions)

(ISCW011739)
prostatespecific
transglutamina
se, putative

NP*

(ISCW000393)
glutamate
dehydrogenase
, putative

K00261
glutamate
dehydroge
nase
(NAD(P)+)

(ISCW015982)
aldehyde
dehydrogenase
, putative

K00294
1-pyrroline5carboxylate
dehydroge
nase

(ISCW001521)
membrane
protein,
putative

NP

(ISCW020361)
glutamine
synthetase 1,
putative

NP

• peptide cross-linking
• protein-glutamine
gammaglutamyltransferase
activity
• transferase activity,
transferring acyl groups
• transferase activity
• cellular amino acid
metabolic process
• oxidation-reduction
process
• oxidoreductase activity,
acting on the CH-NH2
group of donors, NAD
or NADP as acceptor
• oxidoreductase activity
• proline biosynthetic
process
• oxidation-reduction
process
• metabolic process
• oxidoreductase activity,
acting on the aldehyde
or oxo group of donors,
NAD or NADP as
acceptor
• 1-pyrroline-5carboxylate
dehydrogenase activity
• oxidoreductase activity
• oxidation-reduction
process
• saccharopine
dehydrogenase (NAD+,
L-glutamate-forming)
activity
• oxidoreductase activity
• nitrogen compound
metabolic process
• glutamine biosynthetic
process
• ligase activity
• glutamate-ammonia
ligase activity

*NP denotes does not have a KEGG Ortholog.

Orthology to
glutaminolytic
enzyme

Change in
expression

Glutaminase
(Glase)

Increased
expression
with LGTV

Glutamate
dehydrogenase
(GDH)

Increased
expression
with both
LGTV and
UV-LGTV

GDH

Increased
expression
with both
LGTV and
UV-LGTV

GDH

Increased
expression
with both
LGTV and
UV-LGTV

Decreased
expression
with both
LGTV and
UV-LGTV
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Fig 8. Citrate cycle showing ISE6 proteins that exhibited
increased/decreased expression following treatment to LGTV and UV-LGTV.
The enzymes are indicated with KEGG abbreviated nomenclature and the
corresponding substrates are shown in circles. * denotes proteins identified in this
study. Dotted lines denote indirect involvement with production. The increased
expression of malate dehydrogenase (MDH2) was unique to LGTV-treated cells
while increase in the expression of acetyl-CoA acetyltransferase 1 (ACAT1), delta1-pyrroline-5-carboxylate dehydrogenase (ALDH4A1), glutamate dehydrogenase
(GLUD1), and fumarylacetoacetase (FAH) was common to cell samples following
LGTV infection and UV-LGTV treatment. Decreased expression of citrate synthase
(CS) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was observed in
LGTV-treated cells and decreased expression of fumarate hydratase (FH),
aldolase
A/B/C
fructose-bisphosphate
(ALDOA/B/C),
and
aldehyde
dehydrogenase 2/1B1/3A2 family protein (ALDH2/1B1/3A2) was observed in both
LGTV-infected and UV-LGTV--treated cells. ATP citrate lyase (ACLY), aconitase
(ACO), isocitrate dehydrogenase 2/3a (IDH2/3a), oxoglutarate/alpha-ketoglutarate
dehydrogenase complex (OGDH/DLST), succinyl-CoA synthetase alpha/beta
subunit (LSC1/2), succinate dehydrogenase flavoprotein subunit (SDHA),
pyruvate kinase (PK), enolase 1/2/3 (ENO1/2/3), and aldehyde dehydrogenase
7A1 family protein (ALDH7A1).
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Fig 9. Number of ISE6 proteins corresponding to orthologous proteins
identified in proteomic analyses of flavivirus-host systems. Corresponding
percentages correspond to the number of ISE6 orthologs identified with orthologs
identified in: α S5 Fig, S7 Fig, and S11 Fig of Khadka et al [110]; µS2 Table of
Tchankouo-Nguetcheu et al [65]; βTables 1 and 2 of Pastorino et al [109]; ΔS1
Table of Diamond et al [56].
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Fig 10. ISE6 proteins with increased expression associate with pathways for
protein production, transport, assembly, and proteolysis. The ISCW
accession numbers corresponding to proteins identified with increased expression
in LGTV-infected and UV-LGTV-treated cells are shown (KEGG abbreviated
nomenclature provided as well if available in parentheses). The schematic
presents potential mechanisms for LGTV-induced perturbation and increase in cell
protein expression. Underlined proteins denote ISE6 proteins exhibiting increased
expression following flavivirus infection not identified before. “Fld, Srt, & Deg” is
the folding, sorting, and degradation KEGG pathway. ** denotes ortholog in human
[56]; + denotes human ortholog showing increased expression following HCV
infection; -- denotes human ortholog showing decreased expression following HCV
infection. Gray boxes denote cellular protein functions. White boxes denote KEGG
pathways.
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Fig 11. Summary of quantitative proteomic analysis of LGTV-infected and
UV-LGTV-treated I. scapularis ISE6 cells. After whole cell sample harvest of
treated ISE6 cells, cell pellet samples were subject to lipid removal, protein
precipitation, peptide denaturation, and tryptic digest of peptides. Samples were
prepared for the separation phase (nano LC) by injection, using electrospray
ionization (ESI). Mass analysis of the precursor ion spectra was completed,
followed by the second fragment ion MS/MS dimension for downstream peptide
identification. Two group and three group statistical analyses with ISE6 cells
treated with virus (LGTV), UV-inactivated virus (UV-LGTV), and no virus (mock)
were compared utilizing a proteomic/metabolite program InfernoRDN. After
identification of significantly-changing (p < 0.05) MS peaks from LGTV-infected
and UV-LGTV-treated ISE6 cells, corresponding peptides were identified to
specific I. scapularis proteins (VectorBase I. scapularis WIKEL genome IscaW1
predicted protein set database from UniProt). ISE6 proteins were then subject to
protein function and pathway analyses (via KEGG). See materials and methods
section for more detail.
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Table 3. Summary of analyses used to identify proteins from LGTV-infected
and UV-LGTV-treated ISE6 cell samples in LFQ analysis.
Processing Step
No. Proteins per Time point
Description
12 hpi 24 hpi 36 hpi 48 hpi
Total number of
proteins observed

Total number of
proteins observed
following removal of
contaminantb and
reverse database
proteinsc
Total number of
proteins identified in
at least three out of
five biological
replicate samples

LGTV infection
LGTV infection and
UV-LGTV treatment
UV-LGTV treatment
Expression with
LGTV infection
greater than UVLGTV treatment
LGTV infection
LGTV infection and
UV-LGTV treatment
UV-LGTV treatment
aInferno

LC-MS raw data were
aligned and normalized
using Inferno RDNa and
uploaded to MaxQuant
for protein ID output.

960

1,023

991

1,100

896

948

929

1,026

Of three treatments
466
476
(LGTV, UV-LGTV, and
mock), protein identified
in at least three out of
five biological replicates
of at least one
treatment group
Proteins with Increased Expression
34
2
50
74

478

488

2
8

4
4

64
1

8
1

70
4

Proteins with Decreased Expression
23
59
3
10

15
1

74
3

3

3

20
33

6

4

RDN (http://omics.pnl.gov/software/infernordn) encompasses R package
to complete t-test and ANOVA analyses.
bUploaded, searched Uniprot protein database corresponding to the I. scapularis
IscaW1 genome assembly has included contaminant peptide sequences to help
identify non-I. scapularis peptides.
cMaxQuant option for reverse database search was selected in combination with
database search to identify proteins.
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Fig 12. ISE6 proteins identified in quantitative proteomic analysis. ISE6
proteins were identified in (A) at least three out of five biological replicates of at
least one treatment group (LGTV, UV-LGTV, and mock) and in (B) statisticallysignificant (p ≤ 0.05), changing proteins following LGTV infection and/or UV-LGTV
treatment.
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Fig 13. Identification of ISE6 cell proteins following LGTV infection and UVLGTV treatment. For 12 (A), 24 (B), 36 (C), and 48 (D) hpi time points, four
statistical analyses were performed. This included a three-way ANOVA of
treatment groups LGTV, UV-LGTV, mock and two-way t-test comparing the LGTV
vs. mock, UV-LGTV vs. mock, and LGTV vs. UV-LGTV samples. The Venn
diagram shows unique and common ISE6 protein identifications from these
datasets.
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Fig 14. Comparative proteomics analysis identifies ISE6 proteins in I.
scapularis synganglia tissue. ISE6-LGTV protein identifications (*/**Grabowski
et al differential and LFQ) and I. scapularis synganglia protein identifications
(***Oliver et al; [91]) overlap.
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Table 4. Summary of proteins used from LGTV-infected and UV-LGTV-treated
ISE6 cell samples for LFQ analysis in DAVID functional clustering and KEGG
pathway analyses.
Processing Step
No. Proteins per Time point
Description
12 hpi 24 hpi 36 hpi 48 hpi
Total number of
proteins searched

Total number of
proteins searched
by DAVID
Total number of
proteins not
searched by DAVID
Total number of
significant, biological
function clusters of
all DAVID searched
proteins
Total number of
significant, biological
function clusters of
all DAVID searched
proteins
Total number of
significant, biological
function clusters of
all DAVID searched
proteins
Total number of
proteins mapped to
KEGG pathways
aOrthology

Proteins with statistically
significant
increased/decreased
expression following
LGTV infection and/or
UV-LGTV treatment
DAVID will only search I.
scapularis proteins with
orthologya
I. scapularis proteins with
no orthologya

128

177

54

104

100

135

37

75

28

42

17

29

Enrichment (E)b score of
≥ 1.3 is equal to a ≤ 0.05
p value

5

8

0

2

Searched with proteins of
increased expression
following LGTV infection

5

9

0

1

Searched with proteins of
decreased expression
following LGTV infection

0

2

0

0

DAVID will only map
proteins with isc-specificc,
KEGG pathways

33

34

12

18

refers to proteins with corresponding KEGG Orthology.
the E score the increased strength or confidence of the cluster of biological
function occurring with the included proteins.
cProteins with KEGG Orthology have mapped I. scapularis (isc) pathways or no
mapped isc pathways. Proteins with KEGG Orthology and no mapped isc
pathways may be mapped to other pathways identified in other eukaryotic systems.
bHigher
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Table 5. Summary of DAVID functional clustering of proteins with increased
or decreased expressions following LGTV infection of ISE6 cell samples
from LFQ analysis.
Time point

ClusterΔ

12 hpiIncreased
Expression

Cluster 1

Cluster 2

Cluster 3

Cluster 4

24 hpiIncreased
Expression

Cluster 5
Cluster 1

Cluster 2

Cluster 3
Cluster 4
Cluster 5

Cluster 6

Cluster 7

Cluster 8

Cluster 9
36 hpiIncreased
Expression
48 hpiIncreased
Expression
ΔAll

Cluster
Summary
ribonucleotide
complex, ribosome,
and translation
heat shock protein,
nucleotide binding,
and ribonucleotide
binding
thioredoxin function,
homeostatic
response
cellular
macromolecular
complex assembly
and subunit
organization
GTPase activity
ribonucleotide
complex, ribosome,
and translation
protein folding and
unfolded protein
response

ClusterΔ

Cluster
Summary

12 hpiDecreased
Expression

No Clusters

24 hpiDecreased
Expression

Cluster 1

RNA recognition and
nucleotide binding

Cluster 2

ATP,
nucleotide/ribonucle
otide, and nitrogen
biosynthetic/metabol
ic processes. Cation
transmembrane
transporter activity.

RNA recognition and
nucleotide binding
glycosylation activity
and ER involvement
heat shock protein
and reductase
activity; homeostatic
response
nucleotide and
ribonucleotide
binding
GTPase and binding
activity along with
protein
synthesis/elongation
activity
thioredoxin function;
homeostatic
response
cofactor, NAD, and
NADH binding

No
Clusters
Cluster 1

Time point

RNA recognition and
nucleotide binding.

36 hpiDecreased
Expression
48 hpiDecreased
Expression

No Clusters

No Clusters

clusters had an Enrichment score of ≥1.3 and cluster summaries had a p
value ≤ 0.05
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Fig 15. ISE6 pathway change following acute LGTV infection. Pathways with
proteins of increased (A) and decreased (B) expression are identified across 12,
24, 36, and 48 hpi. The Venn diagram shows unique and common ISE6 pathways
identified from these time points. Pathways with at least one protein with differential
expression included.
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Fig 16. ISE6 pathway change following acute LGTV infection at specific time
points. Pathways with proteins of increased and decreased expression are
identified within each 12, 24, 36, and 48 hpi time point. The Venn diagram shows
unique and common ISE6 pathways with proteins of increased and/or decreased
expression identified from each time point.
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Fig 17. Specified ISE6 pathway change following acute LGTV infection at
specific time points. Pathways with proteins with increased or decreased
expression are identified at 12, 24, 36, and 48 hpi. Cellular functions categorize
the pathways listed and are as follows: Metabolism, Genetic Information
Processing (GIP), Cellular Processes, Environmental Information Processing
(EIP), and Organismal Systems.
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Fig 18. Citrate cycle showing ISE6 proteins that exhibited
increased/decreased expression at specific time points following treatment
to LGTV infection and UV-LGTV treatment. The enzymes are indicated with
KEGG abbreviated nomenclature and the corresponding substrates are shown in
circles. * denotes proteins not identified in this study at that specific time point.
Dotted lines denote indirect involvement with production. Enzymes listed include:
malate dehydrogenase (ISCW003528; MDH2), citrate synthase (ISCW009586;
CS), ATP citrate lyase (ISCW009919; ACLY), aconitase (ISCW013457; ACO),
isocitrate dehydrogenase 2/3a (ISCW001977, ISCW004116; IDH2/3a),
dihydrolipoamide acetyltransferase (ISCW008731; DLST), oxoglutarate/alphaketoglutarate dehydrogenase complex (ISCW003165; OGDH), succinyl-CoA
synthetase alpha/beta subunit (ISCW011750; LSC2), succinate dehydrogenase
flavoprotein subunit (ISCW000555; SDHA), fumarate hydratase (ISCW020593;
FH), dihydrolipoamide succinyltransferase (ISCW013308; DLAT), pyruvate
dehydrogenase (ISCW019126; PDHA), and branched chain alpha-keto acid
dehydrogenase (ISCW009219; PDHB).
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Fig 19. ISE6 proteins with lysine acetylation changes following LGTV
infection and UV-LGTV treatment. ISE6 proteins with increased or decreased
expression of lysine acetylated residues is shown (number listed in parentheses).
Red denotes proteins with increased expression of acetylated peptides and blue
denotes proteins with decreased expression of acetylated peptides following LGTV
infection and/or UV-LGTV treatment. ISCW- - - - - - denotes VectorBase accession
ID.
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CHAPTER 4: FUNCTIONAL SMALL MOLECULE AND RNA INTERFERENCE
ASSAYS TO IDENTIFY TICK PROTEINS INVOLVED IN LGTV INFECTION

4.1 INTRODUCTION
Grabowski et al (in review) and Chapter 3 provided a set of I. scapularis
ISE6 proteins differentially-expressed following LGTV infection and identified
metabolic processes that may be involved in LGTV infection [87]. Most ISE6
proteins with increased expression were identified as members of amino acid
metabolism, carbohydrate metabolism, vitamins/cofactor metabolism, lipid
metabolism, nucleotide metabolism, and folding/sorting/degradation pathways.
Here,

we

investigate

the

hypothesis

acid/carbohydrate/vitamin/cofactor/lipid/nucleotide

that
metabolic

ISE6
enzymes

amino
and

folding/sorting/degradation proteins with increased expression following LGTV
infection were involved in LGTV infection. In addition to identifying protein
expression change following LGTV infection, protein modification change was
identified with lysine acetylation change following LGTV infection in Chapter 3.
Increased expression of lysine acetylated histones were identified with LGTV
infection. From this observation, it was hypothesized that an increase in lysine
acetylation of histones increased LGTV infection in ISE6 cells. Currently, there is
limited knowledge on how tick proteins, specifically expression and modification
levels, effect the LGTV life cycle.
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This chapter investigated function of selected proteins identified from
Chapter 3 and from Grabowski et al [87]) on LGTV infection by employing two
complementary approaches—small molecule compound and RNAi assays. Ten
genes of interest were selected for RNAi transcript knockdown and functional
studies based on strength of protein identification and orthology. The ten selected
genes were fumarylacetoacetase (ISCW020196; Fumar; amino acid metabolism),
endoplasmic reticulum protein 29 (ISCW018425; ERP29; folding, sorting, and
degradation), 1-pyrroline-5-carboxylate dehydrogenase (ISCW015982; DPCD;
amino acid metabolism), pantetheine hydrolase (ISCW004822; CNHydro;
metabolism of cofactors and vitamins), malate dehydrogenase (ISCW003528;
MDH2; carbohydrate metabolism), poly [ADP-ribose] polymerase (ISCW019519;
PARP; replication and repair), UMP-CMP kinase (ISCW012446; CUKinase;
nucleotide metabolism), acetyl-CoA acetyltransferase (ISCW016117; ACAT1;
carbohydrate, lipid, amino acid, and terpenoids/polykeytides metabolism),
hypothetical protein (ISCW011195; Hypo195; unknown function), and hypothetical
protein (ISCW020576; Hypo576; unknown function). Transcripts for these genes
of interest were confirmed in ISE6 cells and female I. scapularis. Transcript
knockdowns were conducted and the effect on LGTV genome replication and
infectious virus release was evaluated.
Information from these studies could be used to identify tick proteins to
control TBFs. Host factors have been used to develop or identify therapeutics
against flavivirus infection [141-144] and this study provides new proteins for
potential development of therapeutics against TBFs.
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4.2 MATERIALS AND METHODS
4.2.1 Cell and virus culture
Cells and virus stocks were prepared as described in Chapter 2, Section
2.2.1.
4.2.2 LGTV infection in ISE6 cells and measurement of infectious LGTV
LGTV infection of ISE6 cells and measurement of infectious LGTV was
completed as described in Chapter 2, Section 2.2.3.
4.2.3 Compound and cell viability assays
Trichostatin A (TSA; Sigma-Aldrich; T8552) and Oligomycin A (OligoA;
Sigma-Aldrich; 75351) were re-suspended in DMSO to a final concentration of 10
mM and working concentrations of 0.01, 0.1, 1, and 10 µM concentrations.
Nicotinamide (NAM; Sigma-Aldrich; 72340) was re-suspended in cell media to a
final concentration of 100 mM and working concentrations of 100, 1,000, 10,000,
and 100,000 µM concentrations. Famotidine (FAMO; Sigma-Aldrich; F6889) was
re-suspended in DMSO to a final concentration of 10 mM and working
concentrations of 0.1, 1, 10, 100, 1,000, and 10,000 µM concentrations.
Hexachlorophene (Hexa; Sigma-Aldrich; 45526) was re-suspended in DMSO to a
final concentration of 100 mM and working concentrations of 0.1, 1, 10, 100, 1,000,
and 10,000 µM concentrations. Epigallocatechin (EGC; Sigma-Aldrich; E3768)
was re-suspended in DMSO to a final concentration of 10 mM and working
concentrations of 0.1, 1, 10, 100, 1,000, and 10,000 µM concentrations.
Epicatechin-3-gallate (ECG; Sigma-Aldrich; E3893) was re-suspended in DMSO
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to a final concentration of 100 mM and working concentrations of 0.1, 1, 10, 100,
1,000, and 10,000 µM concentrations.
96 well plates were pretreated with 0.01% Poly-L-Lysine (Sigma Aldrich;
P4832) and allowed to air dry in a biosafety cabinet. Plates were separately
seeded with ISE6 and Vero cells and incubated for 24 hours to final cell density of
~1 x105 cells/96 well, and cells were infected with LGTV passage 4, MOI of 10,
and LGTV passage 4, MOI of 3, respectively (TSA, OligoA, NAM, and FAMO were
screened in ISE6 and Vero cells; Hexa, EGC, and ECG were screened only in
ISE6 cells). Following virus adsorption, compounds diluted in DMSO (1% of total
overlay media) or in cell media were added to cells (0 hpi) and cells were incubated
at 37°C. Culture supernatants were collected at 36 hpi and used to quantify LGTV
replication by plaque assay, and 1:10 dilution of alamarBlue reagent (AbD Serotec;
BUF012A) with fresh media was placed onto infected ISE6 and Vero cells for 12
and 2 hours for subsequent cell viability readings. Fluorescence (excitation at
560nm, emission at 590 nm) was measured at 12 and 2 hours post addition using
a Molecular Devices SpectraMax M5 plate reader coupled with SoftMax Pro v4.8
software to acquire cell viability readings (see Chapter 2, Section 2.2.5). Mocktreated (pre treated cell media) cells underwent the same treatment but without
LGTV infection. Two biological replicates were conducted for each experiment and
five technical replicates were performed at with each compound concentration.
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4.2.4 Measurement of ISE6 cell concentrations
To equalize cell numbers between biological replicates and between
treatment groups prior to protein extraction, the concentration of cells in each
sample (cells/ml) was estimated. See Chapter 2, Section 2.2.2 for more detail.
4.2.5 RNA isolation and cDNA synthesis
Single I. scapularis female ticks (collected from Tippecanoe State Park,
Winimac, IN; October 29, 2013) were flash frozen in liquid N2 and ground in TRIzol
reagent (Invitrogen; 15596-026) using mortar and pestle and RNA was extracted
as per manufacturer instructions. RNA was isolated from ISE6 cells (passage 96100) grown in 96 well plates using Buffer RLT lysis buffer from the RNeasy mini kit
(Qiagen; 74104) and processed according to kit instructions. cDNA from RNA
samples using the iScript cDNA synthesis kit (BIORAD; 170-8891). Thermocycler
conditions used for cDNA synthesis were as follows: 25°C for 5 minutes, 42°C for
50 minutes, and 85°C for 5 minutes.
4.2.6 Transcript expression
Primers ranging from 300-607 bp in length were designed for genes of
interest using Primer3 software [145] in the NCBI Primer-BLAST tool
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/). cDNA template derived from
female I. scapularis or ISE6 cells, primers (25 nmole; Table 1), and Phusion highfidelity PCR master mix with HF buffer (NE Biolabs; M0531S) were used for cDNA
amplification. The following thermocycler conditions were used: 94°C for 5 minutes,
32 cycles of 94°C for 30 seconds/58°C for 30 seconds/72°C for 2 minutes, and
72°C for 7 minutes. After PCR, gel electrophoresis was performed and bands of
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expected sizes were confirmed and excised using the Qiagen gel extraction kit
(Qiagen; 28704). cDNA samples were sequenced (using forward primers from
Table 1) at the DNA Sequencing Low Throughput Laboratory (Purdue Genomics
Core Facility; Purdue University) to confirm identity of genes of interest from both
I. scapularis female ticks and ISE6 cells.
4.2.7 Synthesis of dsRNA for genes of interest
cDNA template and primers with T7 promotor sequence (50 nmole; Table
2) were used in the same manner as in Section 4.2.6 but with the following
thermocycler conditions: 94°C for 5 minutes, 5 cycles at 94°C for 30 seconds/58°C
for 30 seconds/72°C for 2 minutes (anneals the gene-specific section of the primer
to form some PCR product), next 27 cycles at 94°C for 30 seconds/68°C for 30
seconds/72°C for 2 minutes, and final extension at 72°C for 7 minutes (anneals
the entire primer site for further amplification of PCR product). PCR product of
amplified cDNA with T7 promotor sequence was used to create dsRNA with the
MEGAscript RNAi synthesis kit according to Barry et al [146].
4.2.8 Transfection of ISE6 cells with dsRNA
OptiMEM Reduced Serum Medium, Glutamax supplement (Invitrogen;
51985-034) and xtremeGENE siRNA transfection reagent (Roche; 4476093001)
were used in the transfection mix according to Barry et al [146]. ISE6 cells (~1 x
104-5) were grown for 48 hours using 96 well flat-bottom cell culture plates (pre
treated with poly-L-lysine), half of the media volume was removed, transfection mix
(xtremeGENE siRNA transfection reagent, OptiMEM, and 10 ng dsRNA) was
added to replace the removed volume, and 60 hours post transfection of ISE6 cells
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was completed. After 60 hours post transfection, media/transfection mix was
removed and resazurin salt (alamarBlue reagent) media was placed on the cells
for 12 hours growth before fluorescent measurement for cell viability reading. In
parallel, media/transfection mix was removed after 60 hours post transfection and
RNA was extracted from cells with Buffer RLT for further analysis with qRT-PCR
to confirm transcript knockdown of genes of interest.
To measure transcript knockdown effect on LGTV genome replication,
media/transfection mix was removed after 60 hours post transfection, cells were
treated with LGTV, cells were rinsed 3 x PBS, fresh media was placed on the cells
for 12 hpi, and RNA was extracted from cells with Buffer RLT for further analysis
with qRT-PCR. To measure transcript knockdown effect on LGTV replication after
knockdown, media/transfection mix was removed after 60 hours post transfection,
cells were treated with LGTV, cells were rinsed 3 x PBS, fresh media was placed
on the cells for 16 hpi, and media was collected for further analysis with plaque
assays. To measure transcript knockdown effect on LGTV replication during
knockdown, cells were first treated with LGTV, cells were rinsed 3 x PBS,
media/transfection mix was placed on the cells for 60 hours post transfection, and
media/transfection mix was collected for further analysis with plaque assays.
4.2.9 Cell viability measurement
Resazurin sodium salt solution (27.5 mM; 0.346 g in 50 mL 1XPBS) was
used in a 1:100 working stock in media for each cell viability experiment.
Fluorescent cell viability readings were obtained as described in section 2.2.5 and
in Grabowski et al [87].
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4.2.10 Relative transcript quantification
Gene expression was quantified by Quantifast SYBR Green qRT-PCR kit
(Qiagen; 204054) with cDNA derived from ISE6 cells and qRT-PCR primers (Table
3). This was used to quantify relative expression of genes of interest following
dsRNA-mediated transcript knockdown. Additionally, qRT-PCR primers targeting
the negative strand of the LGTV intermediate genome were used as in Mitzel et al
[39] to identify relative LGTV genome expression. The real-time Applied
Biosystems 7300 PCR system (Life Technologies) with MicroAmp Optical 96 well
reaction plate with labeled barcode (Life Technologies; 4306737) was used with
7300 system SDS RQ study software (v 1.4.1) to collect raw Ct cycle values. The
ΔΔCt method was used to determine transcript expression relative to I. scapularis
β-actin for the confirmation of transcript knockdown of genes of interest. Also,
transcript expression relative to I. scapularis β-tubulin was used for determining
effect on LGTV negative strand genome replication levels following transcript
knockdown of genes of interest [39].
4.2.11 DAVID functional clustering analyses
To identify biological function clusters of ISE6 proteins with KEGG orthology
and mapped to I. scapularis KEGG pathways that exhibitied increased expression
following LGTV infection and UV-LGTV treatment [87], Genebank accession IDs
were submitted for search in the Function Annotation Tool of DAVID
(http://david.abcc.ncifcrf.gov/summary). All Gene Ontology options in the DAVID
[147] clustering settings were selected for output. Significant clustering of functions
of the uploaded list of proteins was accomplished with a DAVID assignment of an
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enrichment score (≥1.3 is equal to a p value ≤0.05). Additionally, within each
cluster, a modified Fisher Exact p value (p value ≤0.05 is ideal) was given for each
function term with corresponding uploaded accession IDs.
4.2.12 Analysis of predicted protein-chemical interactions using STITCH
The software STITCH (http://stitch.embl.de; [148]) was used to identify
predicted I. scapularis protein-chemical interactions with compounds (TSA, OligoA,
NAM, FAMO, Hexa, EGC, and ECG) screened in ISE6 cells. Compound
name/abbreviation was uploaded and actions view was used with a prediction
threshold search at >0.500 confidence showing no more than 50 interactants.
4.2.13 Statistical analyses
Unpaired t-test statistical analyses were completed as described in Chapter
2, Section 2.2.6.
4.3 RESULTS
4.3.1 Small molecule compound assays identify energy processes and histone
acetylation associated with LGTV infection
Trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor and
acetylation activator of enzymes involved in intermediate metabolism, including
MDH2, decreased viability of Vero cells (with and without LGTV infection) and
LGTV replication (measured by infectious virus release pfu) directly with higher
concentrations. Conversely, an increase in TSA concentrations directly increased
ISE6 cell viability (with LGTV infection) and increased (~0.5 log pfu) LGTV
replication (Fig 1 and 2A).
The differential proteomic analysis from Chapter 3 identified candidate
histone deacetylase 1, 2, 3 (ISCW007830-PA), histone H4 (ISCW019498-PA),
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core histone H2A/H2B/H3/H4 (ISCW002300-PA). The LFQ quantitative proteomic
analysis from Chapter 3 identified candidate histone deacetylase 1, 2, 3
(ISCW007830-PA), histone H4 (ISCW019498-PA), histone (ISCW012234-PA),
histone H2B (ISCW019496-PA), histone H1 (ISCW016230-PA), histone H2A
(ISCW019497-PA and ISCW004478-PA), and histone H3 (ISCW003178-PA and
ISCW002300-PA). STITCH predicted TSA to bind to candidate histone
deacetylases

(ISCW014481-PA,

ISCW007923-PA,

ISCW008957-PA,

ISCW012528-PA, and ISCW007830-PA), bind and inhibit candidate deacetylases
(ISCW014481-PA and ISCW008957-PA), and activate candidate histones
(ISCW019498-PA and ISCW002300-PA) or candidate histone-modifying proteins
(ISCW019432-PA and ISCW007938-PA) (Fig 3).
In an attempt to inhibit the deacetylase activity of sirtuins (proteins that
regulate biological pathways via deacetylase, demyristoylase, demalonylase,
depalmitoylase, and desuccinylase activity) nicotinamide (NAM) was used and
shown to reduce LGTV replication at high concentration (105 µM) in both Vero and
ISE6 cells (Fig 4). At lower concentrations (≤102 µM), LGTV replication levels
increased in Vero cells (only 102 µM concentration shown) following NAM
treatment, this observation was not seen in ISE6 cells. The differential proteomic
analysis from Chapter 3 identified candidate sirtuin type (ISCW023257-PA) and
candidate poly [ADP-ribose] polymerase (ISCW019519-PA). The LFQ quantitative
proteomic analysis from Chapter 3 identified only candidate poly [ADP-ribose]
polymerase (ISCW019519-PA). STITCH predicted that NAM binds to and inhibits
candidate sirtuins (ISCW006267-PA, ISCW023257-PA, and ISCW011143-PA)
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and

candidate

poly

[ADP-ribose]

polymerases

(ISCW019519-PA

and

ISCW017128-PA) (Fig 5).
Oligomycin A (OligoA), a mitochondrial H+ ATPase pump inhibitor, inhibits
the end process of the electron transport chain by reducing ATP production.
Increasing concentrations of OligoA resulted in a significant decrease in the
viability of both Vero cells (~20%) and ISE6 cells (~60%) in the absence of LGTV.
We observed a significant reduction (~1.5 log reduction in pfu in Vero cells and ~2
log reduction in pfu in ISE6 cells) in LGTV in both mammalian and invertebrate
systems with increasing concentration of OligoA (Fig 1 and 2B). The differential
proteomic analysis from Chapter 3 identified candidate ATP synthase D chain
(ISCW016217-PA) of the mitochondria ATPase pump. The LFQ quantitative
proteomic analysis from Chapter 3 also identified candidate ATP synthase D chain
(ISCW016217-PA). STITCH predicted that OligoA inhibits the candidate ATP
synthase D chain (ISCW016217-PA) of the H+ ATPase pump in the mitochondria,
and activates candidate serine/threonine protein kinase (ISCW020637-PA).
In an effort to perturb the ISE6 glutaminolysis process, compounds were
selected and tested in an assay to disrupt glutamate dehydrogenase, the key
enzyme involved in creating α-ketoglutarate from glutamate (Fig 6), to evaluate the
effect on LGTV infection. The following small molecules were used in functional
compound

assays:

Famotidine

(Famo),

Hexachlorophene

(Hexa),

epigallocatechin (EGC), and epicatechin-3-gallate (ECG). A high concentration of
Famo (105 µM) reduced LGTV replication in Vero (data not shown) and ISE6 cells.
Similarly, high concentrations (103 - 104 µM) of Hexa reduced LGTV replication (103
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µM concentration did not affect cell viability) in ISE6 cells (Fig 7A and 7B). The
differential proteomic analysis from Chapter 3 identified candidate glutamate
dehydrogenase (ISCW000393-PA). The LFQ quantitative proteomic analysis from
Chapter 3 also identified candidate glutamate dehydrogenase (ISCW000393-PA).
STITCH

predicted

that

Hexa

binds

and

inhibits

candidate

glutamate

dehydrogenase (ISCW000393-PA) and binds candidate mitogen-activated protein
kinase (ISCW021966-PA).
Tea polyphenols EGC and ECG reduce LGTV replication with higher
concentrations (103 - 104 µM) and lower concentrations (10-1 - 104 µM) in ISE6 cells,
respectively (Fig 8A and 8B). EGC has a higher IC50 (>50 µM) than ECG (>1.7 µM)
[149-151]. Hexa and tea polyphenols (EGC, ECG, etc) have been found to be
allosteric regulators of GDH. The differential proteomic analysis from Chapter 3
identified candidate glutamate dehydrogenase (ISCW000393-PA). The LFQ
quantitative proteomic analysis from Chapter 3 also identified candidate glutamate
dehydrogenase (ISCW000393-PA). STITCH predicted that ECG binds candidate
glutamate dehydrogenase (ISCW000393-PA) and activates candidate cAMPdependent protein kinase catalytic subunit (ISCW018284-PA).
4.3.2 RNA interference transcript knockdown
4.3.2.1 Identifying and characterizing genes of interest for RNAi-mediated
transcript knockdown
Criteria for choosing genes of interest from hundreds of ISE6 proteins (486
ISE6 proteins from the differential proteomic screen of Chapter 3 and from
Grabowski et al [87]) were derived from protein expression change following LGTV
infection, KEGG orthology or no KEGG orthology (proteins are either orthologous
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or not orthologous based on the KEGG analysis), and stronger protein
identification (proteins identified with ≥2 peptides). Fig 9 shows the process taken
to derive ten genes of interest: FAH (Fumar), ERP29, ALDH4A1 (DPCD), VNN
(CNHydro), MDH2, PARP, CMPK1 (CUKinase), ACAT1, hypothetical protein
(Hypo195), and hypothetical protein (Hypo576).
First, ISE6 proteins that showed increased expression and with ≥ 2 peptides
were selected. Next, the remaining proteins were separated into orthologous and
non-orthologous proteins (orthologous refers to KEGG Orthology). Orthologous
proteins with putative GO function, InterPro protein domain function, and overlap
protein identifications with other flavivirus-host proteomic studies [56, 65, 109, 110]
were then separated. Non-orthologous proteins were separated based on putative
GO function and InterPro protein domain function, which was also used to identify
proteins with no known orthology and orphan proteins.
Cluster analyses provide insight into ISE6 cellular responses following
LGTV infection and UV-LGTV treatment. ISE6 proteins mapped to I. scapularis
KEGG pathways showing increased expression following only LGTV infection,
both LGTV infection and UV-LGTV treatment, and only UV-LGTV treatment [87]
were used to identify clusters of processes derived from GO descriptions from
DAVID. Ribonucleoprotein/ribosomal/translation/protein metabolic functions and
genetic/transcriptional control were the primary functions occurring with LGTV
infection and UV-LGTV treatment (45 proteins searched, DAVID used 33 for
clustering; Fig 10A). Fumar, DPCD, MDH2, PARP, and CUKinase were found to
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be involved in the ribonucleoprotein/ribosomal/translation/protein metabolic
function.
Functional cluster analyses revealed enriched translation, ribosomal
function, and protein metabolic processing (13 proteins searched, DAVID used 8
for clustering) following LGTV infection (Fig 10B). Results revealed enriched
protein transport, cytoplasmic ribonucleoprotein control, along with spliceosome
function (20 proteins searched, DAVID used 16 for clustering) following UV-LGTV
treatment. Results revealed enriched functions of nitrogen metabolic processing
as well as amine/amino acid metabolic processing (12 proteins searched, DAVID
used 9 for clustering) following both LGTV infection and UV-LGTV treatment. Of
the eight ISE6 proteins selected, MDH2 and PARP were found in the enrichment
of translation, ribosomal function, and protein metabolic processing functions.
CUKinase, DPCD, and Fumar were all found in the enrichment of nitrogen
metabolic processing and amine/amino acid metabolic processing. ACAT1 only
clustered in nitrogen metabolic processing function.
Four of the eight proteins have <50% amino acid conservation with the
human ortholog (Table 4). Additionally, the most common function that the
orthologous proteins mapped in was amino acid metabolism. Six of the eight
proteins were involved in metabolic response(s). Upon sequencing cDNA
amplified from the transcripts for the selected ten genes of interest of the female I.
scapularis tick and I. scapularis ISE6 cell line, 96 % and greater conservation was
seen from all genes of interest when compared to IscaW1 annotation gene models
(Table 5). Five genes of interest had decreased sequence similarity in ISE6 cells

107
compared to the female tick, where four genes of interest had decreased sequence
similarity in the female tick compared to ISE6 cells. CUKinase, Hypo195, and
Hypo576 had 2 or less nucleotide mismatches between female tick and/or ISE6
cell line, revealing them to be the three out of ten genes of interest with the least
amount of nucleotide change.
4.3.2.2 Confirmation of dsRNA-mediated, transcript knockdown of genes of
interest
High dsRNA concentrations was detrimental to tick cell viability. Using
dsRNA derived from exogenous pGEM, higher concentrations of 100 and 50 ng
revealed detrimental effects on ISE6 cell viability, while lower concentrations of 25
and 10 ng dsRNA showed no effect or an increase in ISE6 cell viability (Fig 11).
We observed no significant effect on cell viability of RNAi treated cells (Fig
12). In parallel with cell viability readings, transcript knockdown of all genes of
interest was confirmed through qRT-PCR (Fig 13). The 10 ng dsRNA transfections
was used for transcript knockdown of the genes of interest.
4.3.2.3 Transcript knockdown effect of genes of interest on LGTV infection
No significant effect on ISE6 cell viability occurred with transcript
knockdown of genes of interest and LGTV infection (Fig 14). Three genes of
interest (CNHydro, ACAT1, and Hypo576) revealed decreased LGTV negative
strand genome levels compared to the negative pGEM control (Fig 15). Transcript
knockdown of all genes of interest revealed a statistically-significant decrease in
LGTV replication levels compared to negative pGEM control when measuring
LGTV replication in pre knockdown ISE6 cells (Fig 16). In addition, transcript
knockdown of all but three (Fumar, PARP, and CUKinase) genes of interest
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revealed a statistically-significant decrease in LGTV replication levels compared
to the negative pGEM control when measuring LGTV replication during transcript
knockdown of genes of interest in ISE6 cells (Fig 17). Effects on LGTV infection
can be found in Table 6.
Localization of ortholog proteins were predicted as shown in Fig 18. DPCD,
MDH2, and ACAT1 are all predicted to be in the mitochondria. Fumar and
CUKinase are likely found in the cytosol. PARP and CUKinase are predicted to be
found in the nucleus. ERP29 likely maintains a presence in the endoplasmic
reticulum as a secreted protein. CNHydro is likely found in the plasma membrane.
Since no information is known on Hypo195 and Hypo576, the known locations of
these proteins is currently unknown however Hypo576 is suggested to be localized
in the cytoplasm since the transcript knockdown of this gene affected LGTV
negative strand genome replication.
4.4 DISCUSSION
4.4.1 Impact of LGTV infection on signaling in ISE6 cells
Several proteins identified from Chapter 3 were suggested to impact cellular
signaling mechanisms associated with LGTV infection [87]. The candidate histone
deacetylase 1,2,3 (ISCW007830-PA) exhibited decreased expression following
both LGTV infection and UV-LGTV treatment. Histone acetylation can impact viral
replication and virus infection can manipulate histones in order to control host
transcriptional regulation [111, 112]. Viral proteins are capable of binding
deacetylase enzymes [112] and other host proteins associated with acetylation
[152]. In other systems, it has been shown that histone deacetylase can act as a

109
co-repressor in the notch signaling pathway. It was hypothesized that LGTV
infection may be altering this histone deacetylase to better control host gene
regulation. Treatment of LGTV-infected ISE6 cells with TSA increased LGTV
replication, suggesting that LGTV infection impacts gene regulation through
histone deacetylase and associated notch signaling pathway. The candidate 40S
ribosomal protein S6 (ISCW024315-PA) and Mo25 protein (ISCW004710-PA)
exhibited increased expression in LGTV-infected cells. These proteins may be
members

of

the

mTOR

signaling

pathway

(http://www.genome.jp/kegg-

bin/show_pathway?map04150). The mTOR signaling pathway has been
implicated in Human cytomegalovirus (HCMV) infection in mammalian cells [113,
114] and DENV infection in A. aegypti mosquitoes [115]. Increased expression of
Mo25 may reflect a stress response and increased expression of S6 may reflect
an increase in translation to maintain growth of the infected cell or facilitate LGTV
replication. Manipulation of mTOR signaling has been noted with WNV infection in
mammalian systems [116] as well. The candidate calcyclin-binding protein
CacyBP (ISCW013691-PA) had increased expression in UV-LGTV- treated cells
and decreased expression in LGTV-infected cells. In other systems, CacyBP
orthologs function in the Wnt signaling pathway. Our observation suggested an
increase in proteolysis following virus treatment since the Wnt pathway is
associated with the Ca2+-dependent, ubiquitin-mediated proteolysis pathway.
Future investigations regarding roles of post-translational modifications in
regulating signaling pathways following tick-borne flavivirus infection would be a
vital research.

110
4.4.2 Identification of selected proteins associated with LGTV replication
TSA was predicted to bind to candidate histone deacetylase 1, 2, 3
(ISCW007830-PA), activates candidate histone H4 (ISCW19498-PA), and
activates candidate core histone H2A/H2B/H3/H4 (ISCW002300-PA). From these
predictions, it can be further hypothesized that TSA may increase tick histone
acetylation. This suggested that an increased amount of DNA for transcription was
produced by the cell following LGTV infection. Although metabolic enzymes have
also shown increased acetylation levels with TSA [153] in mammalian systems,
STITCH chemical-protein analyses with TSA did not predict any tick metabolic
enzymes interacting. Overall, TSA increases lysine acetylation (histones and
metabolic enzymes) and increases LGTV infection in ISE6 cells although exact
confirmation of acetylated peptides with TSA treatment was not completed. This
suggested but did not prove that an increase in lysine acetylation of ISE6 histones
increases LGTV infection. Further targeted experiments focusing on the
mechanism of histone lysine acetylation and LGTV infection will need to be
completed.
NAM has been known to inhibit sirtuins (although NAM was predicted to
inhibit poly [ADP-ribose] polymerase, most likely through feedback inhibition),
which perform deacetylation activity in the cell. The higher concentrations
screened in Vero and ISE6 cells may have saturated the effect on the cell, hence
why lower concentrations of the compound may have shown an increased LGTV
replication in Vero cells. Additionally, screening of lower concentrations (≤102 µM)

111
of NAM in ISE6 cells needs to be performed before conclusions can be made on
the biological effects from the compound on LGTV replication in the tick system.
Our in vitro studies have shown that the compounds TSA and OligoA can
affect levels of LGTV replication, presumably through impact on a variety of
metabolic processes. TSA is thought to inhibit histone deacetylases and stimulate
the acetylation of metabolic enzymes [153], while OligoA may inhibit oxidative
phosphorylation and electron transport. TSA is known to create effects on
transcription and translation that may subsequently impact metabolic pathways.
OligoA may activate AMPK activity [154], inhibit ATP production, and affect energy
levels. Thus, further studies may be required to determine the mode of action of
TSA and OligoA in the LGTV-ISE6 system.
Glutaminolysis is a process that produces an alternative energy source that
converts glutamine into the production of ATP. Increased expression of proteins
associated with glutaminolysis (Fig 6) suggest that LGTV infection in ISE6 cells
may stimulate glutaminolysis that converts glutamate to α-ketoglutarate, which is
a key intermediate in the TCA cycle. Studies suggest that glutaminolysis is
manipulated by viruses during infection of human cells by both HCMV [129, 130]
and HCV infection [56]. These studies suggest that glutaminolysis/glutamate
metabolic enzymes and α-ketoglutarate are critical for maintaining the TCA cycle,
supporting oxidative phosphorylation, and ATP production in the infected cell.
Additionally, stimulation of α-ketoglutarate has been shown to increase mTOR
activity [131, 132], which works in parallel with glutaminolysis. Small molecule
compound assays assessed the manipulation of glutamate dehydrogenase (GDH)
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activity with the goal of inhibiting activities of glutamate metabolic enzymes during
flavivirus infection. We hypothesized that Hexa disrupted glutamate metabolism
and/or glutaminolysis and decreased LGTV replication. However, assessment of
downstream metabolites from glutamate metabolism (glutamate levels) and
glutaminolysis (α-ketoglutarate levels) following these compound treatments to
cells needs to be completed in order confirm that these processes are being
affected.
4.4.3 Silencing of metabolic and protein processing functions decrease LGTV
infection
4.4.3.1 Optimization of RNA interference conditions and response in LGTV
infection
Transcript knockdown was shown not to cause detrimental effects to ISE6
cells before attempting to measure transcript knockdown effect on LGTV infection.
Figs 12 and 14 suggest that the ISE6 cell viability was not significantly affected by
transcript knockdown of genes of interest using the optimized 10 ng dsRNA. The
10 ng dsRNA concentration was sufficient for knocking down the ten genes of
interest.
By comparing the effect of transcript knockdown of genes of interest to the
LGTV 3UTR positive control on the LGTV negative strand genome replication,
potential steps of the LGTV life cycle being affected may be suggested. It was
predicted that LGTV replication levels would be within the range of the negative
pGEM and positive LGTV 3UTR controls. In combination with the effects of
transcript knockdown on LGTV negative strand genome replication, effect on
LGTV replication contributes a second measurement of the LGTV infection in ISE6
cells.
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4.4.3.2 I. scapularis metabolic and protein processing enzymes necessary for
LGTV infection
Fig 19 shows the possible mechanisms by which seven I. scapularis genes
of interest (ERP29, DPCD, CNHydro, MDH2, ACAT1, Hypo195, and Hypo576)
may affect LGTV replication. Transcript knockdown for two genes of interest with
orthology (CNHydro and ACAT1) and one gene of interest with no known function
resulted in reduction of both LGTV genome replication and LGTV replication.
CNHydro

is

involved

in

cofactors/vitamins

and

pantothenate/CoA

biosynthesis metabolism and location on the plasma membrane that can serve as
a GPI-anchored protein suggest deficiency in formation of the replication complex,
genome replication, LGTV attachment, endocytosis, release of genome into the
cytoplasm.
ACAT1

is

involved

in

carbohydrate,

lipid,

amino

acid,

and

terpenoids/polykeytides metabolism. The identification of a lipid (fatty acid)
metabolism pathway (from KEGG) suggested that ACAT1 may affect the formation
of replication complexes, which require lipids for membrane formation. Also
involved in carbohydrate (pyruvate) metabolism, ACAT1 may affect replication
complex formation through reducing necessary energy processes. The ACAT1
ortholog was identified in an HCV-HUH7.5 cell proteomic study [56], but no
expression change was observed with HCV infection.
The role of Hypo576 was also unknown. It was also suggested to affect
LGTV attachment, endocytosis, virus fusion/release of genome, the formation of
replication complexes/vacuoles, or the formation of dsRNA intermediate genome.
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RNAi-induced, transcript knockdown of genes of interest that led to no
change in LGTV negative strand genome levels compared to the negative pGEM
control may have similar effect on LGTV attachment, endocytosis, virus
fusion/release of genome, formation of replication complexes/vacuoles, or
formation of dsRNA intermediate genome with the negative control. Transcript
knockdown of three genes of interest with orthology (ERP29, DPCD, and MDH2)
and one gene of interest with unknown function (Hypo195) resulted only in a
reduction in LGTV replication.
ERP29 is involved in protein folding/sorting/degradation and its effect on
virus infection associated with transcript knockdown suggested deficiency in virion
assembly, virion egress, prM cleavage, and/or virus budding. The ERP29 ortholog
was identified in an HCV-HUH7.5 cell proteomic study [56], but no expression
change was observed with HCV infection. ERP29, an established stress response
protein, has been found with increased expression in mouse brain tissue following
Japanese Encephalitis virus (flavivirus) infection [155]. In polyomavirus infection,
ERP29 was identified to unfold viral proteins [156-158] to aid in subsequent virus
binding and release from the ER lumen, which implicates ERP29 does have the
ability to aid in virus infection. Although involved in stress response, it is unknown
whether ERP29 is directly aiding in flavivirus infection.
DPCD amino acid metabolic involvement may affect the viral protein
translation. Additionally, involvement in glutamate metabolism (predicted to
influence glutaminolysis) has an effect on energy homeostasis, which may lead to
disruption of replication complexes and/or viral proteins. DPCD completes the
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conversion of delta-1-pyrroline-5-carboxylate (P5C), which is derived either from
proline or ornithine, to glutamate. This is a necessary step in the pathway
interconnecting the urea and tricarboxylic acid cycles with glutaminolysis. In
addition, DPCD was identified with increased protein expression [56] and gene
expression [159] following HCV infection. It is unknown whether the increased
expression of DPCD aids flavivirus infection or whether it is the cell response to
stress and/or to maintain energy levels.
MDH2 carbohydrate metabolic involvement may affect the translation
and/or formation of viral proteins. A key rate-limiting enzyme in the citrate cycle
and in pyruvate metabolism may suggest that MDH2 can control energy
homeostasis levels and in parallel, affecting cellular but also viral protein
production that requires ATP. Increased protein expression of MDH2 has been
identified following HCV infection [56]. Increased transcript expression of MDH2
has been identified with bloodfed salivary gland tissue of I. scapularis nymphs [72].
In addition, MDH2 protein expression has been identified within I. scapularis
synganglia tissue [91]. It is unknown whether the increased expression of MDH2
aids flavivirus infection or whether it is the cell response to stress and/or to maintain
energy levels.
The role of Hypo195 is currently unknown. It was suggested to affect LGTV
viral protein translation, virion assembly, virion egress, prM cleavage, and/or virus
budding. In addition, Hypo195 protein expression has been identified within I.
scapularis synganglia tissue [91].
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Overall, a transcript knockdown of genes of interest that lead to decreased
LGTV negative strand genome levels and a decreased infectious LGTV release
(CNHydro, ACAT1, and Hypo576) reveal that LGTV genome replication may be
affected by reduction in viral protein translation, genome replication complexes, or
synthesis of dsRNA genome intermediate. Infectious LGTV release was reduced
in pre knockdown cells and in cells where transcript knockdown of genes of interest
was completed during LGTV infection with seven genes of interest (ERP29, DPCD,
CNHydro, MDH2, ACAT1, Hypo195, and Hypo576). This provided confidence that
the transcript knockdown of these genes can reduce TBF infection before and
during infection. This study was the first report of CNHydro, Hypo195, and
Hypo576 with increased expression following flavivirus infection. Also, this was the
first report of DPCD, CNHydro, MDH2, ACAT1, Hypo195, and Hypo576 transcript
knockdown and effect on flavivirus infection.
Three genes of interest (Fumar, PARP, and CUKinase) did not reduce
LGTV replication when transfection was completed during LGTV infection in ISE6
cells, thus were not considered to be involved with LGTV infection. Transcript
knockdown of ISE6 amino acid/vitamin/cofactor/carbohydrate/lipid metabolic
enzymes (DPCD, CNHydro, MDH2, and ACAT1) and a folding/sorting/degradation
protein (ERP29) were correlated with a decrease in LGTV replication. This
observation suggested that efficient LGTV replication (denoted as the negative
pGEM control) either directly or indirectly involved these these genes of interest.
The hypothesis that ISE6 amino acid/carbohydrate/vitamin/cofactor/lipid metabolic
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enzymes and folding/sorting/degradation proteins with increased expression
following LGTV infection were involved in LGTV infection was accepted.
4.4.3.3 Candidate proteins for future therapeutic development
Approaches to limit transmission of tick-borne pathogens may target either
the tick vector or the mammalian reservoir. Small molecule compounds may have
application for domestic/companion animals and humans, and, potentially provide
the opportunity to reduce pathogen circulation in natural reservoirs. Vaccines could
reduce pathogen circulation in domestic/companion animals, humans, and in
natural reservoirs. Antigens developed to a pathogen protein have been used for
vaccine development targeting the natural reservoir [160, 161], and this may be
possible with arthropod vector proteins as well. Currently, oral bait formulations
including vaccines targeting pathogen/tick proteins is one way to reduce pathogen
circulation and reduce transmission.
de la Fuente and Merino (2013) suggest that RNAi functional analysis of
tick proteins associated with pathogen infection are necessary before development
of protein vaccines [162]. If successful, vaccines could be developed and vaccine
conducted in clinic [163] and field [161, 164] may be completed. This project
provides the next step to functionally characterize a candidate protein for
development of new therapeutic solutions.
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4.5 FIGURES, TABLES, AND LEGENDS
Table 1. PCR primers for selected genes of interest. Abbreviated names for
genes of interest, housekeeping gene (β-actin), and RNAi controls (pGEM and
LGTV 3UTR) include Fumar = fumarylacetoacetase; ERP29 = endoplasmic
reticulum protein 29; DPCD = 1-pyrroline-5-carboxylate dehydrogenase (aldehyde
dehydrogenase 4A1); CNHydro = pantetheine hydrolase (vanin); MDH2 = malate
dehydrogenase; PARP = poly [ADP-ribose] polymerase; CUKinase = UMP-CMP
kinase; ACAT1 = acetyl-CoA acetyltransferase; Hypo195 = hypothetical protein;
Hypo576 = hypothetical protein; β-actin = beta-actin; pGEM = pGEM plasmid
cloning vector; LGTV 3UTR = LGTV strain TP21 3’ untranslated region of genome.
Primer Name
F Fumar (ISCW020196)
R Fumar (ISCW020196)
F ERP29 (ISCW018425)
R ERP29 (ISCW018425)
F DPCD (ISCW015982)
R DPCD (ISCW015982)
F CNHydro (ISCW004822)
R CNHydro (ISCW004822)
F MDH2 (ISCW003528)
R MDH2 (ISCW003528)
F PARP (ISCW019519)
R PARP (ISCW019519)
F CUKinase (ISCW012446)
R CUKinase (ISCW012446)
F ACAT1 (ISCW016117)
R ACAT1 (ISCW016117)
F Hypo195 (ISCW011195)
R Hypo195 (ISCW011195)
F Hypo576 (ISCW020576)
R Hypo576 (ISCW020576)
F β-actin (ISCW024111)∞
R β-actin (ISCW024111)∞
F pGEM
R pGEM
F LGTV 3UTR (EU790644.1)+
R LGTV 3UTR (EU790644.1)+

Primer Sequence
5’-GGTTCCAATGTCCCAGGCTA-3’
5’-CCTTGTGAAGGAGGTAGGGC-3’
5’-CGAAGTTCAAAGTGACGCTGG-3’
5’-CTGGTGATCTTTCCGTTGCG-3’
5’-TCAGCCCATCACAACAGACC-3’
5’-TTGTCCGGCACGTAGACAC-3’
5’-TACCACGGTGACGAGATTGC-3’
5’-TATGTGAGCTCCGCTTGAGG-3’
5’-CTGCGGACAAATCGCCAAAG-3’
5’-TGAAGCCCTTGACTTGAGGC-3’
5’-GCAAGGATCTTCCGCTGGAT-3’
5’-CGAAGACTCACGTCTCCACC-3’
5’-TACAAGCACCTGTCGGCG-3’
5’-TGAGGCTCTCCATGTTGTCG-3’
5’-CGTCTACGATGGCCTGACTG-3’
5’-TTCGAGCAATGGGCTTCACT-3’
5’-CAACAAACTCGGCGGCTTC-3’
5’-GCACCCTTCAGGAAGTTGCTC-3’
5’-GGAGCCCAACTGCATCTACC-3’
5’-TGAGCCTTGATGCGGTCTAC-3’
5’-GCCGGGACCTTACAGACTATC-3’
5’-CACGGACAATTTCACGCTCG-3’
5’-GGTATCAGCTCACTCAAAGG-3’
5’-GAACGACCTACACCGAACT-3’
5’-GCCAGACACAAGGAGTCCAA-3’
5’-GATGGTGGCTCAGGGAGAAC-3’

*F denotes forward primer
*R denotes reverse primer
*ISCW- - - - - - denotes VectorBase accession ID
∞Derived from [39]
+GenBank accession identified through Virus Pathogen Resource (viprbrc.org/brc)
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Table 2. T7-tagged primers for selected genes of interest. Abbreviated names
for genes of interest and RNAi controls (pGEM and LGTV 3UTR) include Fumar =
fumarylacetoacetase; ERP29 = endoplasmic reticulum protein 29; DPCD = 1pyrroline-5-carboxylate dehydrogenase (aldehyde dehydrogenase 4A1); CNHydro
= pantetheine hydrolase (vanin); MDH2 = malate dehydrogenase; PARP = poly
[ADP-ribose] polymerase; CUKinase = UMP-CMP kinase; ACAT1 = acetyl-CoA
acetyltransferase; Hypo195 = hypothetical protein; Hypo576 = hypothetical protein;
pGEM = pGEM plasmid cloning vector; LGTV 3UTR = LGTV strain TP21 3’
untranslated region of genome.
Primer Name
F T7-Fumar
(ISCW020196)
R T7-Fumar
(ISCW020196)
F T7-ERP29
(ISCW018425)
R T7-ERP29
(ISCW018425)
F T7-DPCD
(ISCW015982)
R T7-DPCD
(ISCW015982)
F T7-CNHydro
(ISCW004822)
R T7-CNHydro
(ISCW004822)
F T7-MDH2
(ISCW003528)
R T7-MDH2
(ISCW003528)
F T7-PARP
(ISCW019519)
R T7-PARP
(ISCW019519)
F T7-CUKinase
(ISCW012446)
R T7-CUKinase
(ISCW012446)
F T7-ACAT1
(ISCW016117)
R T7-ACAT1
(ISCW016117)
F T7-Hypo195
(ISCW011195)
R T7-Hypo195
(ISCW011195)
F T7-Hypo576
(ISCW020576)

Primer Sequence
5’-TAATACGACTCACTATAGGGTTCCAATGTCCCAGGCTA-3’
5’-TAATACGACTCACTATAGGGCCTTGTGAAGGAGGTAGGGC-3’
5’-TAATACGACTCACTATAGGGCGAAGTTCAAAGTGACGCTGG-3’
5’-TAATACGACTCACTATAGGGCTGGTGATCTTTCCGTTGCG-3’
5’-TAATACGACTCACTATAGGGTCAGCCCATCACAACAGACC-3’
5’-TAATACGACTCACTATAGGGTTGTCCGGCACGTAGACAC-3’
5’-TAATACGACTCACTATAGGGTACCACGGTGACGAGATTGC-3’
5’-TAATACGACTCACTATAGGGTATGTGAGCTCCGCTTGAGG-3’
5’-TAATACGACTCACTATAGGGCTGCGGACAAATCGCCAAAG-3’
5’-TAATACGACTCACTATAGGGTGAAGCCCTTGACTTGAGGC-3’
5’-TAATACGACTCACTATAGGGCAAGGATCTTCCGCTGGAT-3’
5’-TAATACGACTCACTATAGGGCGAAGACTCACGTCTCCACC-3’
5’-TAATACGACTCACTATAGGGTACAAGCACCTGTCGGCG-3’
5’-TAATACGACTCACTATAGGGTGAGGCTCTCCATGTTGTCG-3’
5’-TAATACGACTCACTATAGGGCGTCTACGATGGCCTGACTG-3’
5’-TAATACGACTCACTATAGGGTTCGAGCAATGGGCTTCACT-3’
5’-TAATACGACTCACTATAGGGCAACAAACTCGGCGGCTTC-3’
5’-TAATACGACTCACTATAGGGCACCCTTCAGGAAGTTGCTC-3’
5’-TAATACGACTCACTATAGGGAGCCCAACTGCATCTACC-3’
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R T7-Hypo576
(ISCW020576)
F T7-pGEM
R T7-pGEM
F T7-LGTV 3UTR
(EU790644.1)+
R T7-LGTV 3UTR
(EU790644.1)+

5’-TAATACGACTCACTATAGGGTGAGCCTTGATGCGGTCTAC-3’
5’-TAATACGACTCACTATAGGGGGTATCAGCTCACTCAAAGG-3’
5’-TAATACGACTCACTATAGGGGAACGACCTACACCGAACT-3’
5’-TAATACGACTCACTATAGGGCCAGACACAAGGAGTCCAA-3’
5’-TAATACGACTCACTATAGGGATGGTGGCTCAGGGAGAAC-3’

*F denotes forward primer
*R denotes reverse primer
*ISCW- - - - - - denotes VectorBase accession ID
+GenBank accession identified through Virus Pathogen Resource (viprbrc.org/brc)
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Table 3. qRT-PCR primers for selected genes of interest. Abbreviated names
for genes of interest, housekeeping genes (β-actin and β-tubulin), and LGTV
negative strand primers include Fumar = fumarylacetoacetase; ERP29 =
endoplasmic reticulum protein 29; DPCD = 1-pyrroline-5-carboxylate
dehydrogenase (aldehyde dehydrogenase 4A1); CNHydro = pantetheine
hydrolase (vanin); MDH2 = malate dehydrogenase; PARP = poly [ADP-ribose]
polymerase; CUKinase = UMP-CMP kinase; ACAT1 = acetyl-CoA
acetyltransferase; Hypo195 = hypothetical protein; Hypo576 = hypothetical protein;
β-actin = beta-actin; β-tubulin = beta-tubulin; LGTV negative strand = LGTV strain
TP21 negative strand.
Primer Name
Primer Sequence
F Fumar (ISCW020196)
TCACGTTCGAGAATCTGCCG
R Fumar (ISCW020196)
GTAGTCTCCTATGGCCACGC
F ERP29 (ISCW018425)
TCAAAGCGGTCTCACGCTAC
R ERP29 (ISCW018425)
GTACGCTGCCCTTTGTGGTG
F DPCD (ISCW015982)
TTGGAGGCAAGGAGATCAGG
R DPCD (ISCW015982)
CAGGCTGGTGTTTATCGCCT
F CNHydro (ISCW004822)
CTACAACACCAACGTGGCCT
R CNHydro (ISCW004822)
AAGGGCTCCACAAACAGGTG
F MDH2 (ISCW003528)
GGTGTTCAAGAAGCGGGGT
R MDH2 (ISCW003528)
ACGTTCACTGTGGCTGGGTC
F PARP (ISCW019519)
CTCGACGGAGTATGCCAAGT
R PARP (ISCW019519)
CATCTTGGAGAAGGCCCCAT
F CUKinase (ISCW012446)
GGCCTCTTGACCATGTCTGG
R CUKinase (ISCW012446)
AATCTTCTGACACTGGGTGCC
F ACAT1 (ISCW016117)
CAGGAGTTCTTTGGCTGCTG
R ACAT1 (ISCW016117)
TGAACACCTCCTGGACATCG
F Hypo195 (ISCW011195)
CACCTCGACAAACTGAGCAC
R Hypo195 (ISCW011195)
CGTCCGTGCATAACTGGCAA
F Hypo576 (ISCW020576)
TGGCTGAACACGGACATCAAG
R Hypo576 (ISCW020576)
TCGGGCTCAACAGGGGAC
F β-actin (ISCW024111)∞
GCCGGGACCTTACAGACTATC
R β-actin (ISCW024111)∞
CACGGACAATTTCACGCTCG
F β-tubulin (ISCW005137)
ACCTTCATTGGCAACAGCAC
R β-tubulin (ISCW005137)
CCCTCTCCGGTGTACCAGT
F LGTV negative strand (EU790644.1)+∞ GTCTCCGGTTGCAGGACTGT
R LGTV negative strand (EU790644.1)+∞ CTCGGTCAGTAGGATGGTGTTG
*qRT-PCR consisted of cDNA synthesis of I. scapularis ISE6 RNA first, then
conducting qPCR second with cDNA
*F denotes forward primer
*R denotes reverse primer
*ISCW- - - - - - denotes VectorBase accession ID
∞Derived from [39]
+GenBank accession identified through Virus Pathogen Resource (viprbrc.org/brc)
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Fig 1. Predicted effect of Trichostatin A and Oligomycin A in ISE6 cells.
Trichostatin A activation of histones and MDH2; Oligomycin A inhibition of H+ ATP
synthase pump of the mitochondria. Red denotes TCA Cycle, MDH2 enzyme with
increased expression following LGTV infection. Blue denotes TCA Cycle, CS and
FH enyzmes with decreased expression following LGTV infection.

123

Fig 2. In vitro ISE6 assay showing effects of (A) trichostatin A and (B)
oligomycin A on cell viability and LGTV replication. Release of LGTV was
assessed by viral titer (pfu/ml) using plaque assays in BHK cells. Cell viability was
determined with alamarBlue reagent and fluorescent assay and percentage was
normalized against solvent only control in both LGTV-infected and mock- treated
ISE6/Vero cells.
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Fig 3. Predicted interactions of trichostatin A on I. scapularis proteins.
Predictions were completed with STITCH (stitch.embl.de). Circles denote tick
proteins with VectorBase accession IDs. Green arrow: denotes TSA activation of
tick protein. Red line: denotes TSA inhibition of tick protein. Blue line: denotes
binding activity.
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Fig 4. In vitro ISE6 assay showing effects of nicotinamide on cell viability
and LGTV replication. Release of LGTV was assessed by viral titer (pfu/ml) using
plaque assays in BHK cells. Cell viability was determined with alamarBlue reagent
and fluorescent assay and percentage was normalized against solvent only control
in both LGTV-infected and mock- treated ISE6/Vero cells.
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Fig 5. Predicted interactions of nicotinamide on I. scapularis proteins.
Predictions were completed with STITCH (stitch.embl.de). Circles denote tick
proteins with VectorBase accession IDs. Green arrow: denotes nicotinamide
(vitamin B) activation of tick protein. Red line: denotes nicotinamide inhibition of
tick protein. Blue line: denotes binding activity.
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Fig 6. ISE6 proteins associated with glutaminolysis. ISE6 glutaminolysis and
mTOR signaling proteins altered with LGTV infection are shown. GDH denotes
glutamate dehydrogenase enzymes and Glase denotes glutaminase enzymes.
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Fig 7. In vitro ISE6 assay showing effects of (A) famotidine and (B)
hexachlorophene on cell viability and LGTV replication. Release of LGTV was
assessed by viral titer (pfu/ml) using plaque assays in BHK cells. Cell viability was
determined with alamarBlue reagent and fluorescent assay and percentage was
normalized against solvent only control in both LGTV-infected and mock-treated
ISE6/Vero cells.

129

Fig 8. In vitro ISE6 assay showing effects of (A) epigallocatechin and (B)
epicatechin-3-gallate on cell viability and LGTV replication. Release of LGTV
was assessed by viral titer (pfu/ml) using plaque assays in BHK cells. Cell viability
was determined with alamarBlue reagent and fluorescent assay and percentage
was normalized against solvent only control in both LGTV-infected and mocktreated ISE6/Vero cells.
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Fig 9. Selection of genes of interest from large-scale proteomics screen. ISE6
proteins from the differential proteomic analysis at 36 hpi was searched. Using a
combination of protein expression, protein orthology, number of peptides identified
for each protein, pathways, and predicted functional analyses, a small percentage
of proteins were selected for further downstream RNAi transcript knockdown
analyses. ISE6 proteins with increased expression, with ≥2 peptides, were
separated via presence/absence of KEGG orthology to where predicted, putative
function was used (or not used; orphan proteins) to identify a subset of selected
proteins. * denotes ortholog proteins that have been identified in other flavivirushost proteomic studies. Red denotes the followed filtering path to obtain the final
selected protein/genes of interest list.
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Fig 10. DAVID enrichment/cluster analysis identifies significant functions of
ISE6 proteins with increased expression following LGTV infection and UVLGTV treatment. ISE6 proteins with increased expression following LGTV
infection and/or UV-LGTV treatment from the differential proteomic analysis at 36
hpi was searched. Enrichment (E) score of ≥ 1.3 is equal to a ≤ 0.05 p value; higher
the E number, stronger the enrichment of proteins to that particular cluster function.
Proteins searched with all virus treatment (A) and proteins searched specific to
virus-type treatment (B) are listed. Red denotes six of the eight selected proteins
that were selected for RNAi transcript knockdown analyses.
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Table 4. Selected ISE6 proteins/genes of interest.
Tick Protein/Gene of
Ixodes
Function
Interest
scapularis
Gene Model
Accession
ID
Fumarylacetoacetase
(Fumar); K01555
Endoplasmic reticulum
protein 29 (ERP29); K09586
1-pyrroline-5-carboxylate
dehydrogenase (DPCD);
K00294
Pantetheine hydrolase
(CNHydro); K08069

ISCW020196

Malate dehydrogenase
(MDH2); K00026
Poly [ADP-ribose]
polymerase (PARP); K10798
UMP-CMP kinase
(CUKinase); K13800
Acetyl-CoA Cacetyltransferase (ACAT1);
K00626

ISCW003528

Hypothetical protein
(Hypo195)
Hypothetical protein
(Hypo576)

Human (H. sapien)
Ortholog AA %
Conservation

Amino acid
metabolism
Folding, sorting,
& degradation
Amino acid
metabolism

65.9 %

33.9 %

ISCW011195

Metabolism of
cofactors &
vitamins
Carbohydrate
metabolism
Replication &
repair
Nucleotide
metabolism
Carbohydrate,
lipid, amino acid,
terpenoids/polyk
eytides
metabolism
Unknown

ISCW020576

Unknown

ISCW018425
ISCW015982

ISCW004822

ISCW019519
ISCW012446
ISCW016117

17 %
56.7 %

68.9 %
48.6 %
40.2 %
60.2 %

---
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Table 5. Conservation of genes of interest between tick and tick cell systems.
Protein
Female tick
Alignment
ISE6 cell
Alignment
name and
transcript
expect
transcript
expect
transcript
expression
value
expression
value
length
coverage1;
coverage1;
nucleotide
nucleotide
mismatch2
mismatch2
Fumar
482/486 (99%); 4
0.0
500/506 (98%); 6
0.0
551
ERP29
491/495 (99%); 4
0.0
466/470 (99%); 4
0.0
553
DPCD
460/467 (98%); 7
0.0
466/474 (98%); 8
0.0
534
CNHydro
520/531 (97%);
0.0
500/519 (96%);
0.0
607
11
19
MDH2
252/254 (99%); 2
e-134
249/255 (97%); 6
e-125
310
PARP 310 241/250 (96%); 9
e-113
257/259 (99%); 2
e-135
CUKinase 265/267 (99%); 2
e-142
249/250 (99%); 1
e-134
349
ACAT1
240/244 (98%); 4
e-123
253/256 (98%); 3
e-133
392
Hypo195 245/246 (99%); 1
e-129
244/246 (99%); 2
e-127
300
Hypo576 424/425 (99%); 1
0.0
430/430 (100%);
0.0
483
0
1coverage denotes genes of interest length of transcript sequenced to
corresponding gene model sequence from the Wikel strain I. scapularis tick
genome W1.
2nucleotide mismatch compared to sequence of corresponding gene model from
the Wikel strain I. scapularis tick genome W1.
*Red denotes either the highest nucleotide mismatch between a gene of interest
expressed in the tick versus in the tick cell line or the lowest expect value between
a gene of interest expressed in the tick versus in the tick cell line. This reveals the
degree of nucleotide change of each of the genes of interest between wildtype
I.scapularis female tick and I.scapularis tick cells versus the I.scapularis Wikel
strain, colony-based tick.
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Fig 11. Effect of transfection with various dsRNA concentrations on ISE6 cell
viability. Xtreme (Xtr) transfection reagent was used to optimize dsRNA (pGEM
control) concentrations in ISE6 cells transfected for 60 hours. Cell viability readings
were compared with Xtreme + OptiMEM (Xtr + Opti; gray bar) control. Red boxes
denote dsRNA concentrations that were not detrimental to ISE6 cell viability. RLU
denotes relative light units (fluorescent measurement with 560 nm excitation and
590 emission). Error bars represent standard error of the mean. Statistical
unpaired t-test was completed between Xtr + Opti control and specific pGEM
dsRNA concentration. Asterisks denote: *p value≤0.05 and **p value≤0.01. Three
technical replicates for each treatment were performed within a biological replicate.
One biological replicate shown; two biological replicates were completed.
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Fig 12. Effect of transfection with dsRNA for genes of interest on ISE6 cell
viability. Abbreviated names for genes of interest and RNAi controls (pGEM and
LGTV 3UTR) include Fumar = fumarylacetoacetase (ISCW020196); ERP29 =
endoplasmic reticulum protein 29 (ISCW018425); DPCD = 1-pyrroline-5carboxylate dehydrogenase (aldehyde dehydrogenase 4A1; ISCW015982);
CNHydro = pantetheine hydrolase (vanin; ISCW004822); MDH2 = malate
dehydrogenase (ISCW003528); PARP = poly [ADP-ribose] polymerase
(ISCW019519); CUKinase = UMP-CMP kinase (ISCW012446); ACAT1 = acetylCoA acetyltransferase (ISCW016117); Hypo195 = hypothetical protein
(ISCW011195); Hypo576 = hypothetical protein (ISCW020576); pGEM = pGEM
plasmid cloning vector; LGTV 3UTR = LGTV strain TP21 3’ untranslated region of
genome. Xtreme (Xtr) transfection reagent was used with 10 ng dsRNA (pGEM,
LGTV 3UTR, and gene of interest specific) concentration in ISE6 cell transfections
of 96 wells (~1x105 cells) for 60 hours. Cell viability readings were conducted at 12
hours after the 60 hours post transfection. Cell viability readings were compared
with the negative control pGEM dsRNA (light gray bar). LGTV 3UTR dsRNA is the
positive control (dark gray bar) directed towards the LGTV genome that was used
for detrimental effect on LGTV genome replication/replication. RLU denotes
relative light units (fluorescent measurement with 560 nm excitation and 590
emission). Error bars represent standard error of the mean. Statistical unpaired ttest was completed between negative pGEM dsRNA control and specific I.
scapularis dsRNA for gene of interest. Three technical replicates for each
treatment were performed within a biological replicate. One biological replicate
shown; two biological replicates were completed.
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Fig 13. Transcript knockdown of I. scapularis genes of interest in ISE6 cells.
Abbreviated names for genes of interest and RNAi controls (pGEM and LGTV
3UTR) include Fumar = fumarylacetoacetase (ISCW020196); ERP29 =
endoplasmic reticulum protein 29 (ISCW018425); DPCD = 1-pyrroline-5carboxylate dehydrogenase (aldehyde dehydrogenase 4A1; ISCW015982);
CNHydro = pantetheine hydrolase (vanin; ISCW004822); MDH2 = malate
dehydrogenase (ISCW003528); PARP = poly [ADP-ribose] polymerase
(ISCW019519); CUKinase = UMP-CMP kinase (ISCW012446); ACAT1 = acetylCoA acetyltransferase (ISCW016117); Hypo195 = hypothetical protein
(ISCW011195); Hypo576 = hypothetical protein (ISCW020576); pGEM = pGEM
plasmid cloning vector. Relative expression was compared to I. scapularis β-actin
gene in pGEM- and specific gene of interest-transfected cDNA. pGEM dsRNAtransfected (gray bars) compared with I. scapularis-specific dsRNA-transfected
(white bars) ISE6 cells (~1x105 cells). After 10 ng dsRNA transfection was
completed, ISE6 total RNA was collected at 60 hours post transfection. Relative
transcript expression was used to identify fold change (transcript expression of
genes of interest were compared to transcript expression of β-tubulin) from ISE6
cells. Error bars represent standard error of the mean. Statistical unpaired t-test
was completed between negative pGEM dsRNA control and specific I. scapularis
dsRNA for gene of interest. Asterisks denote: *p value≤0.05, **p value≤0.01, and
***p value≤0.001. Three technical replicates for each treatment were performed
within a biological replicate. Two biological replicates were completed and shown.
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Fig 14. Effect of transfection with dsRNA for genes of interest on LGTVinfected ISE6 cell viability. Abbreviated names for genes of interest and RNAi
controls (pGEM and LGTV 3UTR) include Fumar = fumarylacetoacetase
(ISCW020196); ERP29 = endoplasmic reticulum protein 29 (ISCW018425); DPCD
= 1-pyrroline-5-carboxylate dehydrogenase (aldehyde dehydrogenase 4A1;
ISCW015982); CNHydro = pantetheine hydrolase (vanin; ISCW004822); MDH2 =
malate dehydrogenase (ISCW003528); PARP = poly [ADP-ribose] polymerase
(ISCW019519); CUKinase = UMP-CMP kinase (ISCW012446); ACAT1 = acetylCoA acetyltransferase (ISCW016117); Hypo195 = hypothetical protein
(ISCW011195); Hypo576 = hypothetical protein (ISCW020576); pGEM = pGEM
plasmid cloning vector; LGTV 3UTR = LGTV strain TP21 3’ untranslated region of
genome. Xtreme (Xtr) transfection reagent was used with 10 ng dsRNA (pGEM,
LGTV 3UTR, and gene of interest specific) concentration in ISE6 cell transfections
of 96 wells (~1x105 cells) for 60 hours, then LGTV infection was completed with
transfected cells. Cell viability readings were conducted from 12 hours post
infection. Cell viability readings were compared with the negative control pGEM
dsRNA (light gray bar). LGTV 3UTR dsRNA is the positive control (dark gray bar)
directed towards the LGTV genome that was used for detrimental effect on LGTV
genome replication/replication. RLU denotes relative light units (fluorescent
measurement with 560 nm excitation and 590 emission). Error bars represent
standard error of the mean. Statistical unpaired t-test was completed between
negative pGEM dsRNA control and specific I. scapularis dsRNA for gene of
interest. Three technical replicates for each treatment were performed within a
biological replicate. One biological replicate shown; two biological replicates were
completed.
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Fig 15. LGTV negative strand genome replication levels following
knockdown of I. scapularis transcripts for genes of interest in ISE6 cells.
Abbreviated names for genes of interest and RNAi controls (pGEM and LGTV
3UTR) include Fumar = fumarylacetoacetase (ISCW020196); ERP29 =
endoplasmic reticulum protein 29 (ISCW018425); DPCD = 1-pyrroline-5carboxylate dehydrogenase (aldehyde dehydrogenase 4A1; ISCW015982);
CNHydro = pantetheine hydrolase (vanin; ISCW004822); MDH2 = malate
dehydrogenase (ISCW003528); PARP = poly [ADP-ribose] polymerase
(ISCW019519); CUKinase = UMP-CMP kinase (ISCW012446); ACAT1 = acetylCoA acetyltransferase (ISCW016117); Hypo195 = hypothetical protein
(ISCW011195); Hypo576 = hypothetical protein (ISCW020576); pGEM = pGEM
plasmid cloning vector; LGTV 3UTR = LGTV strain TP21 3’ untranslated region of
genome. Following transcript knockdown of genes of interest (60 hours post
transfection with 10 ng dsRNA), effect on LGTV negative strand genome
replication is identified. LGTV negative strand genome replication of dsRNA for
genes of interest was compared to the negative control pGEM dsRNA (light gray
bar). LGTV 3UTR dsRNA is the positive control (dark gray bar) directed towards
the LGTV genome that was used for detrimental effect on LGTV genome
replication. Relative transcript expression was used to identify fold change
(transcript expression LGTV negative strand were compared to transcript
expression of I. scapularis β-tubulin) of LGTV genome levels from ISE6 cells
(~1x105 cells). Error bars represent standard error of the mean. Statistical unpaired
t-test was completed between negative pGEM dsRNA control and specific I.
scapularis dsRNA for gene of interest. Asterisks denote: *p value≤0.05, **p
value≤0.01, and ***p value≤0.001. Three technical replicates for each treatment
were performed within a biological replicate. Two biological replicates were
completed and shown.
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Fig 16. Infectious LGTV replication after knockdown of I. scapularis
transcripts for genes of interest in ISE6 cells. Abbreviated names for genes of
interest and RNAi controls (pGEM and LGTV 3UTR) include Fumar =
fumarylacetoacetase (ISCW020196); ERP29 = endoplasmic reticulum protein 29
(ISCW018425); DPCD = 1-pyrroline-5-carboxylate dehydrogenase (aldehyde
dehydrogenase 4A1; ISCW015982); CNHydro = pantetheine hydrolase (vanin;
ISCW004822); MDH2 = malate dehydrogenase (ISCW003528); PARP = poly
[ADP-ribose] polymerase (ISCW019519); CUKinase = UMP-CMP kinase
(ISCW012446); ACAT1 = acetyl-CoA acetyltransferase (ISCW016117); Hypo195
= hypothetical protein (ISCW011195); Hypo576 = hypothetical protein
(ISCW020576); pGEM = pGEM plasmid cloning vector; LGTV 3UTR = LGTV strain
TP21 3’ untranslated region of genome. Following transcript knockdown of genes
of interest, effect on LGTV replication (infectious virus release) is identified. LGTV
replication following transfections with dsRNA for genes of interest was compared
to the negative control pGEM dsRNA (light gray bar). LGTV 3UTR dsRNA is the
positive control (dark gray bar) directed towards the LGTV genome that was used
for detrimental effect on LGTV replication. Plaque assays with BHK15 cells were
utilized to identify effect on infectious LGTV release from ISE6 cells (~1x105 cells).
Error bars represent standard error of the mean. Statistical unpaired t-test was
completed between negative pGEM dsRNA control and specific I. scapularis
dsRNA for gene of interest. Asterisks denote: **p value≤0.01 and ***p value≤0.001.
Five technical replicates for each treatment were performed within a biological
replicate. One biological replicate shown; two biological replicates were completed.
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Fig 17. Infectious LGTV replication during knockdown of I. scapularis
transcripts for genes of interest in ISE6 cells. Abbreviated names for genes of
interest and RNAi controls (pGEM and LGTV 3UTR) include Fumar =
fumarylacetoacetase (ISCW020196); ERP29 = endoplasmic reticulum protein 29
(ISCW018425); DPCD = 1-pyrroline-5-carboxylate dehydrogenase (aldehyde
dehydrogenase 4A1; ISCW015982); CNHydro = pantetheine hydrolase (vanin;
ISCW004822); MDH2 = malate dehydrogenase (ISCW003528); PARP = poly
[ADP-ribose] polymerase (ISCW019519); CUKinase = UMP-CMP kinase
(ISCW012446); ACAT1 = acetyl-CoA acetyltransferase (ISCW016117); Hypo195
= hypothetical protein (ISCW011195); Hypo576 = hypothetical protein
(ISCW020576); pGEM = pGEM plasmid cloning vector; LGTV 3UTR = LGTV strain
TP21 3’ untranslated region of genome. dsRNA transfection of genes of interest
and LGTV infection were carried out at the same time. At 60 hours post
transfection/infection, effect on LGTV replication (infectious virus release) was
identified. LGTV replication during transfections with dsRNA for genes of interest
was compared to the negative control pGEM dsRNA (light gray bar). LGTV 3UTR
dsRNA is the positive control (dark gray bar) directed towards the LGTV genome
that was used for detrimental effect on LGTV replication. Plaque assays with
BHK15 cells were utilized to identify effect on infectious LGTV release from ISE6
cells (~1x105 cells). Error bars represent standard error of the mean. Statistical
unpaired t-test was completed between negative pGEM dsRNA control and
specific I. scapularis dsRNA for gene of interest. Asterisks denote: *p value≤0.05,
**p value≤0.01, and ***p value≤0.001. Five technical replicates for each treatment
were performed within a biological replicate. One biological replicate shown; two
biological replicates were completed.
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Table 6. Summary of transcript knockdown effect of genes of interest on
LGTV infection in ISE6 cells.
Selected tick
protein

Ixodes
scapularis
gene model
accession
ID

Fumarylacetoace
tase (Fumar)∞;
K01555
Endoplasmic
reticulum protein
29 (ERP29);
K09586
1-pyrroline-5carboxylate
dehydrogenase
(DPCD); K00294
Pantetheine
hydrolase
(CNHydro);
K08069
Malate
dehydrogenase
(MDH2)Δ;
K00026
Poly [ADPribose]
polymerase
(PARP)∞;
K10798
UMP-CMP
kinase
(CUKinase)∞;
K13800
Acetyl-CoA Cacetyltransferase
(ACAT1);
K00626

ISCW020196

Amino acid
metabolism

ISCW018425

Hypothetical
protein
(Hypo195)Δ
Hypothetical
protein
(Hypo576)
Δdenotes

Function

Human (H.
sapien)
Ortholog
AA %
Conservati
on

Transcript
knockdown
effect on
infectious
LGTV
replication

65.9 %

Transcript
knockdown
effect on
LGTV
negative
strand
genome
replication
No change

Folding,
sorting, &
degradation

17 %

No change

Decreased

ISCW015982

Amino acid
metabolism

56.7 %

No change

Decreased

ISCW004822

Metabolism of
cofactors &
vitamins

33.9 %

Decreased

Decreased

ISCW003528

Carbohydrate
metabolism

68.9 %

No change

Decreased

ISCW019519

Replication &
repair

48.6 %

No change

No change

ISCW012446

Nucleotide
metabolism

40.2 %

No change

No change

ISCW016117

60.2 %

Decreased

Decreased

ISCW011195

Carbohydrate,
lipid, amino
acid,
terpenoids/poly
keytides
metabolism
Unknown

--

No change

Decreased

ISCW020576

Unknown

--

Decreased

Decreased

No change

protein identified in I. scapularis synganglia [91]
Fumar, PARP, and CUKinase transcript knockdowns during LGTV
infection in ISE6 cells did not decrease LGTV replication

∞denotes
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Fig 18. Predicted cellular locations of selected proteins in ISE6 cells. Selected
proteins are shown in cellular locations based off knowledge of orthologous protein
locations. Black circles denote ribosomes. Blue lines denote positive strand, LGTV
RNA genomes. Orange lines denote negative strand, LGTV RNA genomes used
as a template for further positive strand, LGTV RNA genome production. Red
circles denote viral proteins in association with replication complexes on/in the ER.
Purple particles/virions denote immature LGTV before prM-furin cleavage. Green
circles denote furin, which cleaves pr from prM, creating mature LGTV. Different
colored proteins denote different expression levels following LGTV infection and
UV-LGTV treatment.
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Fig 19. Predicted effects of genes of interest transcript knockdown on LGTV
life cycle steps. Different colored proteins denote different expression levels
following LGTV infection and UV-LGTV treatment.
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Jeffrey Michael Grabowski
(260)409-6435
jgrabows@purdue.edu
(Curriculum Vitae)
Professional Preparation:
PURDUE UNIVERSITY, Interdisciplinary Life Science Ph.D (PULSe)
(Expected) August

2015
(Dept Entomology and Biological Sciences collaboration; Microbiology concentration)
Advisors: Drs. Catherine A. Hill and Richard J. Kuhn
Thesis Topic: Tick-flavivirus interactions: host proteins affected by virus infection
MANCHESTER UNIVERSITY (as of 2012), Cum Laude, B.S. in Biology
May 2009
Cum. GPA: 3.71 / 4.00
Minor in Chemistry
Undergraduate Thesis: Monitoring Black-legged ticks (Ixodes scapularis), American Dog
ticks (Dermacentor variabilis) and Borrelia burgdorferi in southern Kosciusko county,
IN Advisors: Drs. David P. Kreps (retired) and Jerry E. Sweeten
Appointments:
NIH Intramural Research Postdoctoral Training Award (IRTA) Scientist
2015ongoing
NIAID/NIH Rocky Mountain Laboratories, Hamilton, MT. Primary Investigator: Dr.
Marshall E. Bloom.
• Biology of vector-borne viruses section
NSF Graduate Research Fellow/ICTSI Predoctoral Trainee (Ph.D graduate student)
2010-2015
Research profiles: http://www.gradschool.purdue.edu/oigp/students/PULSe/profile10.cfm
http://www.gradschool.purdue.edu/pulse/profiles/profile12.cfm
http://bilbo.bio.purdue.edu/~viruswww/Kuhn_home/research.php#Jeff
Purdue University, West Lafayette, IN. Advisors: Drs. Catherine Hill and Richard Kuhn.
• Flavivirus host cell factor analyses
o Mass spectroscopy proteomics
o Functional analyses
o Molecular Virology
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o Systems biology
o Medical Entomology/Vector Biology
Graduate Assistant (Ph.D graduate student)
2009-2010
Purdue University, West Lafayette, IN. Advisors: Drs. Catherine Hill, Arun Bhunia,
Richard Kuhn, and Doug LaCount.
•
Bioinformatics of tick heme biosynthesis proteins
• Cloning expressions of LAP protein in Listeria
monocytogenes
• Mass spectroscopy lipidomics of virus-infected cells
• Wheat Germ extract analysis of P. falciparum-host proteins
Lyme disease Student Research Scientist (undergraduate student)
2008-2009
Faculty-Student Research, Manchester College, N. Manchester, IN. Monitoring Blacklegged ticks (Ixodes scapularis), American Dog ticks (Dermacentor variabilis) and
Borrelia burgdorferi in southern Kosciusko county, IN. Collaborators: Dr. David P.
Kreps.
• Discovered and designed the study
• Obtained project funding
• Ecological field methods to look at Lyme disease dynamics
• Fluorescent microscopy
• Supervised undergraduates in research study
Lyme Disease REU Student Researcher (undergraduate student)
2007
“Ecology in Context” REU Program, Cary Institute of Ecosystem Studies (CIES),
Millbrook, NY. Invasive earthworm species effects on the density and microscale habitat
of Ixodes scapularis nymphs in Dutchess County, NY. Advisors: Drs. Mary Killilea and
Rick Ostfeld.
• NSF funded through CIES undergraduate grant
• Ecological field methods to look at Lyme disease dynamics
• Fluorescent Microscopy
Awards and Honors:
*PULSe Travel Grant
2015
*Health and Disease: Science, Culture and Policy 2nd place graduate student poster
2015
*PULSe Travel Grant
2014
*ASV Annual Meeting Student Travel Grant Award
2014
*Entomological Society of America Monsanto Research Grant Award
2013
- http://www.entsoc.org/press-releases/esa-names-2013-monsanto-student-grant-winners
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*Purdue Interdisciplinary Graduate Program Presentation Excellence Award
2013
- http://www.gradschool.purdue.edu/oigp/calendar/winners.cfm
*Indiana CTSI Annual Meeting Outstanding Poster Presentation
2012
*Purdue Interdisciplinary Graduate Program Most Outstanding Project Award
2012
*Purdue College of Agriculture (Interdisciplinary) TEAM Award
2012
http://www3.ag.purdue.edu/entm/Lists/News/DispFormNoSummary.aspx?List=8a0d6fbd
-206c-4231-9f9a-83f1da3610f6&ID=233
*ASV Annual Meeting Student Travel Grant Award
2012
*ESA North Central Branch Presidential Student Travel Scholarship Award
2012
*Entomological Society of America NCB 3rd place Ph.D graduate student poster
2011
*PULSe 1st Year Poster Competition-Runners Up
2010
*Manchester College Director’s Award
2009
*HCAC Academic All-Conference Athlete
2007-2009
*Manchester College Dean’s List Recipient
2005-2009
*Chi Alpha Sigma ( XA∑ ) National College Athlete Honor Society
2008
Funding History:
*PULSe Travel Grant
2015
*PULSe Travel Grant
2014
*ASV Annual Meeting Student Travel Grant Award
2014
*Entomological Society of America Monsanto Research Grant Award
2013
- Proposal Title: “Identifying novel targets for pest control: elucidating the function of
orphan proteins of the Acari (ticks and mites)”
- funding for cell culture and gene knockdown experiments
*Author/coauthor of Indiana CTSI Core Pilot Grant- funded to PI Richard J Kuhn
2013-2015
- Proposal Title: “Comprehensive proteomic analysis of the Ixodes scapularis disease
vector during tick-borne flavivirus infection”
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- NIH/NCATS- Indiana Clinical and Translational Sciences Institute – #UL1
TR000006
*Indiana CTSI Predoctoral Training Award Program
2012-2014
- Proposal Title: “Tick-borne Langat flavivirus growth and host proteome change
following infection: a novel approach to discover host proteins for viral-therapeutic
development”
- NIH/NCATS- Indiana Clinical and Translational Sciences Institute – TL1 Program
(A. Shekhar, PI), 5/01/08-04/30/13
*ASV Annual Meeting Student Travel Grant Award
2012
*ESA North Central Branch Presidential Student Travel Scholarship Award
2012
*NSF Graduate Research Fellowship Program (DGE 1333468)
2010-2015
- Proposal Title: “Molecular basis of tick-virus infection: novel approaches for
flavivirus control”
*Purdue Graduate School Incentive Grant
2010
*Manchester College Faculty-Student Summer Research Grant
2008
*National Science Foundation REU Summer Research Funding (DBI 0552871)
2007
-Website: http://nsf.gov/awardsearch/showAward?AWD_ID=0552871
*Lilly Endowment Inc. Student Grant
2006
Publications (in prep and current):
*Jeffrey M. Grabowski, Monika Gulia-Nuss, Michael F. Oats, Rushika Perera, Richard
J. Kuhn, and Catherine A. Hill. Functional knockdown of Ixodes scapularis ISE6 cell
metabolic and protein processing genes reduce tick-borne Langat virus infection. In Prep
For Insect Biochemistry and Molecular Biology.
*Jeffrey M. Grabowski, Tiago Sobreira, Victoria Hedrick, Ernesto Nakayasu, Lake
Paul, Devika Sirohi, Rushika Perera, Catherine A. Hill, and Richard J. Kuhn. Neuronal
proteins, biological pathway fluctuations, and lysine acetylation associated with Langat
virus-infected I. scapularis ISE6 cells. In Prep For Journal of Proteome Research.
*Nunya Chotiwan, Irma Sanchez-Vargus, Jeffrey M Grabowski, Amber Hopf-Jannasch,
Victoria E Hedrick, Erik Gough, Devika Sirohi, Catherine A Hill, Richard J Kuhn, and
Rushika Perera. Analysis of the Lipidome of the Mosquito Vector During Dengue Virus
Infection. In Prep For PLoS Neglected Tropical Diseases.
*Jeffrey M. Grabowski, Rushika Perera, Ali M. Roumani, Victoria Hedricks, Dorota
Inerowicz, Catherine A. Hill, and Richard J. Kuhn. 2015. Global protein changes in
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Langat-infected Ixodes scapularis ISE6 cells: tick energy-metabolism and glutaminolysis
pathways associated with flavivirus infection. PLoS Neglected Tropical Diseases, in
review.
*Catherine A. Hill, Jason M. Meyer, Jason Miller, Brian Walenz, Sergey Koren, Jessica
Hostseller, Karyn Megy, Mathangi Thiagarahan, Martin Hammond, Vinita Joardar, Dan
Lawson, Linda Hannick, Shelby Bidwell, Andrew B. Nuss, Jenica L. Abrudan, Nieves
Ayllón, Francisca C. Almeida, Brooke W. Bissinger, Elena Bonzón-Kulichenko, Daniel
R. Caffrey, Melissa J. Caimano, Vincent Croset, Don Gilbert, Joseph Gillespie, Gloria I.
Giraldo-Calderón, Jeffrey M. Grabowski, David Jiang, Sayed M.S. Khalil, Donghun
Kim, Katherine M. Kocan, Juraj Koči, Richard J. Kuhn, Tim J. Kurtti, Emma G. Lang,
Joyce Sakamoto, Ryan C. Kennedy, Hyeogsun Kwon, Rushika Perera, Yumin Qi, Justin
D. Radolf, Alejandro Sanchez-Gracia, Maria S. Severo, Neal Silverman, Ladislav Šimo,
Marta Tojo, Christian Tornador, Janice P. Van Zee, Jesús Vázquez, Filipe G. Vieira,
Margarita Villar, Adam R. Wespiser, Yunlong Yang, Jiwei Zhu, Peter Arensburger,
Patricia V. Pietrantonio, Stephen C. Barker, Renfu Shao, Evgeny M. Zdobnov, José M.
Ribeiro, Frank Hauser, Cornelius J.P. Grimmelikhuijzen, Yoonseong Park, Kristin M.
Lees, David B. Sattelle, Julio Rozas, Richard Benton, Joao H.F. Pedra, R. Michael Roe,
Daniel E. Sonenshine, David R. Nelson, Maria F. Unger, Jose M.C. Tubio, Zhijian Tu,
Hugh M. Robertson, José de la Fuente, Robert M. Waterhouse, Granger Sutton, Martin
Shumway, Jennifer M. Wortman, Stephen K. Wikel, Vishvanath M. Nene, Frank Collins,
Bruce Birren, Karen E. Nelson, Elisabet Caler. 2015. Genomic clues to a unique parasitic
lifestyle in the Lyme disease tick, Ixodes scapularis. Nature Communications, in review.
*Theresa D'Aquila, Devika Sirohi, Jeffrey M Grabowski, Victoria E Hedrick, Lake N
Paul, Andrew S Greenburg, Richard J Kuhn, and Kimberly K Buhman. 2015.
Characterization of the proteome of cytoplasmic lipid droplets in mouse enterocytes after
a dietary fat challenge. PLoS ONE 10(5): e0126823.
*Jeffrey M. Grabowski, Mary E. Killilea, and Richard S. Ostfeld. 2007. Invasive
earthworm species effect on the density and microscale habitat of Ixodes scapularis
nymphs in Dutchess County, NY. Undergraduate Ecology Research Reports 2007, Cary
Institute (online publication:
http://www.ecostudies.org/reprints/Grabowski_2007_REU.pdf).
Abstract Publications:
*Perera R, Chotiwan N, Andre B, Vargus I, Grabowski J, Hopf-jannasch A, Gough E,
Nakayasu E, Hill CA, Kuhn RJ. 2015. Metabolic pathways that may regulate vector
competence in Aedes aegypti uring dengue virus infection. EMBO: Molecular and
Population Biology of Mosquitoes and Other Disease Vectors. Kolymbari, Greece.
(submitted abstract-Perera presentation)
*Grabowski J, Gulia-Nuss M, Sobreira T, Hedrick V, Nakayasu E, Roumani AM, Paul
L, Inerowicz HD, Sirohi D, Perera R, Hill CA, and Kuhn RJ. 2015. New tick protein
targets to control transmission of tick-borne flaviviruses. Keystone Symposia- The
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Arthropod Vector: The Controller of Transmission. Sagebrush Inn & Suites, Taos, NM.
(poster presentation)
*Perera R, Chotiwan N, Vargus I, Andre B, Grabowski J, Hopf-jannasch A, Hedrick V,
Gough E, Nakayasu E, Sirohi D, Hill CA, Kuhn RJ. 2015. Metabolic pathways that
regulate vector competence in Aedes aegypti during dengue virus infection. Keystone
Symposia- The Arthropod Vector: The Controller of Transmission. Sagebrush Inn &
Suites, Taos, NM. (Perera oral presentation)
*Grabowski J, Gulia-Nuss M, Sobreira T, Hedrick V, Nakayasu E, Roumani AM, Paul
L, Inerowicz HD, Sirohi D, Perera R, Hill CA, and Kuhn RJ. 2015. New tick protein
targets to control transmission of tick-borne flaviviruses. Interdisciplinary Graduate
Program Reception. Purdue University. (poster presentation)
*Grabowski J, Gulia-Nuss M, Sobreira T, Hedrick V, Nakayasu E, Roumani AM, Paul
L, Inerowicz HD, Sirohi D, Perera R, Hill CA, and Kuhn RJ. 2015. New tick protein
targets to control transmission of tick-borne flaviviruses. Health and Disease: Science,
Culture and Policy Poster Session. Purdue University, West Lafayette, IN. (programpublished abstract-Poster Presentation)
*Chotiwan N, Vargus I, Grabowski J, Hopf-jannasch A, Hedrick V, Gough E, Nakayasu
E, Sirohi D, Hill CA, Kuhn RJ, Perera R. 2014. Exploring the cellular metabolome as a
gateway to target dengue virus replication in the mosquito vector. Annual American
Society of Tropical Medicine and Hygiene Meeting. New Orleans Sheraton Hotel, New
Orleans, LA. (program-published abstract-Chotiwan oral presentation)
*Chotiwan N, Vargus I, Grabowski J, Hopf-jannasch A, Hedrick V, Gough E, Sirohi D,
Hill CA, Kuhn RJ, Perera R. 2014. Analysis of the lipidome of the mosquito vector
during dengue virus infection. Annual American Society for Virology Meeting. Colorado
State University, Fort Collins, CO. (program-published abstract-Chotiwan poster
presentation)
*Grabowski J, Perera R, Roumani AM, Hedrick V, Inerowicz HD, Gulia-Nuss M, Nuss
AB, Hill CA, and Kuhn RJ. 2014. Host proteome changes following infection with
Langat virus: energy-associated and glutaminolysis enzymes involved in tick-borne
flavivirus infection. Annual American Society for Virology Meeting. Colorado State
University, Fort Collins, CO. (program-published abstract-Oral Presentation)
*Grabowski, J, Perera, R, Roumani, AM, Hedrick, V, Inerowicz, HA, Hill, C, and Kuhn,
R. 2014. Host proteome changes following infection with the Langat virus: identification
of novel targets for tick-borne flavivirus control. 2014 ACTS Translational Science
Meeting. Omni Shoreham Hotel, Washington D.C. (program-published abstract-Poster)
*Grabowski, J, Perera, R, Roumani, AM, Hedrick, V, Inerowicz, HA, Hill, C, and Kuhn,
R. 2013. Development of a tick-borne Langat virus-Ixodes scapularis ISE6 cellular
proteomic screen: identification of novel targets for tick-borne flavivirus control. 2013
Entomological Society of America Meeting. Austin Convention Center, Austin, TX.
(program-published abstract-Poster)
*Grabowski, J, Perera, R, Roumani, AM, Hedrick, V, Inerowicz, HA, Hill, C, and Kuhn,
R. 2013. Development of a tick-borne Langat virus-Ixodes scapularis ISE6 cellular
proteomic screen: identification of novel targets for tick-borne flavivirus control. 2013
Annual Indiana CTSI Meeting. Indiana University-Purdue University Indianapolis
University. (program-published abstract-Poster)
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*Grabowski, J, Perera, R, Roumani, AM, Hedrick, V, Inerowicz, HA, Hill, C, and Kuhn,
R. 2013. Development of a tick-borne Langat virus-Ixodes scapularis ISE6 cellular
proteomic screen: identification of novel targets for tick-borne flavivirus control. 7th
Annual Arthropod Genomics Symposium. Notre Dame University. (program-published
abstract-Poster)
*Grabowski, J, Perera, R, Roumani, AM, Hedrick, V, Inerowicz, HA, Hill, C, and Kuhn,
R. 2013. Development of a tick-borne Langat virus-Ixodes scapularis ISE6 cellular
proteomic screen: a novel system to discover host proteins for viral-therapeutic
development. 2013 CTSA National Predoctoral Programs Meeting. Mayo Clinic.
(program-published abstract-Poster)
*Grabowski, J, Perera, R, Roumani, AM, Hedrick, V, Inerowicz, HA, Hill, C, and Kuhn,
R. 2013. Development of a tick-borne Langat virus-Ixodes scapularis ISE6 cellular
proteomic screen: identification of novel targets for tick-borne flavivirus control.
Interdisciplinary Graduate Program Reception. Purdue University. (poster presentation)
*Perera, R, Hopf-Jannasch, A, Hedrick, V, Grabowski, J, Hill, C, and Kuhn, R. 2013. A
balancing act: Changes in the cellular metabolome required for Dengue virus replication.
Keystone Symposia: Positive Strand RNA Viruses. Boston, Massachusetts. (programpublished abstract: Perera oral presentation)
*Perera, R, Hopf-Jannasch, A, Khadka, S, Grabowski, J, Edwards, T, LaCount, D, Hill,
C, and Kuhn, R. 2013. Invading the cellular metabolome: A hallmark of Dengue virus
infection of the human host and mosquito vector. 32nd Annual Meeting of American
Society of Virology. Penn State University. (submitted abstract: Perera poster
presentation)
*Grabowski, J, Perera, R, Roumani, AM, Hedrick, V, Inerowicz, HA, Hill, C, and Kuhn,
R. 2012. Properties of tick-borne Langat virus during growth in Ixodes scapularis ISE6
cells and host proteome change following infection. 2012 Annual Indiana CTSI Meeting.
Indiana University-Purdue University Indianapolis University. (program-published
abstract-Oral Presentation)
*Grabowski, J, Perera, R, Hill, C, and Kuhn, R. 2012. Properties of tick-borne Langat
virus during growth in Ixodes scapularis ISE6 cells and host proteome change following
infection. 31st Annual Meeting of American Society for Virology. University of
Wisconsin-Madison. (program-published abstract-Oral Presentation)
*Grabowski, J, Perera, R, Hill, C, and Kuhn, R. 2012. Properties of tick-borne Langat
virus during growth in Ixodes scapularis ISE6 cells and host proteome change following
infection. Entomological Society of America: North Central Branch Meeting. University
of Nebraska. (program-published abstract-Oral Presentation)
*Grabowski, J, Perera, R, Hill, C, and Kuhn, R. 2012. Properties of tick-borne Langat
virus during growth in Ixodes scapularis ISE6 cells and host proteome change following
infection. Interdisciplinary Graduate Program Reception. Purdue University. (programpublished abstract-Poster)
*Grabowski, J, Perera, R, Hill, C, and Kuhn, R. 2012. Properties of tick-borne Langat
virus during growth in Ixodes scapularis ISE6 cells and host proteome change following
infection. 127th Annual Meeting of Indiana Academy of Science: Microbiology &
Molecular Biology Section. Purdue University. (program-published abstract -Oral
Presentation)
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*Grabowski, J, Perera, R, Hill, C, and Kuhn, R. 2012. Properties of tick-borne Langat
virus during growth in Ixodes scapularis ISE6 cells and host proteome change following
infection. Purdue Chapter Sigma Xi Poster Award Competition. Purdue University.
(program-published abstract-Poster)
*Grabowski, J, Perera, R, Hill, C, and Kuhn, R. 2011. Properties of tick-borne Langat
virus during growth in Ixodes scapularis ISE6 cells and host proteomic change following
infection. Biological Sciences Retreat. Purdue University. (program-published abstractPoster)
*Perera, R, Riley, C, Junjohn, J, Edwards, T, Hopf-Jannasch, A, Mezengie, G,
Grabowski, J, Hill, C, Metz, T, Moore, R, Weitz, K, Pasa-Tolic, L, Adamec, J, and
Kuhn, R. 2011. Dengue virus alters membrane architecture and lipid composition of
mammalian and insect cells during its replication cycle. 4th Annual Membrane
Symposium on Center for Basic and Applied Studies on Membrane Proteins (PUBAMS).
Purdue University. (program-published abstract: Perera oral presention)
*Grabowski, J, Perera, R, Hill, C, and Kuhn, R. 2011. Properties of tick-borne Langat
virus during growth in Ixodes scapularis ISE6 cells. Interdisciplinary Graduate Program
Reception. Purdue University. (program-published abstract-Poster)
*Grabowski, J, Perera, R, Hill, C, and Kuhn, R. 2011. Properties of tick-borne Langat
virus during growth in Ixodes scapularis ISE6 cells. Entomological Society of America:
North Central Branch Meeting. University of Minnesota. (program-published abstractPoster)
*Grabowski, J, Perera, R, Hill, C, and Kuhn, R. 2010. Properties of tick-borne Langat
virus during growth in Ixodes scapularis ISE6 cells. Purdue Chapter Sigma Xi Poster
Award Competition. Purdue University. (program-published abstract-Poster)
*Grabowski, J and Kreps, D. 2009. Monitoring Deer Ticks (Ixodes scapularis) and
Borrelia burgdorferi in Southern Kosciusko County, IN. Manchester University Student
Research Symposium, North Manchester, IN. (program-published abstract -Oral
Presentation)
*Grabowski, J and Kreps, D. 2008. Monitoring Deer Ticks (Ixodes scapularis) and
Borrelia burgdorferi in Southern Kosciusko County, IN. Manchester University Science
Seminar, North Manchester, IN. (program-published abstract -Oral Presentation)
Video: http://users.manchester.edu/Facstaff/CWatson/Seminar/0809/Sept22/Sept22.htm
*Grabowski, J, Killilea, M, and Ostfeld, R. 2007. Invasive earthworm species effect on
the density and microscale habitat of Ixodes scapularis nymphs in Dutchess County, NY.
123rd Annual Meeting of Indiana Academy of Science: Ecology Section. University of
Indianapolis. (program-published abstract -Oral Presentation)
*Grabowski, J, Killilea, M, and Ostfeld, R. 2007. Invasive earthworm species effect on
the density and microscale habitat of Ixodes scapularis nymphs in Dutchess County, NY.
Cary Institute for Ecosystems Study REU Undergraduate Symposium. Millbrook, NY.
(program-published abstract -Oral Presentation)
Research Advisor of Lab Personnel:
*Purdue Department of Biological Sciences Rotation Student- Michael F. Oats
2014
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*Purdue Department of Biological Sciences Undergraduate Student- Scott Marr
2011-2012
*Manchester Department of Biology Undergraduate Students- Kyle Carlson, Alec
Womboldt, and Hannah Reed
2008-2009
Synergistic Activities:
*Coalition for Clinical and Translational Science Capitol Hill Advocacy Day – Indiana
Team Member, Washington D.C.
2014
News Story Result: http://news.sciencemag.org/funding/2014/06/u-s-senate-bill-wouldgive-nih-2-raise-2015
*Bioinformatics Resource for Invertebrate Vectors of Human Pathogens (VectorBase)
User Advisor
Website: https://www.vectorbase.org/sug
2014-current
*Influenza Research Database (IRD)/Virus Pathogen Resource (ViPR) User Advisor
Website:http://www.viprbrc.org/brc/staticContent.do?decorator=vipr&type=ViprInfo&su
btype=ScienceSupport
2012-current
*Teacher Assistant, ENTM 525: Medical and Veterinary Entomology
spring 2013
• Dr. Catherine A Hill, Purdue University, ENTM Department
*Personal Invitations
• NIAID/NIH Rocky Mountain Laboratories, Laboratory of Virology Seminar
o Host: Marshall E. Bloom
o Seminar Title: The proteomics of tick-flavivirus interactions: studies of
the Ixodes scapularis-Langat virus system
March 2015
• Office of Interdisciplinary Graduate Programs Most Outstanding Interdisciplinary
Program Award (MOIPA) Reviewer
2014-2015
• Student presentation at Society for Vector Ecology Meeting (kindly declined)
2014
st
• PULSe 1 Year Poster Competition
2014
o Judge
• Purdue Entomology Department Booth Exhibitor
2013
o Entomological Society of America Meeting
• Office of Interdisciplinary Graduate Programs Student Resource Panel Member
2013
o Discussion Panelist
• PULSe Seminar Series Talk (October 15)
2012
• PULSe “NSF Review Workshop”
2012-2013
o Co-Host Speaker
• PULSe Preliminary Exam Panel Member
2012
o Discussion Panelist
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•
NSF

Purdue Department of Entomology “Survival Skills Workshop”: Applying for
2011
o Host Speaker
• PULSe 1st Year Poster Competition
2011
o Judge
• NSF Peer Mentoring-Graduate Fellow Panel Member, Purdue Graduate School
2010-2014
o Discussion Panelist
o Provided successful application for public view
o Liason for students regarding NSF GRFP questions
*PGSG Senator
2012-2013
• Advancement Committee
*PULSe Graduate Student Organization (GSO)
• Vice President
2011-2012
• Activities Coordinator
2010-2011
*Purdue SURF Symposium Poster Presentation Judge
2011
*Poster Presentation Title: New tick protein targets to control transmission of tick-borne
flaviviruses
• Keystone Symposia- The Arthropod Vector: The Controller of Transmission.
Sagebrush Inn & Suites, Taos, NM.
2015
• Interdisciplinary Graduate Program Reception, Purdue University, IN.
2015
• Health and Disease: Science, Culture and Policy Poster Session, Purdue
University, IN.
2015
*Poster Presentation Title: Host proteome and energy/glutaminolysis enzyme change
with Langat infection
• Interdisciplinary Graduate Program Reception, Purdue University, IN.
2014
• PULSe Welcome Reception and Poster Competition, Purdue University, IN. 2014
*Oral Presentation Title: Host proteome and energy/glutaminolysis enzyme change with
Langat infection
• Annual ASV Meeting: Flavivirus I Section, Fort Collins, CO
2014
• Rossmann/Kuhn Seminar, West Lafayette, IN
2014
• ICTSI Spring Reception, West Lafayette, IN
2014
*Oral Presentation Title: Tick-flavivirus analysis and host proteomic change following
infection
• Infectious Disease Research in Progress Seminar: Purdue University, IN
2013
• ICTSI Presentation Day: Purdue University, IN
2013
• PULSe Seminar Series Talk: Purdue University, IN
2012
• Annual ASV Meeting: Flavivirus I Section, Madison, WI.
2012
• Entomological Society of America NCB Meeting, University of Nebraska, NE.
2012
• Annual IAS Meeting: Microbio & Mol Bio Section, Purdue University, IN. 2012
• Entomology Methods Seminar: Purdue University, IN
2012
*Poster Presentation Title: LGTV-ISE6 proteomic screen-Langat virus growth in ISE6
cells and host proteomic change
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• ACTS Translational Science Meeting: T0-Basic Scientific Discovery Section,
Omni Shoreham Hotel, Washington D.C.
2014
• Entomological Society of America: Austin Convention Center, Austin, TX 2013
• Annual Indiana CTSI Meeting: IUPUI, Indianapolis, IN
2013
• Arthropod Genomics Symposium, University of Notre Dame, IN
2013
• CTSA National Predoctoral Programs Meeting, Mayo Clinic, Rochester, MN2013
• Interdisciplinary Graduate Program Reception, Purdue University, IN.
2013
• Annual Indiana CTSI Meeting: IUPUI, Indianapolis, IN
2012
• Interdisciplinary Graduate Program Reception, Purdue University, IN.
2012
• Purdue Chapter Sigma Xi Poster Award Competition, Purdue University, IN.2012
• Biological Sciences Retreat, Swan Lake Resort, Plymouth, IN
2011
*Poster Presentation Title: Langat virus growth in ISE6 cells
• Interdisciplinary Graduate Program Reception, Purdue University, IN.
2011
• Entomological Society of America NCB Meeting, University of Minnesota, MN.
2011
• Purdue Chapter Sigma Xi Poster Award Competition, Purdue University, IN.2010
*Purdue University Graduate School Exam Proctor
2009-2010
*Oral Presentation Title: Lyme Disease Dynamics of Southern Kosciusko county, IN
• Manchester College Student Research Symposium, N. Manchester, IN.
2009
• Manchester College Science Seminar, N. Manchester, IN.
2008
Video:
http://users.manchester.edu/Facstaff/CWatson/Seminar/0809/Sept22/Sept22.htm
*Oral Presentation Title: Invasive Earthworms and Nymphal Tick Interaction Dynamics
• Annual IAS Conference: Ecology Section, Indianapolis, IN.
2007
• CIES REU Undergraduate Symposium, Millbrook, NY.
2007
• Manchester College Science Seminar, N. Manchester, IN.
2007
Community/Volunteer Activities:
*Purdue Spring Fest, “Magic Milk,” Purdue University, IN.
2012
Educate students and families on the nature of lipids in milk and how to conduct simple
science.
*Purdue zipTrips Speaker, “Disease Detectives” 7th grade episode.
2009-2011
+Association for Communication Excellence in Agriculture, Natural Resources,
and Life and Human Sciences Silver Award for the 2011 ACE Critique and
Awards Program in the category of Electronic Media, Video: Class 30 programs
+International, world-wide viewed PBS-broadcasted program to encourage
interest in STEM sciences
+Recipient of Purdue 2012 College of Agriculture TEAM Award
+2010 show: video.dis.purdue.edu/bns/Agriculture/zipTrips_101118.wmv
*PULSe Science Night Speaker, “DNA Extraction,” Sunnyside Middle School, IN. 2011
Educate elementary students and families on the nature of DNA and how to conduct
simple science.
*PULSe Science Night Speaker, “Fun with Microscopy,” Dayton Elementary School, IN.
2011
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Educate elementary students and parents on the science of microscopy and
microorganisms.
*Big Ten Graduate Expo, Purdue Graduate School.
2010
Graduate student panel discussion for undergraduate students
*“Sharing Science,” Cary Institute of Ecosystem Studies.
2007
Science-based workshop for underprivileged New York City High school students.
Professional Society Student Membership:
*American Society for Virology (ASV)
*American Society of Tropical Medicine and Hygiene (ASTMH)
*Entomological Society of America
*American Association for the Advancement of Science (AAAS)
*Association for Clinical & Translational Science
*Indiana Academy of Sciences (IAS)
*Wildlife Disease Association

2012-present
2011-present
2011-present
2011-present
2014
2012
2011

Workshops Attended:
*VectorBase Workshop, University of Notre Dame, IN
*Virus Pathogen Resource (ViPR) workshop, Purdue University, IN
Resource link: http://www.viprbrc.org/brc/home.do?decorator=vipr
*Annotating a genome sequence: gene models workshop, Purdue University, IN
Resource link: http://academy.nescent.org/wiki/Next-gen_sequencing

2013
2011
2011

Semester Lectures Attended:
*CHEM 69600: Adv Proteomics, Metabolomics, and Bioinformatics, Purdue University,
IN
spring 2011-2012
*BIOL 41600: Viruses and Viral Disease, Purdue University, IN
spring 2011-2012
spring 2012-2013
Animal Care and Use Training
*Mouse and Rat Handling and Restraint
5/28/2013
*Mouse and Rat Basic Injection Techniques (SC, IP, IM)
6/6/2013
*Mouse and Rat Gas Anesthesia
6/25/2013
*Mouse Euthanasia Techniques, Dissection, and Organ Identification
8/5 and 9/19/13
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